<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Reduction in saturated fat intake for cardiovascular disease - Hooper, L - 2020 | Cochrane Library</title> <meta content="Reduction in saturated fat intake for cardiovascular disease - Hooper, L - 2020 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011737.pub3/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Reduction in saturated fat intake for cardiovascular disease - Hooper, L - 2020 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011737.pub3/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD011737.pub3" name="dc.identifier" scheme="DOI"/> <meta content="Reduction in saturated fat intake for cardiovascular disease" name="citation_title"/> <meta content="Lee Hooper" name="citation_author"/> <meta content="University of East Anglia" name="citation_author_institution"/> <meta content="l.hooper@uea.ac.uk" name="citation_author_email"/> <meta content="Nicole Martin" name="citation_author"/> <meta content="University College London" name="citation_author_institution"/> <meta content="Oluseyi F Jimoh" name="citation_author"/> <meta content="University of East Anglia" name="citation_author_institution"/> <meta content="Christian Kirk" name="citation_author"/> <meta content="University of East Anglia" name="citation_author_institution"/> <meta content="Eve Foster" name="citation_author"/> <meta content="University of East Anglia" name="citation_author_institution"/> <meta content="Asmaa S Abdelhamid" name="citation_author"/> <meta content="University of East Anglia" name="citation_author_institution"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="8" name="citation_issue"/> <meta content="10.1002/14651858.CD011737.pub3" name="citation_doi"/> <meta content="2020" name="citation_date"/> <meta content="2020/08/21" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011737.pub3/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011737.pub3/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD011737.pub3/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Cardiovascular Diseases [mortality, *prevention &amp; control]; Cause of Death; Cholesterol [blood]; Dietary Carbohydrates [administration &amp; dosage]; Dietary Fats [*administration &amp; dosage]; Dietary Fats, Unsaturated [administration &amp; dosage]; Dietary Proteins [administration &amp; dosage]; Energy Intake; Fatty Acids [*administration &amp; dosage]; Myocardial Infarction [mortality, prevention &amp; control]; Randomized Controlled Trials as Topic; Stroke [prevention &amp; control]" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD011737.pub3&amp;doi=10.1002/14651858.CD011737.pub3&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772874000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739772901000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513679709000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513679709000"}};Liferay.authToken="xcg9958b";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD011737\x2epub3\x26doi\x3d10\x2e1002\x2f14651858\x2eCD011737\x2epub3\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011737\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011737\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513679709000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","de","ru","ko","ms","hr","fr","zh_HANS","zh_HANT","ja","fa","pl","ro"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD011737.pub3",title:"Reduction in saturated fat intake for cardiovascular disease",firstPublishedDate:"Aug 21, 2020 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Heart Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734064000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xcg9958b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011737.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011737.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD011737.pub3/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD011737.pub3/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011737.pub3%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD011737.PUB3" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;초록&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;摘要&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;hr&quot;,&quot;title&quot;:&quot;Laički sažetak&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ko&quot;,&quot;title&quot;:&quot;쉬운 말 요약&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;pl&quot;,&quot;title&quot;:&quot;Streszczenie prostym językiem&quot;},{&quot;language&quot;:&quot;ro&quot;,&quot;title&quot;:&quot;Sumar&quot;},{&quot;language&quot;:&quot;ru&quot;,&quot;title&quot;:&quot;Резюме на простом языке&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;简语概要&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]},{&quot;param&quot;: &quot;comments&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Comments&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD011737.pub3/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD011737.PUB3" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD011737.pub3/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD011737.pub3/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>42890 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD011737.pub3" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-abs-0002"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-sec-0077"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-sec-0008"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-sec-0009"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-sec-0011"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-sec-0012"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-sec-0036"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-sec-0069"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/appendices#CD011737-sec-0082"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/supinfo/CD011737StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/supinfo/CD011737StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2020 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Reduction in saturated fat intake for cardiovascular disease</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/information#CD011737-cr-0004"><i class="icon corresponding-author fa fa-envelope"></i>Lee Hooper</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/information#CD011737-cr-0005">Nicole Martin</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/information#CD011737-cr-0006">Oluseyi F Jimoh</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/information#CD011737-cr-0007">Christian Kirk</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/information#CD011737-cr-0008">Eve Foster</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD011737.pub3/information#CD011737-cr-0009">Asmaa S Abdelhamid</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/information/en#CD011737-sec-0102">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 21 August 2020 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD011737.pub3">https://doi.org/10.1002/14651858.CD011737.pub3</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD011737-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011737-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD011737-abs-0011">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011737-abs-0017">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011737-abs-0009">Français</a> </li> <li class="section-language"> <a class="" href="full/ko#CD011737-abs-0005">한국어</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011737-abs-0013">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD011737-abs-0001" lang="en"> <section id="CD011737-sec-0001"> <h3 class="title" id="CD011737-sec-0001">Background</h3> <p>Reducing saturated fat reduces serum cholesterol, but effects on other intermediate outcomes may be less clear. Additionally, it is unclear whether the energy from saturated fats eliminated from the diet are more helpfully replaced by polyunsaturated fats, monounsaturated fats, carbohydrate or protein. </p> </section> <section id="CD011737-sec-0002"> <h3 class="title" id="CD011737-sec-0002">Objectives</h3> <p>To assess the effect of reducing saturated fat intake and replacing it with carbohydrate (CHO), polyunsaturated (PUFA), monounsaturated fat (MUFA) and/or protein on mortality and cardiovascular morbidity, using all available randomised clinical trials. </p> </section> <section id="CD011737-sec-0003"> <h3 class="title" id="CD011737-sec-0003">Search methods</h3> <p>We updated our searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE (Ovid) and Embase (Ovid) on 15 October 2019, and searched Clinicaltrials.gov and WHO International Clinical Trials Registry Platform (ICTRP) on 17 October 2019. </p> </section> <section id="CD011737-sec-0004"> <h3 class="title" id="CD011737-sec-0004">Selection criteria</h3> <p>Included trials fulfilled the following criteria: 1) randomised; 2) intention to reduce saturated fat intake OR intention to alter dietary fats and achieving a reduction in saturated fat; 3) compared with higher saturated fat intake or usual diet; 4) not multifactorial; 5) in adult humans with or without cardiovascular disease (but not acutely ill, pregnant or breastfeeding); 6) intervention duration at least 24 months; 7) mortality or cardiovascular morbidity data available. </p> </section> <section id="CD011737-sec-0005"> <h3 class="title" id="CD011737-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed inclusion, extracted study data and assessed risk of bias. We performed random‐effects meta‐analyses, meta‐regression, subgrouping, sensitivity analyses, funnel plots and GRADE assessment. </p> </section> <section id="CD011737-sec-0006"> <h3 class="title" id="CD011737-sec-0006">Main results</h3> <p>We included 15 randomised controlled trials (RCTs) (16 comparisons, 56,675 participants), that used a variety of interventions from providing all food to advice on reducing saturated fat. The included long‐term trials suggested that reducing dietary saturated fat reduced the risk of combined cardiovascular events by 17% (risk ratio (RR) 0.83; 95% confidence interval (CI) 0.70 to 0.98, 12 trials, 53,758 participants of whom 8% had a cardiovascular event, I² = 67%, GRADE moderate‐quality evidence). Meta‐regression suggested that greater reductions in saturated fat (reflected in greater reductions in serum cholesterol) resulted in greater reductions in risk of CVD events, explaining most heterogeneity between trials. The number needed to treat for an additional beneficial outcome (NNTB) was 56 in primary prevention trials, so 56 people need to reduce their saturated fat intake for ~four years for one person to avoid experiencing a CVD event. In secondary prevention trials, the NNTB was 53. Subgrouping did not suggest significant differences between replacement of saturated fat calories with polyunsaturated fat or carbohydrate, and data on replacement with monounsaturated fat and protein was very limited. </p> <p>We found little or no effect of reducing saturated fat on all‐cause mortality (RR 0.96; 95% CI 0.90 to 1.03; 11 trials, 55,858 participants) or cardiovascular mortality (RR 0.95; 95% CI 0.80 to 1.12, 10 trials, 53,421 participants), both with GRADE moderate‐quality evidence. </p> <p>There was little or no effect of reducing saturated fats on non‐fatal myocardial infarction (RR 0.97, 95% CI 0.87 to 1.07) or CHD mortality (RR 0.97, 95% CI 0.82 to 1.16, both low‐quality evidence), but effects on total (fatal or non‐fatal) myocardial infarction, stroke and CHD events (fatal or non‐fatal) were all unclear as the evidence was of very low quality. There was little or no effect on cancer mortality, cancer diagnoses, diabetes diagnosis, HDL cholesterol, serum triglycerides or blood pressure, and small reductions in weight, serum total cholesterol, LDL cholesterol and BMI. There was no evidence of harmful effects of reducing saturated fat intakes. </p> </section> <section id="CD011737-sec-0007"> <h3 class="title" id="CD011737-sec-0007">Authors' conclusions</h3> <p>The findings of this updated review suggest that reducing saturated fat intake for at least two years causes a potentially important reduction in combined cardiovascular events. Replacing the energy from saturated fat with polyunsaturated fat or carbohydrate appear to be useful strategies, while effects of replacement with monounsaturated fat are unclear. The reduction in combined cardiovascular events resulting from reducing saturated fat did not alter by study duration, sex or baseline level of cardiovascular risk, but greater reduction in saturated fat caused greater reductions in cardiovascular events. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD011737-abs-0002" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD011737-abs-0002">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD011737-abs-0003">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD011737-abs-0012">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD011737-abs-0018">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD011737-abs-0010">Français</a> </li> <li class="section-language"> <a class="" href="full/hr#CD011737-abs-0008">Hrvatski</a> </li> <li class="section-language"> <a class="" href="full/ja#CD011737-abs-0016">日本語</a> </li> <li class="section-language"> <a class="" href="full/ko#CD011737-abs-0006">한국어</a> </li> <li class="section-language"> <a class="" href="full/ms#CD011737-abs-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/pl#CD011737-abs-0019">Polski</a> </li> <li class="section-language"> <a class="" href="full/ro#CD011737-abs-0020">Română</a> </li> <li class="section-language"> <a class="" href="full/ru#CD011737-abs-0004">Русский</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD011737-abs-0014">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD011737-abs-0015">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD011737-abs-0002" lang="en"> <h3>Effect of cutting down on the saturated fat we eat on our risk of heart disease</h3> <p><b>Review question</b> </p> <p>We wanted to find out the effects on health of cutting down on saturated fat in our food (replacing animal fats and hard vegetable fats with plant oils, unsaturated spreads or starchy foods). </p> <p><b>Background</b> </p> <p>Health guidance suggests that reducing the amount of saturated fat we eat, by cutting down on animal fats, is good for our health. We wanted to combine all available evidence to see whether following this advice leads to a reduced risk of dying or getting cardiovascular disease (heart disease or stroke). </p> <p><b>Study characteristics</b> </p> <p>We assessed the effect of cutting down the amount of saturated fat we eat for at least two years on health outcomes including dying, heart disease and stroke. We only looked at studies of adults (18 years or older). They included men and women with and without cardiovascular disease. We did not include studies of acutely ill people or pregnant or breastfeeding women. </p> <p><b>Key results</b> </p> <p>We found 15 studies with over 56,000 participants. The evidence is current to October 2019. The review found that cutting down on saturated fat led to a 17% reduction in the risk of cardiovascular disease (including heart disease and strokes), but had little effect on the risk of dying. The review found that health benefits arose from replacing saturated fats with polyunsaturated fat or starchy foods. The greater the decrease in saturated fat, and the more serum total cholesterol is reduced, the greater the protection from cardiovascular events. People who are currently healthy appear to benefit as much as those at increased risk of heart disease or stroke (people with high blood pressure, high serum cholesterol or diabetes, for example), and people who have already had heart disease or stroke. There was no difference in effect between men and women. </p> <p>This means that, if 56 people without cardiovascular disease, or 53 people who already have cardiovascular disease, reduce their saturated fat for around 4 years, then one person will avoid a cardiovascular event (heart attack or stroke) they would otherwise have experienced. </p> <p><b>Quality of the evidence</b> </p> <p>There is a large body of evidence assessing effects of reducing saturated fat for at least two years. These studies provide moderate‐quality evidence that reducing saturated fat reduces our risk of cardiovascular disease. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD011737-sec-0077" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD011737-sec-0077"></div> <h3 class="title" id="CD011737-sec-0078">Implications for practice</h3> <section id="CD011737-sec-0078"> <p>Evidence supports the reduction of saturated fat to reduce risk of combined cardiovascular events in people with and without existing cardiovascular disease, in men and women, over at least two years and in industrialised countries. Little or no effect of saturated fat reduction was seen on all‐cause and cardiovascular mortality, at least on this timescale. </p> <p>Practical ways to achieve reductions in dietary saturated fat include switching to lower fat dairy foods and cutting off meat fats, as well as reducing intake of foods high in saturated fats such as cakes, biscuits, pies and pastries, butter, ghee, lard, palm oil, sausages and cured meats, hard cheese, cream, ice cream, milkshakes and chocolate (for further details see <a href="./references#CD011737-bbs2-0409" title="NHS. How to eat less saturated fat. www.nhs.uk/live-well/eat-well/eat-less-saturated-fat/ (accessed 11 Feb 2020).">NHS 2020</a>). </p> </section> <h3 class="title" id="CD011737-sec-0079">Implications for research</h3> <section id="CD011737-sec-0079"> <p>To complement this review of long‐term RCTs, we need reviews of metabolic studies to clarify the effects of specific replacements for saturated fat in the diet, and systematic reviews of cohort studies to clarify longer‐term effects of saturated fat reductions. </p> <p>The financial implications (costs and savings) of appropriate advice and legislation to modify fat intake in those at various levels of cardiovascular risk should be assessed and reflected in health policy. Whilst interventions to alter dietary fat intake in individuals at high cardiovascular risk have been fairly successful, such health promotion initiatives in the general population have been less successful. Further work is needed to help high‐ and low‐risk individuals to make effective changes to reduce saturated fat and to maintain these changes over their lifetimes. Research into the effects of legislation to alter fat contents of foods, improved labelling, pricing initiatives and improved availability of healthier foods, linking food production and processing into the health agenda, may yield huge advances in this area. </p> <p>It is not clear whether there is an additional benefit of reducing saturated fat in those at high risk of cardiovascular disease who are on lipid‐lowering medication. Further research to examine the need for maintenance of reduced saturated fat whilst on lipid‐lowering medication would be useful, but not as useful as understanding specific dietary fat replacements for saturated fat. However, we did not identify any relevant ongoing trials in our searches. </p> <p>All future trials should be of at least 2 years duration (preferably longer), employ excellent methodology in terms of randomisation and allocation concealment, blinding of outcome assessors, high‐quality assessment of macronutrients and micronutrients during the trial in both arms, and equivalent attention and health professional time to participants in both arms. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD011737-sec-0008" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD011737-sec-0008"></div> <div class="table" id="CD011737-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Effect of reducing saturated fat compared to usual saturated fat on CVD risk in adults (note: for the full set of GRADE tables see additional tables 24 to 28)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Low saturated fat compared with usual saturated fat for CVD risk</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: people at any baseline risk of CVD</b> </p> <p><b>Intervention: lower saturated fat intake</b> </p> <p><b>Comparison: higher saturated fat intake</b> </p> <p><b>Settings: Any, including community‐dwelling and institutions. Included RCTs were conducted in North America, Europe and Australia/New Zealand, no studies were carried out in industrialising or developing countries.</b> </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Anticipated absolute effects (95% CI)</b> </p> </td> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Risk with higher SFA intake</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk with lower SFA intake</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> <p>follow‐up mean duration 56 months<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.96</b> (0.90 to 1.03) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>62 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 per 1000</p> <p>(56 to 64)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55,858<br/>(12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>2,3,4,5,6</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical importance. Reducing saturated fat intake probably makes little or no difference to all‐cause mortality. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cardiovascular mortality</b> </p> <p>follow‐up mean duration 53 months<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.94</b> (0.78 to 1.13) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>19 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18 per 1000<br/>(15 to 22) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53,421<br/>(11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>2,3,4,6,7</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical importance. Reducing saturated fat intake probably makes little or no difference to cardiovascular mortality. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Combined cardiovascular events</b> </p> <p>follow‐up mean duration 52 months<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.83</b> (0.70 to 0.98) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>85 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70 per 1000</p> <p>(59 to 83)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53,758<br/>(13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>4,8,9,10,11</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical importance. Reducing saturated fat intake probably reduces cardiovascular events (to a greater extent with greater cholesterol reduction). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Myocardial infarctions</b> </p> <p>follow‐up mean duration 55 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.90</b> (0.80 to 1.01) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>32 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29 per 1000</p> <p>(25 to 32)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53,167<br/>(11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very</b> <b>Low <sup>3,4,5,11,12</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical importance. The effect of reducing saturated fat intake on risk of myocardial infarction is unclear as the evidence is of very low quality. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Non‐fatal MI</b> </p> <p>follow‐up mean duration 55 months<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.97</b> (0.87 to 1.07) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>26 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25 per 1000</p> <p>(23 to 28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52,834<br/>(8) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>3,4,5,6,13</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical importance. Reducing saturated fat may have little or no effect on risk of non‐fatal myocardial infarction. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Stroke</b> </p> <p>follow‐up mean duration 59 months<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.92</b> (0.68 to 1.25) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>22 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20 per 1000</p> <p>(15 to 27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50,952<br/>(7) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very</b> <b>Low <sup>3,4,6,13,14</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical importance. The effect of reducing saturated fat on the risk of stroke is unclear as the evidence was of very low quality. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CHD mortality</b> </p> <p>follow‐up mean duration 65 months<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.97</b> (0.82 to 1.16) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>16 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 per 1000</p> <p>(13 to 19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53,159<br/>(9) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>2,3,4,6,14</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical importance. Reducing saturated fat intake may have little or no effect on CHD mortality. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CHD events</b> </p> <p>follow‐up mean duration 59 months<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.83</b> (0.68 to 1.01) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>42 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35 per 1000</p> <p>(29 to 43)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53,199<br/>(11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very</b> <b>low <sup>4,5,6,12,15</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical importance. The effect of reducing saturated fat on risk of CHD events is unclear as the evidence is of very low quality. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; CHD: coronary heart disease. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Minimum study duration was 24 months. </p> <p><sup>2</sup><b>Risk of bias.</b> Limiting trials to those at low summary risk of bias also suggested little or no effect. Not downgraded. </p> <p><sup>3</sup><b>Inconsistency</b>. We found no important heterogeneity; I² ≤ 30%. Not downgraded. </p> <p><sup>4</sup><b>Indirectness</b>. These RCTs directly assessed the effect of lower vs higher saturated fat intake on health outcomes of interest. Participants included men and women with and without CVD at baseline (also some participants with CVD risk factors like diabetes, or at risk of cancers). However, no trials included participants from developing countries. Not downgraded. </p> <p><sup>5</sup><b>Imprecision</b>. The 95% CI includes both no effect and a benefit. Downgraded once. </p> <p><sup>6</sup><b>Publication bias</b>. The funnel plot, and comparison of fixed‐ and random‐effects meta‐analyses did not suggest major small‐study (publication) bias. Not downgraded. </p> <p><sup>7</sup><b>Imprecision</b>. The 95% CI includes both harm and benefit. Downgraded once. </p> <p><sup>8</sup><b>Risk of bias.</b> Limiting trials to those at low summary risk of bias suggested a smaller and non‐statistically significant effect (RR 0.96, 95% CI 0.76 to 1.20) suggesting little or no effect on risk of CVD events. Downgraded once (along with publication bias). </p> <p><sup>9</sup><b>Inconsistency</b>. Although heterogeneity was high, I² = 65%, this was mostly explained by the degree of cholesterol‐lowering (a dose effect). Not downgraded. </p> <p><sup>10</sup><b>Imprecision</b>. The 95% CI includes only benefit or minimal effect. Not downgraded. </p> <p><sup>11</sup><b>Publication bias</b>. The funnel plot did not suggest publication bias, but comparison of fixed‐ and random‐effects meta‐analyses suggested possible small‐study (publication) bias. Downgraded once (along with risk of bias, downgraded once in total). </p> <p><sup>12</sup><b>Risk of bias.</b> Limiting trials to those at low summary risk of bias moved the RR slightly towards 1.0, suggesting little or no effect on total MI. Downgraded once. </p> <p><sup>13</sup><b>Risk of bias.</b> Limiting trials to those at low summary risk of bias moved the RR slightly away from 1.0, suggesting that reducing SFA reduces the risk of non‐fatal MI. This was also seen in several other sensitivity analyses. Downgraded once. </p> <p><sup>14</sup><b>Imprecision</b>. The 95% CI includes both important benefits and important harms. Downgraded twice. </p> <p><sup>15</sup><b>Inconsistency</b>. Heterogeneity was high, I² = 65%. Downgraded once. </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD011737-sec-0009" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD011737-sec-0009"></div> <p>In 1949, Ryle and Russell in Oxford documented a dramatic increase in coronary heart disease (CHD), and the Registrar General’s Statistical Tables of 1920 to 1955 showed that there had been a 70‐fold increase in coronary deaths during this 35‐year period (<a href="./references#CD011737-bbs2-0413" title="OliverMF . Pioneer research in Britain into atherosclerosis and coronary heart disease - an historical review. Atherosclerosis2000;150(1):1-12.">Oliver 2000</a>; <a href="./references#CD011737-bbs2-0422" title="RyleJA , RussellWT . The natural history of coronary disease. A clinical and epidemiological study. British Heart Journal1949;11(4):370.">Ryle 1949</a>). This sudden surge in coronary heart disease sparked research into its causes. A case‐control study published in 1953 of 200 post‐myocardial infarction patients and age‐matched controls established that those with disease had higher plasma cholesterol levels (<a href="./references#CD011737-bbs2-0412" title="OliverMF , BoydGS . The plasma lipids in coronary artery disease. British Heart Journal1953;15(4):387-90.">Oliver 1953</a>). </p> <p>Meanwhile in 1949 in the USA, Gofman had separated lipids into lipoprotein classes through ultra centrifugation, describing the LDL as ‘atherosclerogenic’ (<a href="./references#CD011737-bbs2-0372" title="GofmanJW , LindgrenFT , ElliottHA . Ultracentrifugal studies of lipoproteins of human serum. Journal of Biological Chemistry1949;179(2):973-9.">Gofman 1949</a>). The following year <a href="./references#CD011737-bbs2-0391" title="KeysA , MickelsenO , MillerEV , CarletonB . The relation in man between cholesterol levels in the diet and in the blood. Science1950;112(2899):79-81.">Keys 1950</a> proposed that the concentration of plasma cholesterol was proportional to dietary saturated fatty acids (SFA) intake. This relationship was confirmed in work by Hegsted (<a href="./references#CD011737-bbs2-0379" title="HegstedDM , McGandyRB , MyersML , StareFJ . Quantitative effects of dietary fat on serum cholesterol in man. American Journal of Clinical Nutrition1965;17(5):281-95.">Hegsted 1965</a>; <a href="./references#CD011737-bbs2-0380" title="HegstedDM . From chick nutrition to nutrition policy. Annual Review of Nutrition2000;20:1-19.">Hegsted 2000</a>), who published an equation explaining the relationship in 1965 and subsequently in 2000. The equation suggests that dietary saturated fat increases serum cholesterol and so increases cardiovascular (CV) risk, while polyunsaturated fats (PUFA) reduce both. This has since been further refined: </p> <p>Δ serum cholesterol (in mg/dL) = 2.16 * Δ dietary saturated fat intake (as percentage of energy) – 1.65 * Δ dietary PUFA intake (as percentage of energy, %E) + 6.77 * Δ dietary cholesterol intake (in units of 100 mg/day) – 0.53 </p> <p>The Seven Countries Study compared CHD mortality in 12,000 men aged 40 to 59 in seven countries, and found positive correlations between CHD mortality and total fat intake in 1970, then in 1986 between CHD mortality and saturated fat intake (<a href="./references#CD011737-bbs2-0392" title="KeysA , MenottiA , KarvonenMJ , AravanisC , BlackburnH , BuzinaRM , et al. The diet and 15-year death rate in the seven countries study. American Journal of Epidemiology1986;124(6):903-15.">Keys 1986</a>; <a href="./references#CD011737-bbs2-0439" title="ThorogoodM . Nutrition. In: LawrenceM , NeilA , MantD , FowlerG , editors(s). Prevention of Cardiovascular Disease: an Evidence-Based Approach. Kings Lynn: Oxford University Press, 1996:54-66.">Thorogood 1996</a>). A migrant study of Japanese men living in different cultures confirmed in 1974 that men in California had the diet richest in saturated fat and cholesterol, and the highest CHD rates, those in Hawaii had intermediate saturated fat and CHD rates, and those in Japan had a diet lowest in saturated fat and cholesterol, and the least CHD (<a href="./references#CD011737-bbs2-0388" title="KaganA , HarrisBR , Winkelstein W Jr, JohnsonKG , KatoH , SymeSL , et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: demographic, physical, dietary and biochemical characteristics. Journal of Chronic Disease1974;27(7-8):345-64.">Kagan 1974</a>; <a href="./references#CD011737-bbs2-0419" title="RobertsonTL , KatoH , RhoadsGG , KaganA , MarmotM , SymeSL , et al. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California. Incidence of myocardial infarction and death from coronary heart disease. American Journal of Cardiology1977;39(2):239-43.">Robertson 1977</a>). However, systematic reviews of the observational data have not confirmed these early studies. <a href="./references#CD011737-bbs2-0434" title="SkeaffCM , MillerJ . Dietary fat and coronary heart disease: summary of evidence from prospective cohort and randomised controlled trials. Annals of Nutrition and Metabolism2009;55(1-3):173-201.">Skeaff 2009</a> included 28 USA and European cohorts (including 6600 CHD deaths among 280,000 participants) investigating the effects of total, saturated, monounsaturated, trans and omega‐3 fats on CHD deaths and events. They found no clear relationship between total, saturated or monounsaturated fat (MUFA) intake and coronary heart disease events or deaths. There was evidence that trans fats increased both coronary heart disease events and deaths, and that total PUFAs and omega‐3 fats decreased them. Intervention studies are needed to clarify cause and effect, to ensure that confounding is not hiding true relationships, or suggesting relationships where they do not exist. Trials also directly address the issue of whether altering dietary saturated fat in adults is helpful in reducing the risk of CVD in the general population and in those at high risk. Intervention trials are crucial in forming the basis of evidence‐based practice in this area. </p> <p>Most intervention studies have assessed effects of dietary interventions on risk factors for heart disease, and separate work ties the effect of altering these risk factors to changes in disease incidence and mortality. Systematic reviews in this area follow the same pattern. There are systematic reviews of the effect of dietary fat advice on serum lipid levels (<a href="./references#CD011737-bbs2-0359" title="BrunnerE , WhiteI , ThorogoodM , BristowA , CurleD , MarmotM . Can dietary interventions change diet and cardiovascular risk factors? A meta-analysis of randomized controlled trials. American Journal of Public Health1997;87(9):1415-22.">Brunner 1997</a>; <a href="./references#CD011737-bbs2-0362" title="ClarkeR , FrostC , CollinsR , ApplebyP , PetoR . Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ1997;314(7074):112-7.">Clarke 1997</a>; <a href="./references#CD011737-bbs2-0367" title="DenkeMA . Cholesterol-lowering diets. A review of the evidence. Archives of Internal Medicine1995;155(1):17-26.">Denke 1995</a>; <a href="./references#CD011737-bbs2-0393" title="KodamaS , SaitoK , TanakaS , MakiM , YachiY , SatoM , et al. Influence of fat and carbohydrate proportions on the metabolic profile in patients with type 2 diabetes: a meta-analysis. Diabetes Care2009;32(5):959-65.">Kodama 2009</a>; <a href="./references#CD011737-bbs2-0402" title="MalhotraA , ShafiqN , AroraA , SinghM , KumarR , MalhotraS . Dietary interventions (plant sterols, stanols, omega-3 fatty acids, soy protein and dietary fibers) for familial hypercholesterolaemia. Cochrane Database of Systematic Reviews2014, Issue 6. Art. No: CD001918. [DOI: 10.1002/14651858.CD001918.pub3]">Malhotra 2014</a>; <a href="./references#CD011737-bbs2-0404" title="MensinkRP , KatanMB . Effect of dietary fatty acids on serum lipids and lipoproteins: a meta-analysis of 27 trials. Arteriosclerosis and Thrombosis1992;12(8):911-9.">Mensink 1992</a>; <a href="./references#CD011737-bbs2-0405" title="MensinkRP , ZockPL , KesterADM , KatanMB . Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. American Journal of Clinical Nutrition2003;77(5):1146-55.">Mensink 2003</a>; <a href="./references#CD011737-bbs2-0417" title="ReesK , DyakovaM , WilsonN , WardK , ThorogoodM , BrunnerE . Dietary advice for reducing cardiovascular risk. Cochrane Database of Systematic Reviews2013, Issue 12. Art. No: CD002128. [DOI: 10.1002/14651858.CD002128.pub5]">Rees 2013</a>; <a href="./references#CD011737-bbs2-0441" title="WeggemansRM , ZockPL , KatanMB . Dietary cholesterol from eggs increases the ratio of total cholesterol to high-density lipoprotein cholesterol in humans: a meta-analysis. American Journal of Clinical Nutrition2001;73(5):885-91.">Weggemans 2001</a>; <a href="./references#CD011737-bbs2-0444" title="Yu-PothS , ZhaoG , EthertonT , NaglakM , JonnalagaddaS , Kris-EthertonPM . Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. American Journal of Clinical Nutrition1999;69(4):632-46.">Yu‐Poth 1999</a>), suggesting that dietary changes cause changes in serum lipids. There are also systematic reviews on the effect of lipid level alterations on CV morbidity and mortality (<a href="./references#CD011737-bbs2-0357" title="BrielM , Ferreira-GonzalezI , YouJJ , KaranicolasPJ , AklEA , WuP , et al. Association between change in high density lipoprotein cholesterol and cardiovascular disease morbidity and mortality: systematic review and meta-regression analysis. BMJ2009;338:b92. [DOI: 10.1136/bmj.b92]">Briel 2009</a>; <a href="./references#CD011737-bbs2-0365" title="De CaterinaR , ScaranoM , MarfisiRM , LucisanoG , PalmaF , TatascioreA , et al. Cholesterol-lowering interventions and stroke. Journal of the American College of Cardiology2010;55(3):198-211.">De Caterina 2010</a>; <a href="./references#CD011737-bbs2-0396" title="LawMR , WaldNJ , ThompsonSG . By how much and how quickly does reduction in serum cholesterol concentration lower risk of ischaemic heart disease?BMJ1994;308(6925):367-73.">Law 1994</a>; <a href="./references#CD011737-bbs2-0420" title="RobinsonJG , WangS , SmithBJ , JacobsonTA . Meta-analysis of the relationship between non-high-density lipoprotein cholesterol reduction and coronary heart disease risk. Journal of the American College of Cardiology2009;53(4):316-22.">Robinson 2009</a>; <a href="./references#CD011737-bbs2-0421" title="RubinsHB . Cholesterol in patients with coronary heart disease: how low should we go?Journal of General Internal Medicine1995;10(8):464-71.">Rubins 1995</a>; <a href="./references#CD011737-bbs2-0440" title="WalshJME , GradyD . Treatment of hyperlipidaemia in women. JAMA1995;274(14):1152-8.">Walsh 1995</a>), suggesting that changes in lipids do affect CVD risk. Other risk factors dealt with in a similar way are blood pressure (<a href="./references#CD011737-bbs2-0360" title="BucherHC , CookRJ , GuyattGH , LangJD , CookDJ , HatalaR , et al. Effects of dietary calcium supplementation on blood pressure: a meta-analysis of randomised controlled trials. JAMA1996;275(13):1016-22.">Bucher 1996</a>; <a href="./references#CD011737-bbs2-0395" title="LawMR , FrostCD , WaldNJ . By how much does dietary salt restriction lower blood pressure?BMJ1991;302(6780):811-24.">Law 1991</a>; <a href="./references#CD011737-bbs2-0429" title="ShahM , Adams-HuetB , GargA . Effect of high-carbohydrate or high-cis-monounsaturated fat diets on blood pressure: a meta-analysis of intervention trials. American Journal of Clinical Nutrition2007;85(5):1251-6.">Shah 2007</a>), body weight or fatness (<a href="./references#CD011737-bbs2-0352" title="AstrupA , RyanL , GrunwaldGK , StorgaardM , SarisW , MelansonE , et al. The role of dietary fat in body fatness: evidence from a preliminary meta-analysis of ad libitum low-fat dietary intervention studies. British Journal of Nutrition2000;83(Suppl 1):S25-32.">Astrup 2000</a>; <a href="./references#CD011737-bbs2-0381" title="HessionM , RollandC , KulkarniU , WiseA , BroomJ . Systematic review of randomized controlled trials of low-carbohydrate vs. low-fat/low-calorie diets in the management of obesity and its comorbidities. Obesity Reviews2009;10(1):36-50.">Hession 2009</a>; <a href="./references#CD011737-bbs2-0432" title="Scottish Intercollegiate Guidelines Network. Management of obesity (national guideline). https://www.sign.ac.uk/sign-115-management-of-obesity (accessed prior to 30 April 2020);115.">SIGN 1996</a>), angiographic measurements (<a href="./references#CD011737-bbs2-0403" title="MarchioliR , PrietoJC , TognoniG . Surrogate end-points: the case of trials on coronary atherosclerotic plaque regression. Clinical Trials and Meta-Analyses1994;29(2-3):139-76.">Marchioli 1994</a>), antioxidant intake (<a href="./references#CD011737-bbs2-0408" title="NessAR , PowlesJW . Fruit and vegetables, and cardiovascular disease: a review. International Journal of Epidemiology1997;26(1):1-13.">Ness 1997</a>), metabolic profile (<a href="./references#CD011737-bbs2-0393" title="KodamaS , SaitoK , TanakaS , MakiM , YachiY , SatoM , et al. Influence of fat and carbohydrate proportions on the metabolic profile in patients with type 2 diabetes: a meta-analysis. Diabetes Care2009;32(5):959-65.">Kodama 2009</a>) and alcohol intake (<a href="./references#CD011737-bbs2-0418" title="RimmEB , KlatskyA , GrobbeeD , StampferMJ . Review of moderate alcohol consumption and reduced risk of coronary heart disease: is the effect due to beer, wine or spirits?BMJ1996;312(7033):731-6.">Rimm 1996</a>). A problem with this two‐level approach is that any single dietary alteration may have effects over a wide range of risk factors for CVD. An example of this is the choice of substitution of saturated fats by carbohydrate, PUFAs, MUFAs or protein in the diet. This choice may alter lipid profile, and may also affect blood pressure, body weight, oxidative state, rate of cholesterol efflux from fibroblasts, insulin resistance, post‐prandial triacylglycerol response, blood clotting factors, and platelet aggregation. There may also be further risk factors of which we are not yet aware. Evidence of beneficial effect on one risk factor does not rule out an opposite effect on another unstudied risk factor, and therefore an overall null (or harmful) effect of intervention. While understanding the effects of dietary advice on intermediate risk factors helps to ensure diets are truly altered by advice, and illuminates mechanisms, the best way of combining the effects on all of these risk factors is to not study risk factors, but to study the effects of dietary change on important outcomes, on CV morbidity and mortality, and on total mortality. </p> <p>Substantial randomised controlled trial data on the effects of dietary fat on mortality and morbidity do exist and have been previously reviewed (<a href="./references#CD011737-bbs2-0350" title="AbdelhamidAS , BrownTJ , BrainardJS , BiswasP , ThorpeGC , MooreHJ , DeaneKHO , SummerbellCD , WorthingtonHV , SongF , HooperL . Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2020, Issue 3. Art. No: CD003177. [DOI: 10.1002/14651858.CD003177.pub5] [CD003177]">Abdelhamid 2020</a>; <a href="./references#CD011737-bbs2-0348" title="AbdelhamidAS , MartinN , BridgesC , BrainardJS , WangX , BrownTJ , et al. Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2018, Issue 11. Art. No: CD012345. [DOI: 10.1002/14651858.CD012345.pub2] [CD012345]">Abdelhamid 2018</a>; <a href="./references#CD011737-bbs2-0349" title="AbdelhamidAS , HooperL , SivakaranR , HayhoeR , WelchAA , PUFAH Group. The relationship between omega-3, omega-6 and total polyunsaturated fat and musculoskeletal health and functional status in adults: a systematic review and meta-analysis of RCTs. Calcified Tissue International2019;105(4):353-72. [DOI: 10.1007/s00223-019-00584-3]">Abdelhamid 2019</a>; <a href="./references#CD011737-bbs2-0356" title="BrainardJ , JimohOF , DeaneK , BiswasP , DonaldsonD , MaasK , et al. Omega-3, omega-6, and polyunsaturated fat for cognition: systematic review and meta-analysis of randomized trials. Journal of the American Medical Directors Association2020;15 April 2020 [Epub ahead of print]. [DOI: 10.1016/j.jamda.2020.02.022]">Brainard 2020</a>; <a href="./references#CD011737-bbs2-0358" title="BrownTJ , BrainardJ , SongF , WangX , AbdelhamidA , HooperL . Omega-3, omega-6, and total dietary polyunsaturated fat for prevention and treatment of type 2 diabetes mellitus: systematic review and meta-analysis of randomised controlled trials. BMJ2019;366:l4697.">Brown 2019</a>; <a href="./references#CD011737-bbs2-0366" title="DeaneKHO , JimohOF , BiswasP , O'BrienA , HansonS , AbdelhamidAS , et al. Omega-3 and polyunsaturated fat for prevention of depression and anxiety symptoms: systematic review and meta-analysis of randomised trials. British Journal of Psychiatry 2019 Oct 24 [E-pub ahead of print]. [DOI: 10.1192/bjp.2019.234]">Deane 2019</a>; <a href="./references#CD011737-bbs2-0376" title="HansonS , ThorpeG , WinstanleyL , AbdelhamidAS , HooperL , PUFAH Group. Omega-3, omega-6 and total dietary polyunsaturated fat on cancer incidence: systematic review and meta-analysis of randomised trials. British Journal of Cancer2020;122:1260-70. [DOI: 10.1038/s41416-020-0761-6]">Hanson 2020</a>; <a href="./references#CD011737-bbs2-0385" title="HooperL , Al-KhudairyL , AbdelhamidAS , ReesK , BrainardJS , BrownTJ , et al. Omega-6 fats for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews2018, Issue 11. Art. No: CD011094. [DOI: 10.1002/14651858.CD011094.pub3] [CD011094]">Hooper 2018</a>; <a href="./references#CD011737-bbs2-0386" title="HooperL , AbdelhamidA , BrainardJ , DeaneKHO , SongF . Creation of a database to assess effects of omega-3, omega-6 and total polyunsaturated fats on health: database and methodology for a set of reviews. BMJ Open2019;9(5):e029554. [DOI: 10.1136/bmjopen-2019-029554]">Hooper 2019</a>; <a href="./references#CD011737-bbs2-0448" title="HooperL , SummerbellCD , ThompsonR , SillsD , RobertsFG , MooreHJ , et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database of Systematic Reviews2012, Issue 5. Art. No: CD002137. [DOI: 10.1002/14651858.CD002137.pub3]">Hooper 2012</a>). A recent very large trial, the Women's Health Initiative, that included over 2000 women with, and over 48,000 women without, CVD at baseline for over eight years (<a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>)) has raised many questions about both the effects of fat on health and on how we best conduct research to understand the relationship (<a href="./references#CD011737-bbs2-0353" title="AstrupA , DyerbergJ , ElwoodP , HermansenK , HuFB , JakobsenMU , et al. The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: where does the evidence stand in 2010?American Journal of Clinical Nutrition2011;93(4):684–8.">Astrup 2011</a>; <a href="./references#CD011737-bbs2-0406" title="MichelsKB , WillettWC . The Women's Health Initiative randomized controlled dietary modification trial: a post-mortem. Breast Cancer Research and Treatment2009;114(1):1-6.">Michels 2009</a>; <a href="./references#CD011737-bbs2-0416" title="PrenticeRL . Observational studies, clinical trials, and the Women's Health Initiative. Lifetime Data Analysis2007;13(4):449-62.">Prentice 2007</a>; <a href="./references#CD011737-bbs2-0436" title="SteinK . After the media feeding frenzy: whither the Women's Health Initiative Dietary Modification Trial?Journal of the American Dietetic Association2006;106(6):794-800.">Stein 2006</a>; <a href="./references#CD011737-bbs2-0443" title="YngveA , HambraeusL , LissnerL , Serra MajemL , Vaz de AlmeidaMD , BergC , et al. Invited Commentary. The Women's Health Initiative. What is on trial: nutrition and chronic disease? Or misinterpreted science, media havoc and the sound of silence from peers. Public Health Nutrition2006;9(2):269-72.">Yngve 2006</a>). We incorporated these findings into an update of a Cochrane review on dietary fat and CVD risk with a search in 2010 (<a href="./references#CD011737-bbs2-0448" title="HooperL , SummerbellCD , ThompsonR , SillsD , RobertsFG , MooreHJ , et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database of Systematic Reviews2012, Issue 5. Art. No: CD002137. [DOI: 10.1002/14651858.CD002137.pub3]">Hooper 2012</a>), finding reductions in cardiovascular events in studies that modified dietary fat, and in studies of at least two years' duration, but not in studies of fat reduction or studies with less than two years' follow‐up. </p> <section id="CD011737-sec-0010"> <h3 class="title" id="CD011737-sec-0010">Why it is important to do this review</h3> <p>Public health dietary advice on prevention of cardiovascular disease (CVD) has changed over time, with a focus on fat modification during the 1960s and fat reduction during the 1990s following the introduction of USA and UK dietary guidance on fat reduction, limiting saturated fat intake to 10% of energy (<a href="./references#CD011737-bbs2-0377" title="HarcombeZ , BakerJS , CooperSM , DaviesB , SculthorpeN , DiNicolantonioJJ , et al. Evidence from randomised controlled trials did not support the introduction of dietary fat guidelines in 1977and 1983: a systematic review and meta-analysis. Open Heart2015;2(1):e000196. [DOI: 10.1136/openhrt-2014-000196]">Harcombe 2015</a>). In 2006, recommendations by the American Heart Association suggested that, among other dietary measures, Americans should "limit intake of saturated fat to 7% of energy, trans fat to 1% of energy, and cholesterol to 300 mg/day by choosing lean meats and vegetable alternatives, fat‐free (skim) or low‐fat (1% fat) dairy products and minimise intake of partially hydrogenated fats" (<a href="./references#CD011737-bbs2-0399" title="LichtensteinAH , AppelLJ , BrandsM , CarnethonM , DanielsS , FranchHA , et al. Diet and lifestyle recommendations revision 2006: a scientific statement from the American Heart Association Nutrition Committee. Circulation2006;114(1):82-96.">Lichtenstein 2006</a>). Current American Heart Association guidelines suggest that Americans should "Aim for a dietary pattern that achieves 5% to 6% of calories from saturated fat" and "Reduce percent of calories from saturated fat" (both graded as strong evidence on the basis of effects on serum lipids ‐ trials with cardiovascular outcomes are not referenced or discussed, <a href="./references#CD011737-bbs2-0369" title="EckelRH , JakicicJM , ArdJD , De JesusJM , Houston MillerN , HubbardVS , et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation2013;129(25 suppl 2):S76-99. [DOI: 10.1161/01.cir.0000437740.48606.d1]">Eckel 2013</a>). European guidance on the treatment of dyslipidaemia is similarly based on dietary effects on lipids, recommending reduction in saturated fats (<a href="./references#CD011737-bbs2-0371" title="Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). ESC/EAS Guidelines for the management of dyslipidaemias. European Heart Journal2011;32(14):1769-1818. [DOI: 10.1093/eurheartj/ehr158]">ESC/EAS 2011</a>) and referencing <a href="./references#CD011737-bbs2-0405" title="MensinkRP , ZockPL , KesterADM , KatanMB . Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. American Journal of Clinical Nutrition2003;77(5):1146-55.">Mensink 2003</a>, while the Joint British Societies' guidance on preventing CVD recommends a healthy diet including low saturated fat intake (<a href="./references#CD011737-bbs2-0401" title="MachF , BaigentC , CatapanoAL , KoskinasKC , CasulaM , BadimonL , et al. 2019 ESC/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Atherosclerosis2019;290:140-205.">Mach 2019</a>), referencing a variety of evidence including several recent systematic reviews. This is reflected in UK Scientific Advisory Committee on Nutrition recommendations that "dietary reference value for saturated fats remains unchanged: the [population] average contribution of saturated fatty acids to [total] dietary energy be reduced to no more than about 10%", and that "saturated fats are substituted with unsaturated fats. More evidence is available supporting substitution with PUFA than substitution with MUFA" (<a href="./references#CD011737-bbs2-0423" title="Scientific Advisory Committee on Nutrition. Saturated fat and health. www.gov.uk/government/publications/saturated-fats-and-health-sacn-report (accessed prior to 30 April 2020).">SACN 2019</a>). </p> <p>Recent UK National Institute for Health and Care Excellence<b>(</b>NICE) guidance suggests that for people at high risk of or with CVD that they "eat a diet in which total fat intake is 30% or less of total energy intake, saturated fats are 7% or less of total energy intake, intake of dietary cholesterol is less than 300 mg/day and where possible saturated fats are replaced by monounsaturated and polyunsaturated fats". This statement was based on long‐term randomised controlled trials reporting hard outcomes, and NICE separately assessed effects of high polyunsaturated diets, including four of the trials included in this review (<a href="./references#CD011737-bbs2-0410" title="National Institute of Health and Care Excellence. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. www.nice.org.uk/guidance/cg181/resources/guidance-lipid-modification-cardiovascular-risk-assessment-and-the-modification-of-blood-lipids-for-the-primary-and-secondary-prevention-of-cardiovascular-disease-pdf (accessed 29th Dec 2019).">NICE 2014</a>). </p> <p>We were interested in assessing the direct evidence from trials of the effects of reducing saturated fats, and considering what macronutrients the saturated fats were replaced by, updating <a href="./references#CD011737-bbs2-0449" title="HooperL , MartinN , JimohOF , AbdelhamidAS . Reduction in saturated fat intake for cardiovascular disease. Cochrane Database of Systematic Reviews2015, Issue 6. Art. No: CD011737. [DOI: 10.1002/14651858.CD011737]">Hooper 2015a</a>. This update also supports a request from the World Health Organization Nutrition Guidance Expert Advisory Group (WHO NUGAG) to more accurately assess effects of reducing saturated fats on all‐cause mortality, CV morbidity and other health outcomes, and to consider the differential effects on health outcomes of replacement of the energy from saturated fat by other fats, carbohydrates or protein. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD011737-sec-0011" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD011737-sec-0011"></div> <p>To assess the effect of reducing saturated fat intake and replacing it with carbohydrate (CHO), polyunsaturated (PUFA) or monounsaturated fat (MUFA) and/or protein on mortality and cardiovascular morbidity, using all available randomised clinical trials. </p> <p>Additional World Health Organization Nutrition Guidance Expert Advisory Group (WHO NUGAG) specific questions included: </p> <p> <ol id="CD011737-list-0001"> <li> <p>In adults, what is the effect in the population of reduced percentage of energy (%E) intake from saturated fatty acids (SFA) relative to higher intake for reduction in risk of noncommunicable diseases (NCDs)? </p> </li> <li> <p>What is the effect on coronary heart disease mortality and coronary heart disease events? </p> </li> <li> <p>What is the effect in the population of replacing SFA with polyunsaturated fats (PUFAs), monounsaturated fats (MUFAs), carbohydrates (CHO) (refined versus unrefined), protein or trans fatty acids (TFAs) relative to no replacement for reduction in risk of NCDs? </p> </li> <li> <p>What is the effect in the population of consuming &lt; 10%E as SFA relative to &gt; 10%E as SFA for reduction in risk of NCDs? </p> </li> <li> <p>What is the effect in the population of a reduction in %E from SFA from 10% in gradual increments relative to higher intake for reduction in risk of NCDs? </p> </li> </ol> </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD011737-sec-0012" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD011737-sec-0012"></div> <section id="CD011737-sec-0013"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD011737-sec-0014"> <h4 class="title">Types of studies</h4> <p>Randomised controlled trials only. We accepted randomisation of individuals, or of larger groups (clusters) where there were at least six of these groups randomised. We excluded studies where allocation was not truly randomised (e.g. divisions based on days of the week or first letter of the family name), or where allocation was not stated as randomised, and no further information was available from the authors. </p> </section> <section id="CD011737-sec-0015"> <h4 class="title">Types of participants</h4> <p>We included studies of adults (18 years or older, no upper age limit) at any risk of cardiovascular disease, with or without existing cardiovascular disease, using or not using lipid‐lowering medication. Participants could be of either gender, but we excluded those who were acutely ill, pregnant or lactating. </p> </section> <section id="CD011737-sec-0016"> <h4 class="title">Types of interventions</h4> <p>We included randomised controlled trials stating an intention to reduce saturated fat (SFA) intake (by suggesting appropriate nutrient‐based or food‐based aims) OR which provided a general dietary aim, such as improving heart health or reducing total fat, that also achieved a statistically significant saturated fat reduction (P &lt; 0.05) during the trial in the intervention arm compared with the control arm. The intervention had to be dietary advice, supplementation of fats, oils or modified or low‐fat foods, or a provided diet, compared to higher saturated fat intake which could be usual diet, higher saturated fat, placebo or a control diet. Intended duration of the dietary intervention was at least two years (24 months or 104 weeks). </p> <p>We excluded multiple risk factor interventions other than diet or supplementation (unless effects of diet or supplementation could be separated, as in a factorial design, so that the additional intervention was consistent or randomised between the intervention or control groups) and studies that aimed for weight loss in one arm but not the other. Atkins‐type diets aiming to increase protein and fat intake were excluded, as were studies where fat was reduced by means of a fat‐substitute (like Olestra). Enteral and parenteral feeds were excluded, as were formula weight reducing diets. </p> <p>Examples: studies that reduced saturated fats and encouraged physical activity in one arm and compared with encouraging physical activity in the control were included; studies that reducedsaturated fats and encouraged physical activity in one arm and compared with no intervention in the control were excluded; studies that reduced saturated fats and encouraged fruit and vegetables in one arm and compared with no intervention in the control were included. </p> </section> <section id="CD011737-sec-0017"> <h4 class="title">Types of outcome measures</h4> <section id="CD011737-sec-0018"> <h5 class="title">Primary outcomes</h5> <p> <ul id="CD011737-list-0002"> <li> <p>All‐cause mortality (deaths from any cause)</p> </li> <li> <p>Cardiovascular (CVD) mortality (deaths from myocardial infarction, stroke, and/or sudden death) </p> </li> <li> <p>Combined CVD events. These included data available on number of people experiencing any of the following: cardiovascular death, cardiovascular morbidity (non‐fatal myocardial infarction, angina, stroke, heart failure, peripheral vascular events, atrial fibrillation) and unplanned cardiovascular interventions (coronary artery bypass surgery or angioplasty). </p> </li> </ul> </p> <p>To meet our inclusion criteria, trials had to report either deaths or CVD events. These could be reported as serious adverse events (SAEs) or via communication with authors. </p> </section> <section id="CD011737-sec-0019"> <h5 class="title">Secondary outcomes</h5> <p> <ul id="CD011737-list-0003"> <li> <p>Additional health events; the outcomes CHD mortality and CHD events were added at the request of the WHO NUGAG group, and were not present in the original overarching systematic review. For each of these, we assessed number of participants experiencing any of these: </p> <ul id="CD011737-list-0004"> <li> <p>Myocardial infarction, total (fatal and non‐fatal)</p> </li> <li> <p>Myocaridal infarction, non‐fatal</p> </li> <li> <p>Stroke</p> </li> <li> <p>CHD mortality, which includes death from myocardial infarction or sudden CVD death</p> </li> <li> <p>CHD events, which include any of the following: fatal or non‐fatal myocardial infarction, angina or sudden CVD death </p> </li> <li> <p>type II diabetes incidence</p> </li> </ul> </li> <li> <p>Blood measures including serum blood lipids</p> <ul id="CD011737-list-0005"> <li> <p>total cholesterol (TC, mmol/L)</p> </li> <li> <p>low‐density lipoprotein (LDL) cholesterol, mmol/L</p> </li> <li> <p>high‐density lipoprotein (HDL) cholesterol, mmol/L</p> </li> <li> <p>triglyceride (TG), mmol/L</p> </li> <li> <p>TG/HDL ratio</p> </li> <li> <p>LDL/HDL ratio</p> </li> <li> <p>total/HDL ratio</p> </li> <li> <p>lipoprotein (a) (Lp(a)), mmol/L</p> </li> <li> <p>insulin sensitivity including glucose tolerance (homeostatic model assessment (HOMA), intravenous glucose tolerance test (IV‐GTT), clamp, glycosylated haemoglobin (HbA1C)) </p> </li> </ul> </li> <li> <p>Other outcomes including adverse effects reported by study authors</p> <ul id="CD011737-list-0006"> <li> <p>cancer diagnoses</p> </li> <li> <p>cancer deaths</p> </li> <li> <p>body weight, kg</p> </li> <li> <p>body mass index (BMI, kg/m<sup>2</sup>) </p> </li> <li> <p>systolic blood pressure (sBP, mmHg)</p> </li> <li> <p>diastolic blood pressure (dBP, mmHg)</p> </li> <li> <p>quality of life (any measure)</p> </li> </ul> </li> </ul> </p> <p>As all trials collect data on deaths and cardiovascular events (as serious adverse events if not as planned outcome measures), we only included trials where we knew that at least one primary outcome occurred, by communication with authors if necessary. Where we knew that at least one primary outcome occurred, we included the study even where we were unable to use that data in meta‐analysis. We excluded studies where we knew that no primary outcome events occurred (for a study to be excluded in this way the paper needed to be very explicit about the lack of all outcomes or we received confirmation from the authors) and this was noted as the reason for exclusion. Lack of a single primary outcome only occurs in very small studies or in young cohorts, so omitting these studies will make no difference to effect sizes and very little difference to absolute effect sizes (NNTs etc). All other trials were considered unclear and where we could not gain clarification on events from authors, they were classified as “awaiting assessment”. </p> <p>For composite outcomes (like CVD events), we worked to collect data on the number of participants in each arm who experienced any type of CVD event, and did not double‐count people (so that a person experiencing a stroke and two heart attacks during a trial was counted as one person experiencing CVD events, not as three CVD events). </p> <p>We extracted event and continuous outcome data for the latest time point available within the trial, and always at least 24 months from inception. We collected change data (with a measure of variance) for continuous outcomes where these were available, and end data where change data were not provided in usable format. </p> </section> </section> </section> <section id="CD011737-sec-0020"> <h3 class="title">Search methods for identification of studies</h3> <section id="CD011737-sec-0021"> <h4 class="title">Electronic searches</h4> <p>The updated searches were run on 15 October 2019 on the following databases:</p> <p> <ul id="CD011737-list-0007"> <li> <p>CENTRAL (Issue 10 of 12, 2019, Cochrane Library)</p> </li> <li> <p>MEDLINE (Epub Ahead of Print, In‐Process &amp; Other Non‐Indexed Citations, MEDLINE Daily and MEDLINE, Ovid, 1946 to October 14, 2019) </p> </li> <li> <p>Embase (Ovid, 1980 to 2019 week 41).</p> </li> </ul> </p> <p>For this update, we introduced searches of two trials registers on 17 October 2019; Clinicaltrials.gov (<a href="http://Clinicaltrials.gov" target="_blank">www.clinicaltrials.gov</a>) and WHO International Clinical Trials Registry Platform (ICTRP) (<a href="http://apps.who.int/trialsearch/" target="_blank">apps.who.int/trialsearch/</a>). The searches are described in <a href="./appendices#CD011737-sec-0083">Appendix 1</a>. The RCT filter for MEDLINE was the Cochrane sensitivity and precision‐maximising RCT filter (<a href="./references#CD011737-bbs2-0397" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Lefebvre 2011</a>), and for Embase, terms as recommended in the Cochrane Handbook were applied (<a href="./references#CD011737-bbs2-0397" title="LefebvreC , ManheimerE , GlanvilleJ . Chapter 6: Searching for studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Lefebvre 2011</a>). </p> <p>As we were updating another Cochrane review relating to dietary fat (<a href="./references#CD011737-bbs2-0384" title="HooperL , AbdelhamidA , BunnD , BrownT , SummerbellCD , SkeaffCM . Effects of total fat intake on body weight. Cochrane Database of Systematic Reviews2015, Issue 8. Art. No: CD011834. [DOI: 10.1002/14651858.CD011834]">Hooper 2015b</a>) at the same time, results of the searches for both reviews were combined and de‐duplicated before assessment of titles and abstracts. </p> <p>The search to 2014 is described in <a href="./references#CD011737-bbs2-0449" title="HooperL , MartinN , JimohOF , AbdelhamidAS . Reduction in saturated fat intake for cardiovascular disease. Cochrane Database of Systematic Reviews2015, Issue 6. Art. No: CD011737. [DOI: 10.1002/14651858.CD011737]">Hooper 2015a</a>, and previous searches in <a href="./references#CD011737-bbs2-0448" title="HooperL , SummerbellCD , ThompsonR , SillsD , RobertsFG , MooreHJ , et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database of Systematic Reviews2012, Issue 5. Art. No: CD002137. [DOI: 10.1002/14651858.CD002137.pub3]">Hooper 2012</a>. . </p> </section> <section id="CD011737-sec-0022"> <h4 class="title">Searching other resources</h4> <p>We searched for recent publications of the included studies, to ensure the best possible data set for each study. </p> </section> </section> <section id="CD011737-sec-0023"> <h3 class="title" id="CD011737-sec-0023">Data collection and analysis</h3> <section id="CD011737-sec-0024"> <h4 class="title">Selection of studies</h4> <p>Search results were loaded into Covidence software. All authors independently assessed titles and abstracts from the search, differences were resolved by discussion and, when the findings were not clear cut, the full text was collected for assessment. We only rejected articles on initial screen if the author could determine from the title and abstract that the article was not a report of a randomised controlled trial; the trial did not address a low or modified fat diet; the trial was exclusively in children less than 18 years old, pregnant women or the critically ill; the trial was of less than 24 months duration; or the intervention was multifactorial. When we could not reject a title/abstract with certainty, we obtained the full text of the article for further evaluation. </p> </section> <section id="CD011737-sec-0025"> <h4 class="title">Data extraction and management</h4> <p>We used a data extraction form designed for earlier versions of this review. We extracted data concerning participants, interventions and outcomes, trial quality characteristics (<a href="./references#CD011737-bbs2-0361" title="ChalmersI , AdamsM , DickersinK , HetheringtonJ , Tarnow-MordiW , MeinertC , et al. A cohort study of summary reports of controlled trials. JAMA1990;263(10):1401-5.">Chalmers 1990</a>), data on potential effect modifiers including participants' baseline risk of cardiovascular disease, trial duration, intensity of intervention (dietary advice, diet provided, dietary advice plus supplementation, supplementation alone), medications used (particularly lipid‐lowering medication) and smoking status, numbers of events and total participant years in trial. Where provided, we collected data on risk factors for cardiovascular disease including blood pressure, lipids and weight. </p> <p>We defined baseline risk of cardiovascular disease as follows: high risk are participants with existing vascular disease including a history of myocardial infarction, stroke, peripheral vascular disease, angina, heart failure or previous coronary artery bypass grafting or angioplasty; moderate risk are participants with a familial risk, dyslipidaemia, diabetes mellitus, hypertension, chronic renal failure; low risk are other participants or mixed‐population groups. Those at low or moderate risk combined are primary prevention trials. </p> <p>Data were extracted independently in duplicate by AA, FOJ and/or LH, alongside assessment of risk of bias. </p> </section> <section id="CD011737-sec-0026"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>We carried out 'Risk of bias' assessment independently in duplicate as part of data extraction. We assessed trial risk of bias using the Cochrane tool for assessment of risk of bias (<a href="./references#CD011737-bbs2-0383" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). For included RCTs, we also assessed whether each study: </p> <p> <ol id="CD011737-list-0008"> <li> <p>was free of systematic differences in care,</p> </li> <li> <p>aimed to reduce SFA intake,</p> </li> <li> <p>achieved SFA reduction, or</p> </li> <li> <p>achieved total serum cholesterol reduction.</p> </li> </ol> </p> <p>We used the category 'other bias' to note any further issues of methodological concern. Funding was not formally a part of our assessment of bias in RCTs as it is not a core part of the Cochrane 'Risk of bias' tool, but was reported in the <a href="./references#CD011737-sec-0108" title="">Characteristics of included studies</a>. </p> <p>Two authors (LH, NM) independently extracted validity data from studies identified by the previous search, and resolved differences by discussion. </p> <p>Poorly concealed allocation is associated with a 40% greater effect size (<a href="./references#CD011737-bbs2-0427" title="SchulzKF , ChalmersI , HayesRJ , AltmanDG . Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA1995;273(5):408-12.">Schulz 1995</a>), so randomisation and allocation concealment are core issues for all trials. Lack of blinding is associated with bias, though smaller levels of bias than lack of allocation concealment (<a href="./references#CD011737-bbs2-0424" title="SavovicJ , JonesH , AltmanD , HarrisR , JüniP , PildalJ , et al. Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies. Health Technology Assessment2012;16:1-82.">Savovic 2012</a>), especially in studies with objectively measured outcomes (<a href="./references#CD011737-bbs2-0442" title="WoodL , EggerM , GluudLL , SchulzK , JüniP , AltmanDG , et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. British Medical Journal2008;336:601-5.">Wood 2008</a>). </p> <p>For this review, we introduced the concept of summary risk of bias for whole trials. We considered dietary advice or all‐food‐provided type trials to be at low summary risk of bias where we judged randomisation, allocation concealment, and blinding of outcome assessors to be adequate. Summary risk of bias was considered moderate to high in all other included trials. </p> </section> <section id="CD011737-sec-0027"> <h4 class="title">Measures of treatment effect</h4> <p>The effect measures of choice were risk ratios (RR) for dichotomous data and mean difference (MD) for continuous data. </p> </section> <section id="CD011737-sec-0028"> <h4 class="title">Unit of analysis issues</h4> <p>We did not include any cluster‐randomised trials in this review, as no relevant studies included at least six clusters. </p> <p>Where there was more than one relevant intervention arm but only one control arm, we either pooled the relevant intervention arms to create a single pairwise comparison (where the intervention arms were equivalently appropriate for this review) as described in the <i>Cochrane Handbook</i> (<a href="./references#CD011737-bbs2-0383" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>), or we excluded intervention arms that were not appropriate for this review, or less appropriate than another arm. When two arms were appropriate for different subgroups (<a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose corn oil 1965</a>; <a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose olive 1965</a>), then we used the control group once with each intervention arm, and divided the number of events in the control group, and the number of participants in the control group, evenly between the two study comparisons. </p> <p>In the previous version of this review, data for <a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a> were presented separately for those without baseline CVD, and with baseline CVD, for most outcomes. This has been altered in this version of the review, so that both sets of data are presented as a single trial except when subgrouping by CVD risk. This has the effect of representing this study in the same way others are represented (which is appropriate), and slightly reducing the weight of the <a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a> study in random‐effects meta‐analysis, altering the numbers in the analysis. </p> <p>When assessing event data, we aimed to assess number of participants experiencing an event (rather than numbers of events), to avoid counting more than one outcome event for any one individual within any one comparison. Where we were unclear (for example, where a paper reported numbers of myocardial infarcts but not by arm), we asked authors for further information. </p> </section> <section id="CD011737-sec-0029"> <h4 class="title">Dealing with missing data</h4> <p>Where trials satisfied the inclusion criteria of our review but did not report mortality and morbidity, or not by study arm, we tried to contact study authors. This allowed inclusion of studies that would otherwise have had to be excluded. We excluded studies which were otherwise relevant but where we could not establish the presence or absence of primary outcomes, despite multiple attempts at author contact. </p> <p>It was often unclear whether data on primary or secondary outcome events may still have been missing, and so we did not impute data for this review. </p> <p>Where included studies used methods to infer missing data (such as carrying the latest measurement forward), then we used these data in analyses. Where this was not done, we used the data as presented. </p> </section> <section id="CD011737-sec-0030"> <h4 class="title">Assessment of heterogeneity</h4> <p>We examined heterogeneity using the I² test, and considered it important where greater than 50% (<a href="./references#CD011737-bbs2-0382" title="HigginsJPT , ThompsonSG , DeeksJJ , AltmanDG . Measuring inconsistency in meta-analyses. BMJ2003;327(7414):557-60.">Higgins 2003</a>; <a href="./references#CD011737-bbs2-0383" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>). Where we identified important clinical or unexplained statistical heterogeneity, we did not pool but instead summarised the studies in a narrative format. We used the assessment of heterogeneity in our GRADE assessments, so that the quality of evidence was downgraded where heterogeneity was important, and not explained by subgrouping or meta‐regression. </p> </section> <section id="CD011737-sec-0031"> <h4 class="title">Assessment of reporting biases</h4> <p>We used funnel plots to examine the possibility of small study bias, including publication bias (<a href="./references#CD011737-bbs2-0370" title="EggerM , Davey SmithG , SchneiderM , MinderC . Bias in meta-analysis detected by a simple graphical test. BMJ1997;315(7109):629-34.">Egger 1997</a>), for the primary outcomes of total mortality and combined cardiovascular events. For this update, we also compared findings of fixed‐ and random‐effects meta‐analysis since the two methods weight small trials differently, and different effect sizes suggest potential small study bias (<a href="./references#CD011737-bbs2-0414" title="PageMJ , HigginsJPT , SterneJAC . Chapter 13: Assessing risk of bias due to missing results in a synthesis. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 6.0 (updated July 2019). Cochrane 2019. Available from www.training.cochrane.org/handbook.">Page 2019</a>). </p> </section> <section id="CD011737-sec-0032"> <h4 class="title">Data synthesis</h4> <p>We carried out data synthesis in the absence of clinical heterogeneity. We used numbers of events in each study arm, and total number of participants randomised, where extracted, and Mantel‐Haenszel random‐effects meta‐analysis carried out in Review Manager 5 software, to assess risk ratios. We extracted event and continuous outcome data for the latest time point available within the trial, and always at least 24 months from inception. </p> <p>We excluded trials where we knew that there were no events in either group. Where trials ran one control group and more than one included intervention group, we used data from the intervention group providing the comparison that best assessed the effect of altering dietary fat. Where the intervention groups appeared equal in this respect, we merged the intervention groups (simply added for dichotomous data, and using the techniques described in <a href="./references#CD011737-bbs2-0383" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a> for continuous data). We had planned that if we identified trials randomised by cluster we would reduce the participant numbers to an "effective sample size" (as described by <a href="./references#CD011737-bbs2-0378" title="HauckWW , GillissCL , DonnerA , GortnerS . Randomisation by cluster. Nursing Research1991;40(6):356-8.">Hauck 1991</a>); however, we found none that were both included and had cardiovascular events or deaths. </p> <p>To assess the WHO NUGAG question on the effect of consuming &lt; 10%E as SFA relative to &gt; 10%E as SFA on the risk of noncommunicable diseases (NCDs) in the population, we combined studies with a control group saturated fat intake of &gt; 10%E and an intervention group saturated fat intake of &lt; 10%E. To assess the effect of a reduction in %E from SFA from 10% in gradual increments relative to higher intake, we repeated this with saturated fat cut‐offs between 7%E and 13%E. </p> </section> <section id="CD011737-sec-0033"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>Prespecified analyses included:</p> <p>Effects of SFA reduction compared with usual or standard diet on all (primary and secondary) outcomes and potential adverse effects. This main analysis addressed the main objective of the review and the first WHO specific question. </p> <p>Prespecified subgroups for all outcomes included:</p> <p> <ul id="CD011737-list-0009"> <li> <p>energy substitution ‐ we intended to subgroup studies according to the main energy replacement for SFA ‐ PUFA, MUFA, CHO (refined or unrefined), protein, trans fats, a mixture of these, or unclear. However, when we presented these data to the WHO NUGAG group, they suggested that this subgrouping be altered. They suggested that we use all studies where SFA was reduced and any of PUFA, MUFA, CHO or protein were statistically significantly increased (P &lt; 0.05) in the intervention compared to the control group to assess the effects of replacement by each, regardless of whether or not it constituted the main replacement for SFA. This meant that some studies appeared in more than one subgroup. As there were almost no data in the studies on trans fats, or on refined and unrefined carbohydrates, we did not include a trans group or distinguish by carbohydrate type. This subgrouping addresses the main objective of the review, and the third WHO specific question. </p> </li> </ul> </p> <p>Further subgroups, run for primary and CVD health‐related secondary outcomes only, included: </p> <p><b>Prespecified</b>: </p> <p> <ul id="CD011737-list-0010"> <li> <p>Baseline SFA intake, represented by control group SFA intake (up to 12%E from SFA, &gt; 12 to 15%E, &gt; 15 to 18%E, &gt; 18%E from SFA, or unclear) </p> </li> <li> <p>Sex (men, women and mixed populations)</p> </li> <li> <p>Baseline CVD risk (low‐risk or general populations, moderate‐risk populations which were defined by risk factors for CVD such as hypertension or diabetes, high‐risk populations with existing CVD at baseline) </p> </li> <li> <p>Duration in study (mean duration in trial up to 24 months, &gt; 24 to 48 months, &gt; 48 months, and unclear). Duration was a prespecified subgroup that we used in earlier versions of this review to separate studies with duration of less than two years from those of at least two years. As we have excluded shorter studies from this review, and have access to longer studies, we have explored duration over longer time spans. As some long studies had a high proportion of participants whose time in trial was censored, and we wanted to express mean experience of the trial, we used mean duration of participants in the study, rather than the formal study duration for this subgrouping, so that some two‐year intervention trials, because they had some deaths or dropouts, had a mean duration in trial of 21 or 22 months. </p> </li> </ul> </p> <p><b>WHO NUGAG added subgroups:</b> </p> <p> <ul id="CD011737-list-0011"> <li> <p>Degree of SFA reduction, represented by the difference between SFA intake in the intervention and control groups during the study (up to 4%E from SFA reduction achieved, &gt; 4 to 8% reduction achieved, &gt; 8% reduction achieved, unclear). We prespecified that we intended to explore the degree of SFA reduction in meta‐regression, but its addition as a subgroup was post hoc, and requested by the WHO NUGAG group. </p> </li> <li> <p>Serum total cholesterol reduction achieved (reduced by a mean of at least 0.2 mmol/L, reduced by less than 0.2 mmol/L or unclear). We prespecified that we intended to explore the degree of serum total cholesterol reduction in meta‐regression. </p> </li> <li> <p>Ethnic group. Insufficient information was presented to make this feasible. Hence, we report ethnicity information in the <a href="./references#CD011737-sec-0108" title="">Characteristics of included studies</a>. </p> </li> </ul> </p> <p>We explored the effects of different levels of SFA, PUFAs, MUFAs and total dietary fats, and CHO achieved in trials (all as difference between the intervention and control groups, as %E, and for SFA as a percentage of SFA in the intervention compared with control), baseline SFA intake (as %E), change in total cholesterol (difference between intervention and control groups, in mmol/L), sex, study duration in months, and baseline CVD risk using meta‐regression on total cardiovascular events. We performed random‐effects meta‐regression (<a href="./references#CD011737-bbs2-0354" title="BerkleyCS , HoaglinDC , MostellerF , ColditzGA . A random-effects regression model for meta-analysis. Statistics in Medicine1995;14(4):395-411.">Berkley 1995</a>) using the STATA command metareg (<a href="./references#CD011737-bbs2-0430" title="SharpS . Meta-analysis regression. Stata Technical Bulletin1998;42:16-22.">Sharp 1998</a>; <a href="./references#CD011737-bbs2-0437" title="SterneJA , BradburnMJ , EggerM . Meta-analysis in STATA. In: EggerM , Davey SmithG , AltmanDG , editors(s). Systematic Reviews in Health Care: Meta-analysis in Context. London: BMJ Books, 2001.">Sterne 2001</a>; <a href="./references#CD011737-bbs2-0438" title="SterneJA . Meta-Analysis in Stata: an Updated Collection from the Stata Journal. Texas, USA: STATA Press, 2009.">Sterne 2009</a>). </p> <p>To explore the WHO NUGAG specific question about the effect of the population consuming &lt; 10%E as SFA relative to &gt; 10%E SFA, we assessed effects of all studies where the mean assessed intervention SFA intake was &lt; 10%E and the mean control SFA intake was &gt; 10%E. We explored the effect of reduction of %E from SFA in gradual increments by using cut‐offs of 7%E (where all studies with a mean intervention SFA intake &lt; 7%E and mean control SFA intake &gt; 7%E were pooled), 8%, 9%, 10%, 11%, 12% and 13%. We omitted studies where SFA intakes were not reported from these analyses. For each primary outcome, we plotted the pooled risk ratio of that outcome against the cut‐off, %E from SFA. </p> <p><b>Referee‐added subgroups:</b> </p> <p>In response to the suggestion of a referee of this systematic review, and to better understand the effect of use of statins since the 1990s, we subgrouped studies by decade of publication. </p> </section> <section id="CD011737-sec-0034"> <h4 class="title">Sensitivity analysis</h4> <p>We carried out sensitivity analyses for primary outcomes assessing the effect of:</p> <p> <ol id="CD011737-list-0012"> <li> <p>Excluding studies which did not state an aim to reduce SFA</p> </li> <li> <p>Excluding studies which did not report SFA intake during the trial, or did not find a statistically significant reduction in SFA in the intervention compared to the control </p> </li> <li> <p>Excluding studies where total cholesterol (TC) was not reduced (statistically significant reduction of TC, or of LDL where TC was not reported (considered reduced where P &lt; 0.05), or where reduction was not at least 0.2 mmol/L in intervention compared to control where variance was not reported) </p> </li> <li> <p>Excluding the largest study (<a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>) </p> </li> <li> <p>Analysis run with Mantel‐Haenszel fixed‐effect model</p> </li> <li> <p>Analysis run with Peto fixed‐effect model</p> </li> </ol> </p> <p>For this update we also introduced sensitivity analysis excluding trials not at low summary risk of bias. We used results of these analysis to inform GRADE assessment of risk of bias. </p> <section id="CD011737-sec-0035"> <h5 class="title">GRADE</h5> <p>All primary outcomes, and secondary additional health events, were represented in the 'Summary of findings' table, and underwent GRADE assessment. The GRADE Working Group has developed a common, sensible and transparent approach to grading quality of evidence and strength of recommendations (<a href="http://www.gradeworkinggroup.org/" target="_blank">www.gradeworkinggroup.org/</a>; <a href="./references#CD011737-bbs2-0373" title="AtkinsD , BestD , BrissPA , EcclesM , Falck-YtterY , FlottorpS , et al. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490.">GRADE 2004</a>). The evidence within this systematic review was first assessed using the GRADE system by the review authors and then discussed and modified by the WHO NUGAG group. </p> <p>Outcome data were interpreted as follows:</p> <p> <ol id="CD011737-list-0013"> <li> <p>Is there an effect? (options were ‘increased risk’, ‘decreased risk’, or ‘little or no effect’). Our main outcome measure was RR so we decided on existence of an effect using RR. RR &gt; 8% (RR &lt; 0.92 or &gt; 1.08) for the highest quality evidence suggested increased or decreased risk (otherwise little or no effect). The presence or not of an effect was decided on the RR for the main analysis and sensitivity analyses, the highest quality evidence (the main analysis, the sensitivity analyses of trials at low summary risk of bias and at low risk of compliance problems). </p> </li> <li> <p>For continuous outcomes, reducing SFA was considered to have little or no effect unless effect sizes represented at least 5% change from baseline (or 2% in the case of cumulative outcomes such as adiposity). </p> </li> <li> <p>Quality of evidence was assessed using GRADE assessment (<a href="./references#CD011737-bbs2-0373" title="AtkinsD , BestD , BrissPA , EcclesM , Falck-YtterY , FlottorpS , et al. Grading quality of evidence and strength of recommendations. BMJ2004;328(7454):1490.">GRADE 2004</a>) for key outcomes. We used the five GRADE considerations (risk of bias, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence as it related to the studies that contributed data to the meta‐analyses for the prespecified outcomes. We used methods and recommendations described in Section 8.5 and Chapter 12 of the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD011737-bbs2-0383" title="HigginsJPT , Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from handbook.cochrane.org.">Higgins 2011</a>), plus GRADEpro GDT software (<a href="./references#CD011737-bbs2-0374" title="GRADEpro GDT. https://gradepro.org/: McMaster University and Evidence Prime Inc, 2015.">GRADEpro 2015</a>). We justified all decisions to downgrade the quality of studies using footnotes and made comments to aid reader's understanding of the review. </p> </li> <li> <p>Where there was a suggested effect, the size of effect was assessed using the number needed to treat for an additional beneficial outcome (NNTB), number needed to treat for an additional harmful outcome (NNTH) or absolute risk reduction (ARR). </p> </li> </ol> </p> </section> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD011737-sec-0036" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD011737-sec-0036"></div> <section id="CD011737-sec-0037"> <h3 class="title">Description of studies</h3> <section id="CD011737-sec-0038"> <h4 class="title">Results of the search</h4> <p><a href="#CD011737-fig-0001">Figure 1</a> displays the flow diagram for inclusion of studies. We assessed the 7991 titles and abstracts from the updated electronic search, as well as assessing the 8930 titles and abstracts from the search for our sister review (<a href="./references#CD011737-bbs2-0384" title="HooperL , AbdelhamidA , BunnD , BrownT , SummerbellCD , SkeaffCM . Effects of total fat intake on body weight. Cochrane Database of Systematic Reviews2015, Issue 8. Art. No: CD011834. [DOI: 10.1002/14651858.CD011834]">Hooper 2015b</a>), which de‐duplicated to 15,314 titles and abstracts. Of these, 530 were considered potentially relevant to one or both reviews, so were collected as full text. Ten publications were considered relevant for this systematic review, and these were grouped into: </p> <div class="figure" id="CD011737-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram for this systematic review (update searches run October 2019)." data-id="CD011737-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram for this systematic review (update searches run October 2019).</p> </div> </div> </div> <p> <ul id="CD011737-list-0014"> <li> <p>three new publications for two already included trials (<a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>; <a href="./references#CD011737-bbs2-0016" title="ChlebowskiRT , BlackburnGL , BuzzardIM , RoseDP , MartinoS , KhandekarJD , et al. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. Journal of Clinical Oncology1993;11(11):2072-80. ChlebowskiRT , BlackburnGL , ThomsonCA , NixonDW , ShapiroA , HoyMK , et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition study. Journal of the National Cancer Institute2006;98(24):1767-76. ChlebowskiRT , BlackburnGL . Final survival analysis from the randomized Womens Intervention Nutrition Study (WINS) evaluating dietary intervention as adjuvant breast cancer therapy. Cancer Research2015;75(9 Supplement):S5-08. ChlebowskiRT , RoseD , BlackburnG , BuzzardM , KhandekarJ , YorkR , et al. Feasibility of using dietary fat intake reduction in adjuvant breast cancer management. Proceedings of American Society of Clinical Oncology1991;86:86. ChlebowskiRT , RoseDP , BuzzardIM , BlackburnGL , YorkM , Insull W Jr, et al. Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues. Adjuvant: the Cancer Journal1990;6:357-63. HoyMK , WintersBL , ChlebowskiRT , PapoutsakisC , ShapiroA , LubinMP , et al. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study. Journal of the American Dietetic Association2009;109(4):688-96. RoseDP , ChlebowskiRT , ConnollyJM , JonesLA , WynderEL . Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Cancer Research1992;52(19):5386-90. RoseDP , ConnollyJM , ChlebowskiRT , BuzzardIM , WynderEL . The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Research &amp; Treatment1993;27(3):253-62. WynderEL , CohenLA , WintersBL . The challenges of assessing fat intake in cancer research investigations. Journal of the American Dietetic Association1997;97(7 Suppl):S5-8. ">WINS 2006</a>), </p> </li> <li> <p>two publications for one study awaiting assessment (not enough details to confirm inclusion, <a href="./references#CD011737-bbs2-0342" title="LapetraJ , Lozano-RodríguezJM , Caballero-ValderramaMR , Santos-LozanoJM , Ortega-CalvoM , García de la CorteFJ , et al. Effect of a Mediterranean diet on the primary prevention of atrial fibrillation and major cardiovascular events in hypertensive patients with high cardiovascular risk: results of ICFAMED study. In: Obesity and Nutrition in the 21st Century. VIII Symposium Ciber Fisiopatología de la Obesidad y Nutrición; 2017; Madrid. Madrid: Ciber Fisiopatología de la Obesidad y Nutrición, 2017:71. LapetraJ , Lozano-RodriguezJM , Miro-MorianoL , Ortega-CalvoM , Santos-LozanoJM , Garcia-CorteFJ , et al. Effect of a Mediterranean diet on the primary prevention of atrial fibrillation and major cardiovascular events in hypertensive patients with high cardiovascular risk: results of ICFAMED randomized trial. European Journal of Clinical Investigation2018;48:182‐3. ">ICFAMED</a>), and </p> </li> <li> <p>five publications for four ongoing trials (<a href="./references#CD011737-bbs2-0343" title="EnglishC , PattersonA , MacDonald-WicksL , AttiaJ , CallisterR , HillierS , et al. ENAbLE: Secondary prevention of stroke. A physical activity and diet trial protocol. Abstracts Presented at the SMART STROKES 2019 Conference, 8–9 August 2019, Hunter Valley, NSW. International Journal of Stroke2019;14(1 Suppl):12. [DOI: 10.1177/1747493019858233]">ENAbLE due unclear</a>; <a href="./references#CD011737-bbs2-0344" title="NCT02481466. The combined portfolio diet and exercise study (PortfolioEx). clinicaltrials.gov/ct2/show/NCT02481466 (first posted 25 June 2015). ">NCT02481466 due 2020</a>; <a href="./references#CD011737-bbs2-0345" title="NCT02938832. Does the advice to eat a Mediterranean diet with low carbohydrate intake, compared with a low-fat diet, reduce diabetes and cardiovascular disease?clinicaltrials.gov/ct2/show/NCT02938832 (first posted 19 October 2016). ">NCT02938832 due 2023</a>; <a href="./references#CD011737-bbs2-0346" title="NCT03354377. Nutritious Eating With Soul (The NEW Soul Study). https://clinicaltrials.gov/ct2/show/NCT03354377 (first posted 27 November 2017). Turner-McGrievyG , WilcoxS , FrongilloEA , MurphyA , HuttoB , WilliamsK , et al. The Nutritious Eating with Soul (NEW Soul) Study: Study design and methods of a two-year randomized trial comparing culturally adapted soul food vegan vs. omnivorous diets among African American adults at risk for heart disease. Contemporary Clinical Trials2020;88:105897. ">NEW Soul Study due 2022</a>). </p> </li> </ul> </p> <p>There were no new included trials, but there were new data for <a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a> and <a href="./references#CD011737-bbs2-0016" title="ChlebowskiRT , BlackburnGL , BuzzardIM , RoseDP , MartinoS , KhandekarJD , et al. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. Journal of Clinical Oncology1993;11(11):2072-80. ChlebowskiRT , BlackburnGL , ThomsonCA , NixonDW , ShapiroA , HoyMK , et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition study. Journal of the National Cancer Institute2006;98(24):1767-76. ChlebowskiRT , BlackburnGL . Final survival analysis from the randomized Womens Intervention Nutrition Study (WINS) evaluating dietary intervention as adjuvant breast cancer therapy. Cancer Research2015;75(9 Supplement):S5-08. ChlebowskiRT , RoseD , BlackburnG , BuzzardM , KhandekarJ , YorkR , et al. Feasibility of using dietary fat intake reduction in adjuvant breast cancer management. Proceedings of American Society of Clinical Oncology1991;86:86. ChlebowskiRT , RoseDP , BuzzardIM , BlackburnGL , YorkM , Insull W Jr, et al. Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues. Adjuvant: the Cancer Journal1990;6:357-63. HoyMK , WintersBL , ChlebowskiRT , PapoutsakisC , ShapiroA , LubinMP , et al. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study. Journal of the American Dietetic Association2009;109(4):688-96. RoseDP , ChlebowskiRT , ConnollyJM , JonesLA , WynderEL . Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Cancer Research1992;52(19):5386-90. RoseDP , ConnollyJM , ChlebowskiRT , BuzzardIM , WynderEL . The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Research &amp; Treatment1993;27(3):253-62. WynderEL , CohenLA , WintersBL . The challenges of assessing fat intake in cancer research investigations. Journal of the American Dietetic Association1997;97(7 Suppl):S5-8. ">WINS 2006</a>, as well as the ongoing studies and the study awaiting assessment. This resulted in an updated review including 15 RCTs (16 comparisons as the Rose trial has two comparisons, <a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose corn oil 1965</a> and <a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose olive 1965</a>). </p> </section> <section id="CD011737-sec-0039"> <h4 class="title">Included studies</h4> <p>We included 15 randomised controlled trials (RCTs) randomising 56,675 participants in the review (<a href="./references#CD011737-bbs1-0001" title="">Included studies</a>), and describe them in <a href="./references#CD011737-sec-0108" title="">Characteristics of included studies</a>. The interventions are compared in <a href="#CD011737-tbl-0002">Table 1</a>. </p> <div class="table" id="CD011737-tbl-0002"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Comparison of study interventions for included RCTs</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Reference</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Population</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>CVD risk category</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Is intervention delivered to Individual or group?</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>intervention given by?</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Face‐to‐face or other?</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of visits</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Is intervention advice only or other intervention?</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0001" title="BlackHS , HerdJA , GoldbergLH , Wolf JE Jr, ThornbyJI , RosenT , et al. Effect of a low-fat diet on the incidence of actinic keratosis. New England Journal of Medicine1994;330(18):1272-5. BlackHS , ThornbyJI , Wolf JE Jr, GoldbergLH , HerdJA , RosenT , et al. Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer. International Journal of Cancer1995;62(2):165-9. JaaxS , ScottLW , Wolf JE Jr, ThornbyJI , BlackHS . General guidelines for a low-fat diet effective in the management and prevention of nonmelanoma skin cancer. Nutrition and Cancer1997;27(2):150-6. "><b>Black 1994</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>People with non‐melanoma skin cancer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 x weekly classes then monthly follow‐up sessions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice (behaviour techniques learning)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0002" title="BurrML , FehilyAM , GilbertJF , RogersS , HollidayRM , SweetnamPM , et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet1989;2(8666):757-61. BurrML , FehilyAM , RogersS , WelsbyE , KingS , SandhamS . Diet and reinfarction trial (DART): design, recruitment, and compliance. European Heart Journal1989;10(6):558-67. BurrML , FehilyAM . Fish and the heart. Lancet1989;ii:1450-2. BurrML , HollidayRM , FehilyAM , WhiteheadPJ . Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). European Heart Journal1992;13(2):166-70. BurrML , SweethamPM , FehilyAM . Diet and reinfarction [letter]. European Heart Journal1994;15(8):1152-3. FehilyAM , Vaughan-WilliamsE , ShielsK , WilliamsAH , HornerM , BinghamG , et al. The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART). Journal of Human Nutrition &amp; Dietetics1989;2(4):225-5. "><b>DART 1989</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Men recovering from a MI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice (diet advice, recipes and encouragement)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0003" title="HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Favourable influences of linoleic acid on the progression of diabetic micro- and macroangiopathy. Nutrition and Metabolism1980;24(Suppl 1):105-18. HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Influence of different diets on the progression of diabetic retinopathy. Progress in Food Nutritition and Science1980;4(5):41-6. HoutsmullerAJ , ZahnKJ , HenkesHE . Unsaturated fats and progression of diabetic retinopathy. Documenta Ophthalmologia1979;48(2):363-71. "><b>Houtsmuller 1979</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults with newly‐diagnosed diabetes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice?</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0004" title="LeySJ , MetcalfPA , ScraggRK , SwinburnBA . Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance. Diabetes Research and Clinical Practice2004;63(2):103-12. SwinburnBA , MetcalfPA , LeySJ . Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care2001;24(4):619-24. SwinburnBA , WoollardGA , ChangEC , WilsonMR . Effects of reduced-fat diets consumed ad libitum on intake of nutrients particularly antioxidant vitamins. Journal of the American Dietetic Association1999;99(11):1400-5. "><b>Ley 2004</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>People with impaired glucose intolerance or high normal blood glucose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Monthly meetings</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice (education, personal goal‐setting, self‐monitoring)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0005" title="MoyTF , YanekLR , RaquenoJV , BezirdjianPJ , BlumenthalRS , WilderLB , et al. Dietary counseling for high blood cholesterol in families at risk of coronary disease. Preventive Cardiology2001;4(4):158-64. "><b>Moy 2001</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Middle‐aged siblings of people with early CHD, with at least 1 CVD risk factor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trained nurse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 ‐ 8 weekly for 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice (individualised counselling sessions)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0006" title="EdererF , LerenP , TurpeinenO , Frantz ID Jr. Cancer among men on cholesterol lowering diets: experience of five clinical trials. Lancet1971;2(7717):203-6. HeadyJA . Are PUFA harmful?British Medical Journal1974;1(898):115-6. MRC. Controlled trial of soya-bean oil in myocardial infarction. Lancet1968;2(570):693-9. "><b>MRC 1968</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Free‐living men who have survived a 1st MI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice and supplement (soy oil)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0007" title="LerenP . Prevention of coronary heart disease, some results from the Oslo secondary and primary intervention studies. Journal of the American College of Nutrition1989;8(5):407-10. LerenP . The Oslo diet-heart study. Eleven year report. Circulation1970;42(5):935-42. LerenP . The effect of a cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial) [Virkningen av cholesterolsenkende diett hos menn som har gjennomgatt hjerteinfarkt. Et kontrollert klinisk fors/ok]. Nordisk Medicin1967;77(21):658-61. LerenP . The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Medica Scandinavia1966;466 Suppl:1-92. LerenP . The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Bulletin of the New York Academy of Medicine1968;44(8):1012-20. "><b>Oslo Diet‐Heart 1966</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Men with previous MI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face and other</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice and supplement (food)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0008" title="CoppackSW , DollHA , PimB , HockadayTD . Intravenous glucose tolerance and mortality in non-insulin-dependant diabetes mellitus. Quarterly Journal of Medicine1990;75(277):451-60. HillsonRM , HockadayTD , MannJI , NewtonDJ . Hyperinsulinaemia is associated with development of ECG abnormalities in diabetics. Diabetes Research1984;1(3):143-9. HockadayTD , HockadayJM , MannJI , TurnerRC . Prospective comparison of modified fat-high-carbohydrate with standard low-carbohydrate dietary advice in the treatment of diabetes: one year follow-up study. British Journal of Nutrition1978;39(2):357-62. Howard-WilliamsJ , PatelP , JelfsR , CarterRD , AwdryP , BronA , et al. Polyunsaturated fatty acids and diabetic retinopathy. British Journal of Ophthalmology1985;69(1):15-8. Lopez-EspinozaI , HowardWJ , MannJI , CarterRD , HockadayTD . Fatty acid composition of platelet phospholipids in non-insulin-dependent diabetics randomized for dietary advice. British Journal of Nutrition1984;52(1):41-7. "><b>Oxford Retinopathy 1978</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Newly‐diagnosed non‐insulin‐dependent diabetics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diabetes dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After 1 month then at 3‐month intervals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. "><b>Rose corn oil 1965</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Men (?) with angina or following MI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Follow‐up clinic monthly, then every 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice and supplement (oil)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. "><b>Rose olive 1965</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Men (?) with angina or following MI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Follow‐up clinic monthly, then every 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice and supplement (oil)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0011" title="DjuricZ , HeilbrunLK , ReadingBA , BoomerA , ValerioteFA , MartinoS . Effects of a low fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells. Journal of the National Cancer Institute1991;83(11):766-9. DjuricZ , MartinoS , HeilbrunLK , HartRW . Dietary modulation of oxidative DNA damage. Advances In Experimental Medicine and Biology1994;354:71-83. KasimSE , MartinoS , Kim P-N, KhilnaniS , BoomerA , DepperJ , et al. Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women. American Journal of Clinical Nutrition1993;57(2):146-53. SimonMS , HeilbrunLK , BoomerA , KresgeC , DepperJ , KimPN , et al. A randomised trial of a low-fat dietary intervention in women at high risk for breast cancer. Nutrition and Cancer1997;27(2):136-42. "><b>Simon 1997</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Women with a high risk of breast cancer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual followed by individual or group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bi‐weekly over 3 months followed by monthly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice (individualised eating plan and counselling sessions)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0012" title="BlannAD , JacksonP , BathPM , WattsGF . Von Willebrand factor, a possible indicator of endothelial cell damage, decreases during long-term compliance with a lipid-lowering diet. Journal of Internal Medicine1995;237(6):557-61. WattsGF , BruntJN , ColtartDJ , LewisB . The St. Thomas Atherosclerosis Regression Study (STARS). Atherosclerosis1992;97:231. WattsGF , JacksonP , BurkeV , LewisB . Dietary fatty acids and progression of coronary artery disease in men. American Journal of Clinical Nutrition1996;64(2):202-9. WattsGF , JacksonP , MandaliaS , BruntJN , LewisES , ColtartDJ , et al. Nutrient intake and progression of coronary artery disease. American Journal of Cardiology1994;73(5):328-32. WattsGF , LewisB , BruntJN , LewisES , ColtartDJ , SmithLD , et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet1992;339(8793):563-9. WattsGF , LewisB , BruntJNH , SwanAV . Coronary atheroma regression trials. Lancet1992;339(i):1241-3. WattsGF , LewisB , JacksonP , BurkeV , LewisES , BruntJN , et al. Relationships between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography. Canadian Journal of Cardiology1995;11(Suppl G):110G-4G. WattsGF , MandaliaS , BruntJN , SlavinBM , ColtartDJ , LewisB . Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism: Clinical and Experimental1993;42(11):1461-7. WattsGF , MandaliaS , SlavinBM , BruntJN , ColtartDJ , LewisB . Metabolic determinants of the course of coronary artery disease in men. Clinical Chemistry1994;40(12):2240-6. WattsGF . Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group. Journal of Cardiovascular Pharmacology1995;25(Suppl 4):S11-9. "><b>STARS 1992</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Men with angina referred for angiography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinic visits at 3‐month intervals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0013" title="BlacketRB , LeelarthaepinB , McGilchristC , PalmerAJ , WoodhillJM . The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart disease. Australian and New Zealand Journal of Medicine1979;9(5):521-9. RamsdenCE , ZamoraD , LeelarthaepinB , Majchrzak-HongSF , FaurotKR , SuchindranCM , et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ2013;346:e8707. [DOI: 10.1136/bmj.e8707]WoodhillJM , PalmerAJ , LeelarthaepinB , McGilchristC , BlacketRB . Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Advances in Experimental Medicine and Biology1978;109:317-30. "><b>Sydney Diet‐Heart 1978</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Men with angina referred for angiography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times in 1st year and twice annually thereafter</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. "><b>Veterans Admin 1969</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Men living at the Veterans Administration Center</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear (whole diet provided)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diet provided</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. "><b>WHI 2006</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postmenopausal women aged 50 ‐ 79 with or without CVD at baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low and High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nutritionists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18 sessions/1st yr and quarterly maintenance sessions after</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0016" title="ChlebowskiRT , BlackburnGL , BuzzardIM , RoseDP , MartinoS , KhandekarJD , et al. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. Journal of Clinical Oncology1993;11(11):2072-80. ChlebowskiRT , BlackburnGL , ThomsonCA , NixonDW , ShapiroA , HoyMK , et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition study. Journal of the National Cancer Institute2006;98(24):1767-76. ChlebowskiRT , BlackburnGL . Final survival analysis from the randomized Womens Intervention Nutrition Study (WINS) evaluating dietary intervention as adjuvant breast cancer therapy. Cancer Research2015;75(9 Supplement):S5-08. ChlebowskiRT , RoseD , BlackburnG , BuzzardM , KhandekarJ , YorkR , et al. Feasibility of using dietary fat intake reduction in adjuvant breast cancer management. Proceedings of American Society of Clinical Oncology1991;86:86. ChlebowskiRT , RoseDP , BuzzardIM , BlackburnGL , YorkM , Insull W Jr, et al. Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues. Adjuvant: the Cancer Journal1990;6:357-63. HoyMK , WintersBL , ChlebowskiRT , PapoutsakisC , ShapiroA , LubinMP , et al. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study. Journal of the American Dietetic Association2009;109(4):688-96. RoseDP , ChlebowskiRT , ConnollyJM , JonesLA , WynderEL . Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Cancer Research1992;52(19):5386-90. RoseDP , ConnollyJM , ChlebowskiRT , BuzzardIM , WynderEL . The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Research &amp; Treatment1993;27(3):253-62. WynderEL , CohenLA , WintersBL . The challenges of assessing fat intake in cancer research investigations. Journal of the American Dietetic Association1997;97(7 Suppl):S5-8. "><b>WINS 2006</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Women with localised resected breast cancer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual followed by group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 bi‐weekly sessions, then 3‐monthly contact and optional monthly sessions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>MI: myocardial infarction<br/>N/A: not applicable </p> </div> </div> <p>The main study papers ranged in publication date from 1965 to 2006, but with supplementary publications included up to 2019. The RCTs were conducted in North America (six), Europe (seven), and Australia/New Zealand (two); no studies were carried out in industrialising or developing countries. Six RCTs included only people at high risk of cardiovascular disease, four at moderate risk, and four at low risk (three with raised cancer risk or cancer diagnosis, one with no specific health risks), while one trial included participants at low and high CVD risk (<a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>, <a href="#CD011737-tbl-0002">Table 1</a>; this trial made assessments in each of these groups). Seven studies included only men, three only women, and five both men and women. However, as the largest trial (<a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>) was in women only, women are the largest group represented. Trial duration ranged from two to more than eight years, with a mean duration of 4.7 years. </p> <p>The form of interventions varied (<a href="#CD011737-tbl-0002">Table 1</a>). Interventions were of advice to alter intake in 15 of the 16 intervention arms, and additional supplements such as oil or other foods were provided in three trials (four arms: <a href="./references#CD011737-bbs2-0006" title="EdererF , LerenP , TurpeinenO , Frantz ID Jr. Cancer among men on cholesterol lowering diets: experience of five clinical trials. Lancet1971;2(7717):203-6. HeadyJA . Are PUFA harmful?British Medical Journal1974;1(898):115-6. MRC. Controlled trial of soya-bean oil in myocardial infarction. Lancet1968;2(570):693-9. ">MRC 1968</a>; <a href="./references#CD011737-bbs2-0007" title="LerenP . Prevention of coronary heart disease, some results from the Oslo secondary and primary intervention studies. Journal of the American College of Nutrition1989;8(5):407-10. LerenP . The Oslo diet-heart study. Eleven year report. Circulation1970;42(5):935-42. LerenP . The effect of a cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial) [Virkningen av cholesterolsenkende diett hos menn som har gjennomgatt hjerteinfarkt. Et kontrollert klinisk fors/ok]. Nordisk Medicin1967;77(21):658-61. LerenP . The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Medica Scandinavia1966;466 Suppl:1-92. LerenP . The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Bulletin of the New York Academy of Medicine1968;44(8):1012-20. ">Oslo Diet‐Heart 1966</a>; <a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose corn oil 1965</a>; <a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose olive 1965</a>), while all food was provided in a residential facility in one RCT (<a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. ">Veterans Admin 1969</a>). Of the 15 arms with an advice element, most interventions were delivered face‐to‐face, but this was unclear in three arms (<a href="./references#CD011737-bbs2-0003" title="HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Favourable influences of linoleic acid on the progression of diabetic micro- and macroangiopathy. Nutrition and Metabolism1980;24(Suppl 1):105-18. HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Influence of different diets on the progression of diabetic retinopathy. Progress in Food Nutritition and Science1980;4(5):41-6. HoutsmullerAJ , ZahnKJ , HenkesHE . Unsaturated fats and progression of diabetic retinopathy. Documenta Ophthalmologia1979;48(2):363-71. ">Houtsmuller 1979</a>; <a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose corn oil 1965</a>; <a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose olive 1965</a>). Advice was provided individually in nine intervention arms (followed by later group sessions in two arms), in groups only in two trials (<a href="./references#CD011737-bbs2-0004" title="LeySJ , MetcalfPA , ScraggRK , SwinburnBA . Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance. Diabetes Research and Clinical Practice2004;63(2):103-12. SwinburnBA , MetcalfPA , LeySJ . Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care2001;24(4):619-24. SwinburnBA , WoollardGA , ChangEC , WilsonMR . Effects of reduced-fat diets consumed ad libitum on intake of nutrients particularly antioxidant vitamins. Journal of the American Dietetic Association1999;99(11):1400-5. ">Ley 2004</a>; <a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>), and was unclear in three RCTs (<a href="./references#CD011737-bbs2-0001" title="BlackHS , HerdJA , GoldbergLH , Wolf JE Jr, ThornbyJI , RosenT , et al. Effect of a low-fat diet on the incidence of actinic keratosis. New England Journal of Medicine1994;330(18):1272-5. BlackHS , ThornbyJI , Wolf JE Jr, GoldbergLH , HerdJA , RosenT , et al. Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer. International Journal of Cancer1995;62(2):165-9. JaaxS , ScottLW , Wolf JE Jr, ThornbyJI , BlackHS . General guidelines for a low-fat diet effective in the management and prevention of nonmelanoma skin cancer. Nutrition and Cancer1997;27(2):150-6. ">Black 1994</a>; <a href="./references#CD011737-bbs2-0003" title="HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Favourable influences of linoleic acid on the progression of diabetic micro- and macroangiopathy. Nutrition and Metabolism1980;24(Suppl 1):105-18. HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Influence of different diets on the progression of diabetic retinopathy. Progress in Food Nutritition and Science1980;4(5):41-6. HoutsmullerAJ , ZahnKJ , HenkesHE . Unsaturated fats and progression of diabetic retinopathy. Documenta Ophthalmologia1979;48(2):363-71. ">Houtsmuller 1979</a>; <a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose corn oil 1965</a>; <a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose olive 1965</a>). Advice was provided by a dietitian in nine arms, a nutritionist in one, a trained nurse in one and was unclear in four. Frequency of study visits for advice and follow‐up varied between three times in the first year and twice annually thereafter up to 18 sessions in the first year and quarterly maintenance visits thereafter. </p> <p>Of the 15 included studies (16 intervention arms), 11 RCTs (12 comparisons) provided data on all‐cause mortality (including 55,858 participants and 3518 deaths), 10 RCTs (11 comparisons) on CV mortality (53,421 participants and 1096 cardiovascular deaths), and 11 RCTs (12 comparisons) on combined cardiovascular CVD events (53,300 participants, of whom 4476 participants experienced at least one CVD event) (<a href="#CD011737-tbl-0003">Table 2</a>). In two included studies, it was clear that events had occurred, but it was not clear in which arm(s) the events had occurred (<a href="./references#CD011737-bbs2-0008" title="CoppackSW , DollHA , PimB , HockadayTD . Intravenous glucose tolerance and mortality in non-insulin-dependant diabetes mellitus. Quarterly Journal of Medicine1990;75(277):451-60. HillsonRM , HockadayTD , MannJI , NewtonDJ . Hyperinsulinaemia is associated with development of ECG abnormalities in diabetics. Diabetes Research1984;1(3):143-9. HockadayTD , HockadayJM , MannJI , TurnerRC . Prospective comparison of modified fat-high-carbohydrate with standard low-carbohydrate dietary advice in the treatment of diabetes: one year follow-up study. British Journal of Nutrition1978;39(2):357-62. Howard-WilliamsJ , PatelP , JelfsR , CarterRD , AwdryP , BronA , et al. Polyunsaturated fatty acids and diabetic retinopathy. British Journal of Ophthalmology1985;69(1):15-8. Lopez-EspinozaI , HowardWJ , MannJI , CarterRD , HockadayTD . Fatty acid composition of platelet phospholipids in non-insulin-dependent diabetics randomized for dietary advice. British Journal of Nutrition1984;52(1):41-7. ">Oxford Retinopathy 1978</a>; <a href="./references#CD011737-bbs2-0011" title="DjuricZ , HeilbrunLK , ReadingBA , BoomerA , ValerioteFA , MartinoS . Effects of a low fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells. Journal of the National Cancer Institute1991;83(11):766-9. DjuricZ , MartinoS , HeilbrunLK , HartRW . Dietary modulation of oxidative DNA damage. Advances In Experimental Medicine and Biology1994;354:71-83. KasimSE , MartinoS , Kim P-N, KhilnaniS , BoomerA , DepperJ , et al. Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women. American Journal of Clinical Nutrition1993;57(2):146-53. SimonMS , HeilbrunLK , BoomerA , KresgeC , DepperJ , KimPN , et al. A randomised trial of a low-fat dietary intervention in women at high risk for breast cancer. Nutrition and Cancer1997;27(2):136-42. ">Simon 1997</a>), so that we could not include the data in the meta‐analyses. Secondary health events and other secondary outcomes were reported in varying number of studies (between 1 and 15 studies reported on any single outcome, see <a href="#CD011737-tbl-0003">Table 2</a> and <a href="#CD011737-tbl-0004">Table 3</a>). </p> <div class="table" id="CD011737-tbl-0003"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Number of participants and number of outcomes for dichotomous variables (by intervention arm)</span></div> <tbody> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>All‐cause mortality</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>CV mortality</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>CVD events</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>MI</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Non‐fatal MI</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Stroke</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>CHD mortality</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>CHD events</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Diabetes Diagnoses</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0001" title="BlackHS , HerdJA , GoldbergLH , Wolf JE Jr, ThornbyJI , RosenT , et al. Effect of a low-fat diet on the incidence of actinic keratosis. New England Journal of Medicine1994;330(18):1272-5. BlackHS , ThornbyJI , Wolf JE Jr, GoldbergLH , HerdJA , RosenT , et al. Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer. International Journal of Cancer1995;62(2):165-9. JaaxS , ScottLW , Wolf JE Jr, ThornbyJI , BlackHS . General guidelines for a low-fat diet effective in the management and prevention of nonmelanoma skin cancer. Nutrition and Cancer1997;27(2):150-6. "><b>Black 1994</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0002" title="BurrML , FehilyAM , GilbertJF , RogersS , HollidayRM , SweetnamPM , et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet1989;2(8666):757-61. BurrML , FehilyAM , RogersS , WelsbyE , KingS , SandhamS . Diet and reinfarction trial (DART): design, recruitment, and compliance. European Heart Journal1989;10(6):558-67. BurrML , FehilyAM . Fish and the heart. Lancet1989;ii:1450-2. BurrML , HollidayRM , FehilyAM , WhiteheadPJ . Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). European Heart Journal1992;13(2):166-70. BurrML , SweethamPM , FehilyAM . Diet and reinfarction [letter]. European Heart Journal1994;15(8):1152-3. FehilyAM , Vaughan-WilliamsE , ShielsK , WilliamsAH , HornerM , BinghamG , et al. The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART). Journal of Human Nutrition &amp; Dietetics1989;2(4):225-5. "><b>DART 1989</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0003" title="HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Favourable influences of linoleic acid on the progression of diabetic micro- and macroangiopathy. Nutrition and Metabolism1980;24(Suppl 1):105-18. HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Influence of different diets on the progression of diabetic retinopathy. Progress in Food Nutritition and Science1980;4(5):41-6. HoutsmullerAJ , ZahnKJ , HenkesHE . Unsaturated fats and progression of diabetic retinopathy. Documenta Ophthalmologia1979;48(2):363-71. "><b>Houtsmuller 1979</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0004" title="LeySJ , MetcalfPA , ScraggRK , SwinburnBA . Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance. Diabetes Research and Clinical Practice2004;63(2):103-12. SwinburnBA , MetcalfPA , LeySJ . Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care2001;24(4):619-24. SwinburnBA , WoollardGA , ChangEC , WilsonMR . Effects of reduced-fat diets consumed ad libitum on intake of nutrients particularly antioxidant vitamins. Journal of the American Dietetic Association1999;99(11):1400-5. "><b>Ley 2004</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0005" title="MoyTF , YanekLR , RaquenoJV , BezirdjianPJ , BlumenthalRS , WilderLB , et al. Dietary counseling for high blood cholesterol in families at risk of coronary disease. Preventive Cardiology2001;4(4):158-64. "><b>Moy 2001</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0006" title="EdererF , LerenP , TurpeinenO , Frantz ID Jr. Cancer among men on cholesterol lowering diets: experience of five clinical trials. Lancet1971;2(7717):203-6. HeadyJA . Are PUFA harmful?British Medical Journal1974;1(898):115-6. MRC. Controlled trial of soya-bean oil in myocardial infarction. Lancet1968;2(570):693-9. "><b>MRC 1968</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0007" title="LerenP . Prevention of coronary heart disease, some results from the Oslo secondary and primary intervention studies. Journal of the American College of Nutrition1989;8(5):407-10. LerenP . The Oslo diet-heart study. Eleven year report. Circulation1970;42(5):935-42. LerenP . The effect of a cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial) [Virkningen av cholesterolsenkende diett hos menn som har gjennomgatt hjerteinfarkt. Et kontrollert klinisk fors/ok]. Nordisk Medicin1967;77(21):658-61. LerenP . The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Medica Scandinavia1966;466 Suppl:1-92. LerenP . The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Bulletin of the New York Academy of Medicine1968;44(8):1012-20. "><b>Oslo Diet‐Heart 1966</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0008" title="CoppackSW , DollHA , PimB , HockadayTD . Intravenous glucose tolerance and mortality in non-insulin-dependant diabetes mellitus. Quarterly Journal of Medicine1990;75(277):451-60. HillsonRM , HockadayTD , MannJI , NewtonDJ . Hyperinsulinaemia is associated with development of ECG abnormalities in diabetics. Diabetes Research1984;1(3):143-9. HockadayTD , HockadayJM , MannJI , TurnerRC . Prospective comparison of modified fat-high-carbohydrate with standard low-carbohydrate dietary advice in the treatment of diabetes: one year follow-up study. British Journal of Nutrition1978;39(2):357-62. Howard-WilliamsJ , PatelP , JelfsR , CarterRD , AwdryP , BronA , et al. Polyunsaturated fatty acids and diabetic retinopathy. British Journal of Ophthalmology1985;69(1):15-8. Lopez-EspinozaI , HowardWJ , MannJI , CarterRD , HockadayTD . Fatty acid composition of platelet phospholipids in non-insulin-dependent diabetics randomized for dietary advice. British Journal of Nutrition1984;52(1):41-7. "><b>Oxford Retinopathy 1978</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>249 (data not provided by arm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. "><b>Rose corn oil 1965</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. "><b>Rose olive 1965</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0011" title="DjuricZ , HeilbrunLK , ReadingBA , BoomerA , ValerioteFA , MartinoS . Effects of a low fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells. Journal of the National Cancer Institute1991;83(11):766-9. DjuricZ , MartinoS , HeilbrunLK , HartRW . Dietary modulation of oxidative DNA damage. Advances In Experimental Medicine and Biology1994;354:71-83. KasimSE , MartinoS , Kim P-N, KhilnaniS , BoomerA , DepperJ , et al. Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women. American Journal of Clinical Nutrition1993;57(2):146-53. SimonMS , HeilbrunLK , BoomerA , KresgeC , DepperJ , KimPN , et al. A randomised trial of a low-fat dietary intervention in women at high risk for breast cancer. Nutrition and Cancer1997;27(2):136-42. "><b>Simon 1997</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>194 (data not provided by arm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0012" title="BlannAD , JacksonP , BathPM , WattsGF . Von Willebrand factor, a possible indicator of endothelial cell damage, decreases during long-term compliance with a lipid-lowering diet. Journal of Internal Medicine1995;237(6):557-61. WattsGF , BruntJN , ColtartDJ , LewisB . The St. Thomas Atherosclerosis Regression Study (STARS). Atherosclerosis1992;97:231. WattsGF , JacksonP , BurkeV , LewisB . Dietary fatty acids and progression of coronary artery disease in men. American Journal of Clinical Nutrition1996;64(2):202-9. WattsGF , JacksonP , MandaliaS , BruntJN , LewisES , ColtartDJ , et al. Nutrient intake and progression of coronary artery disease. American Journal of Cardiology1994;73(5):328-32. WattsGF , LewisB , BruntJN , LewisES , ColtartDJ , SmithLD , et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet1992;339(8793):563-9. WattsGF , LewisB , BruntJNH , SwanAV . Coronary atheroma regression trials. Lancet1992;339(i):1241-3. WattsGF , LewisB , JacksonP , BurkeV , LewisES , BruntJN , et al. Relationships between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography. Canadian Journal of Cardiology1995;11(Suppl G):110G-4G. WattsGF , MandaliaS , BruntJN , SlavinBM , ColtartDJ , LewisB . Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism: Clinical and Experimental1993;42(11):1461-7. WattsGF , MandaliaS , SlavinBM , BruntJN , ColtartDJ , LewisB . Metabolic determinants of the course of coronary artery disease in men. Clinical Chemistry1994;40(12):2240-6. WattsGF . Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group. Journal of Cardiovascular Pharmacology1995;25(Suppl 4):S11-9. "><b>STARS 1992</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0013" title="BlacketRB , LeelarthaepinB , McGilchristC , PalmerAJ , WoodhillJM . The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart disease. Australian and New Zealand Journal of Medicine1979;9(5):521-9. RamsdenCE , ZamoraD , LeelarthaepinB , Majchrzak-HongSF , FaurotKR , SuchindranCM , et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ2013;346:e8707. [DOI: 10.1136/bmj.e8707]WoodhillJM , PalmerAJ , LeelarthaepinB , McGilchristC , BlacketRB . Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Advances in Experimental Medicine and Biology1978;109:317-30. "><b>Sydney Diet‐Heart 1978</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. "><b>Veterans Admin 1969</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. "><b>WHI 2006</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0016" title="ChlebowskiRT , BlackburnGL , BuzzardIM , RoseDP , MartinoS , KhandekarJD , et al. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. Journal of Clinical Oncology1993;11(11):2072-80. ChlebowskiRT , BlackburnGL , ThomsonCA , NixonDW , ShapiroA , HoyMK , et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition study. Journal of the National Cancer Institute2006;98(24):1767-76. ChlebowskiRT , BlackburnGL . Final survival analysis from the randomized Womens Intervention Nutrition Study (WINS) evaluating dietary intervention as adjuvant breast cancer therapy. Cancer Research2015;75(9 Supplement):S5-08. ChlebowskiRT , RoseD , BlackburnG , BuzzardM , KhandekarJ , YorkR , et al. Feasibility of using dietary fat intake reduction in adjuvant breast cancer management. Proceedings of American Society of Clinical Oncology1991;86:86. ChlebowskiRT , RoseDP , BuzzardIM , BlackburnGL , YorkM , Insull W Jr, et al. Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues. Adjuvant: the Cancer Journal1990;6:357-63. HoyMK , WintersBL , ChlebowskiRT , PapoutsakisC , ShapiroA , LubinMP , et al. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study. Journal of the American Dietetic Association2009;109(4):688-96. RoseDP , ChlebowskiRT , ConnollyJM , JonesLA , WynderEL . Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Cancer Research1992;52(19):5386-90. RoseDP , ConnollyJM , ChlebowskiRT , BuzzardIM , WynderEL . The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Research &amp; Treatment1993;27(3):253-62. WynderEL , CohenLA , WintersBL . The challenges of assessing fat intake in cancer research investigations. Journal of the American Dietetic Association1997;97(7 Suppl):S5-8. "><b>WINS 2006</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total Participants</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56,675</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55,858</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53,421</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53,758</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53,167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52,834</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50,952</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53,159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53,199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Percent of participants for this outcome</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>93%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86%</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>These numbers are the numbers of participants in each study who were available for assessment of outcomes within meta‐analysis (not necessarily the number of participants randomised within the trial). </p> <p>CHD: coronary heart disease<br/>CV: cardiovascular<br/>CVD: cardiovascular disease </p> </div> </div> <div class="table" id="CD011737-tbl-0004"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Number of participants and number of participants with data for continuous outcomes (by intervention arm)</span></div> <tbody> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total cholesterol</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>LDL cholesterol</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>HDL cholesterol</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Triglycerides</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>TG/HDL ratio</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total cholesterol/HDL ratio</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>LDL/HDL ratio</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>LP (a)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Insulin sensitivity</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0001" title="BlackHS , HerdJA , GoldbergLH , Wolf JE Jr, ThornbyJI , RosenT , et al. Effect of a low-fat diet on the incidence of actinic keratosis. New England Journal of Medicine1994;330(18):1272-5. BlackHS , ThornbyJI , Wolf JE Jr, GoldbergLH , HerdJA , RosenT , et al. Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer. International Journal of Cancer1995;62(2):165-9. JaaxS , ScottLW , Wolf JE Jr, ThornbyJI , BlackHS . General guidelines for a low-fat diet effective in the management and prevention of nonmelanoma skin cancer. Nutrition and Cancer1997;27(2):150-6. "><b>Black 1994</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>133</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0002" title="BurrML , FehilyAM , GilbertJF , RogersS , HollidayRM , SweetnamPM , et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet1989;2(8666):757-61. BurrML , FehilyAM , RogersS , WelsbyE , KingS , SandhamS . Diet and reinfarction trial (DART): design, recruitment, and compliance. European Heart Journal1989;10(6):558-67. BurrML , FehilyAM . Fish and the heart. Lancet1989;ii:1450-2. BurrML , HollidayRM , FehilyAM , WhiteheadPJ . Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). European Heart Journal1992;13(2):166-70. BurrML , SweethamPM , FehilyAM . Diet and reinfarction [letter]. European Heart Journal1994;15(8):1152-3. FehilyAM , Vaughan-WilliamsE , ShielsK , WilliamsAH , HornerM , BinghamG , et al. The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART). Journal of Human Nutrition &amp; Dietetics1989;2(4):225-5. "><b>DART 1989</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1855</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1855</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0003" title="HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Favourable influences of linoleic acid on the progression of diabetic micro- and macroangiopathy. Nutrition and Metabolism1980;24(Suppl 1):105-18. HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Influence of different diets on the progression of diabetic retinopathy. Progress in Food Nutritition and Science1980;4(5):41-6. HoutsmullerAJ , ZahnKJ , HenkesHE . Unsaturated fats and progression of diabetic retinopathy. Documenta Ophthalmologia1979;48(2):363-71. "><b>Houtsmuller 1979</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0004" title="LeySJ , MetcalfPA , ScraggRK , SwinburnBA . Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance. Diabetes Research and Clinical Practice2004;63(2):103-12. SwinburnBA , MetcalfPA , LeySJ . Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care2001;24(4):619-24. SwinburnBA , WoollardGA , ChangEC , WilsonMR . Effects of reduced-fat diets consumed ad libitum on intake of nutrients particularly antioxidant vitamins. Journal of the American Dietetic Association1999;99(11):1400-5. "><b>Ley 2004</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0005" title="MoyTF , YanekLR , RaquenoJV , BezirdjianPJ , BlumenthalRS , WilderLB , et al. Dietary counseling for high blood cholesterol in families at risk of coronary disease. Preventive Cardiology2001;4(4):158-64. "><b>Moy 2001</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>267</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0006" title="EdererF , LerenP , TurpeinenO , Frantz ID Jr. Cancer among men on cholesterol lowering diets: experience of five clinical trials. Lancet1971;2(7717):203-6. HeadyJA . Are PUFA harmful?British Medical Journal1974;1(898):115-6. MRC. Controlled trial of soya-bean oil in myocardial infarction. Lancet1968;2(570):693-9. "><b>MRC 1968</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0007" title="LerenP . Prevention of coronary heart disease, some results from the Oslo secondary and primary intervention studies. Journal of the American College of Nutrition1989;8(5):407-10. LerenP . The Oslo diet-heart study. Eleven year report. Circulation1970;42(5):935-42. LerenP . The effect of a cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial) [Virkningen av cholesterolsenkende diett hos menn som har gjennomgatt hjerteinfarkt. Et kontrollert klinisk fors/ok]. Nordisk Medicin1967;77(21):658-61. LerenP . The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Medica Scandinavia1966;466 Suppl:1-92. LerenP . The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Bulletin of the New York Academy of Medicine1968;44(8):1012-20. "><b>Oslo Diet‐Heart 1966</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>329</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0008" title="CoppackSW , DollHA , PimB , HockadayTD . Intravenous glucose tolerance and mortality in non-insulin-dependant diabetes mellitus. Quarterly Journal of Medicine1990;75(277):451-60. HillsonRM , HockadayTD , MannJI , NewtonDJ . Hyperinsulinaemia is associated with development of ECG abnormalities in diabetics. Diabetes Research1984;1(3):143-9. HockadayTD , HockadayJM , MannJI , TurnerRC . Prospective comparison of modified fat-high-carbohydrate with standard low-carbohydrate dietary advice in the treatment of diabetes: one year follow-up study. British Journal of Nutrition1978;39(2):357-62. Howard-WilliamsJ , PatelP , JelfsR , CarterRD , AwdryP , BronA , et al. Polyunsaturated fatty acids and diabetic retinopathy. British Journal of Ophthalmology1985;69(1):15-8. Lopez-EspinozaI , HowardWJ , MannJI , CarterRD , HockadayTD . Fatty acid composition of platelet phospholipids in non-insulin-dependent diabetics randomized for dietary advice. British Journal of Nutrition1984;52(1):41-7. "><b>Oxford Retinopathy 1978</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>249</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. "><b>Rose corn oil 1965</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. "><b>Rose olive 1965</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0011" title="DjuricZ , HeilbrunLK , ReadingBA , BoomerA , ValerioteFA , MartinoS . Effects of a low fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells. Journal of the National Cancer Institute1991;83(11):766-9. DjuricZ , MartinoS , HeilbrunLK , HartRW . Dietary modulation of oxidative DNA damage. Advances In Experimental Medicine and Biology1994;354:71-83. KasimSE , MartinoS , Kim P-N, KhilnaniS , BoomerA , DepperJ , et al. Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women. American Journal of Clinical Nutrition1993;57(2):146-53. SimonMS , HeilbrunLK , BoomerA , KresgeC , DepperJ , KimPN , et al. A randomised trial of a low-fat dietary intervention in women at high risk for breast cancer. Nutrition and Cancer1997;27(2):136-42. "><b>Simon 1997</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>194</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0012" title="BlannAD , JacksonP , BathPM , WattsGF . Von Willebrand factor, a possible indicator of endothelial cell damage, decreases during long-term compliance with a lipid-lowering diet. Journal of Internal Medicine1995;237(6):557-61. WattsGF , BruntJN , ColtartDJ , LewisB . The St. Thomas Atherosclerosis Regression Study (STARS). Atherosclerosis1992;97:231. WattsGF , JacksonP , BurkeV , LewisB . Dietary fatty acids and progression of coronary artery disease in men. American Journal of Clinical Nutrition1996;64(2):202-9. WattsGF , JacksonP , MandaliaS , BruntJN , LewisES , ColtartDJ , et al. Nutrient intake and progression of coronary artery disease. American Journal of Cardiology1994;73(5):328-32. WattsGF , LewisB , BruntJN , LewisES , ColtartDJ , SmithLD , et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet1992;339(8793):563-9. WattsGF , LewisB , BruntJNH , SwanAV . Coronary atheroma regression trials. Lancet1992;339(i):1241-3. WattsGF , LewisB , JacksonP , BurkeV , LewisES , BruntJN , et al. Relationships between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography. Canadian Journal of Cardiology1995;11(Suppl G):110G-4G. WattsGF , MandaliaS , BruntJN , SlavinBM , ColtartDJ , LewisB . Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism: Clinical and Experimental1993;42(11):1461-7. WattsGF , MandaliaS , SlavinBM , BruntJN , ColtartDJ , LewisB . Metabolic determinants of the course of coronary artery disease in men. Clinical Chemistry1994;40(12):2240-6. WattsGF . Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group. Journal of Cardiovascular Pharmacology1995;25(Suppl 4):S11-9. "><b>STARS 1992</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0013" title="BlacketRB , LeelarthaepinB , McGilchristC , PalmerAJ , WoodhillJM . The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart disease. Australian and New Zealand Journal of Medicine1979;9(5):521-9. RamsdenCE , ZamoraD , LeelarthaepinB , Majchrzak-HongSF , FaurotKR , SuchindranCM , et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ2013;346:e8707. [DOI: 10.1136/bmj.e8707]WoodhillJM , PalmerAJ , LeelarthaepinB , McGilchristC , BlacketRB . Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Advances in Experimental Medicine and Biology1978;109:317-30. "><b>Sydney Diet‐Heart 1978</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. "><b>Veterans Admin 1969</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>843</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. "><b>WHI 2006</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2832</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2832</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2832</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2832</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2832</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2832</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2832</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0016" title="ChlebowskiRT , BlackburnGL , BuzzardIM , RoseDP , MartinoS , KhandekarJD , et al. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. Journal of Clinical Oncology1993;11(11):2072-80. ChlebowskiRT , BlackburnGL , ThomsonCA , NixonDW , ShapiroA , HoyMK , et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition study. Journal of the National Cancer Institute2006;98(24):1767-76. ChlebowskiRT , BlackburnGL . Final survival analysis from the randomized Womens Intervention Nutrition Study (WINS) evaluating dietary intervention as adjuvant breast cancer therapy. Cancer Research2015;75(9 Supplement):S5-08. ChlebowskiRT , RoseD , BlackburnG , BuzzardM , KhandekarJ , YorkR , et al. Feasibility of using dietary fat intake reduction in adjuvant breast cancer management. Proceedings of American Society of Clinical Oncology1991;86:86. ChlebowskiRT , RoseDP , BuzzardIM , BlackburnGL , YorkM , Insull W Jr, et al. Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues. Adjuvant: the Cancer Journal1990;6:357-63. HoyMK , WintersBL , ChlebowskiRT , PapoutsakisC , ShapiroA , LubinMP , et al. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study. Journal of the American Dietetic Association2009;109(4):688-96. RoseDP , ChlebowskiRT , ConnollyJM , JonesLA , WynderEL . Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Cancer Research1992;52(19):5386-90. RoseDP , ConnollyJM , ChlebowskiRT , BuzzardIM , WynderEL . The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Research &amp; Treatment1993;27(3):253-62. WynderEL , CohenLA , WintersBL . The challenges of assessing fat intake in cancer research investigations. Journal of the American Dietetic Association1997;97(7 Suppl):S5-8. "><b>WINS 2006</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2437</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>196</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total Participants</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56,675</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7115</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3291</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5147</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3845</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2985</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2882</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3081</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Percent of participants for this outcome</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5%</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>These numbers are the numbers of participants in each study who were available for assessment of outcomes within meta‐analysis (not necessarily the number of participants randomised within the trial). </p> <p>HDL: high density lipoprotein<br/>LDL: low density lipoprotein<br/>Lp(a): lipoprotein (a)<br/>TG: triglyceride </p> </div> </div> </section> <section id="CD011737-sec-0040"> <h4 class="title">Excluded studies</h4> <p>We excluded 520 full‐text publications at this update, having assessed the full texts in duplicate. We describe the reasons for some of these exclusions in <a href="./references#CD011737-sec-0109" title="">Characteristics of excluded studies</a> tables. We excluded 29 studies where data on events were not reported in publications and contact with authors confirmed that there had been no deaths or cardiovascular events, where contact with authors confirmed that data were not available, or where we could not establish contact with authors. </p> </section> </section> <section id="CD011737-sec-0041"> <h3 class="title">Risk of bias in included studies</h3> <p>We display 'Risk of bias' assessments in the individual included study arms in <a href="#CD011737-fig-0002">Figure 2</a>. </p> <div class="figure" id="CD011737-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study. Please note that while Rose 1965 (Rose corn oil 1965; Rose olive 1965) appears twice in this summary, it is a single trial. Rose 1965 was a 3‐arm trial and we have used the two intervention arms separately in the review." data-id="CD011737-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-02.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. Please note that while Rose 1965 (<a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose corn oil 1965</a>; <a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose olive 1965</a>) appears twice in this summary, it is a single trial. Rose 1965 was a 3‐arm trial and we have used the two intervention arms separately in the review. </p> </div> </div> </div> <section id="CD011737-sec-0042"> <h4 class="title">Allocation</h4> <p>All the included trials were randomised controlled trials, and some detail of the randomisation process was provided for all studies, so all were considered at low risk of bias. We excluded those with detected pseudo‐random allocation (for example where participants are randomised according to birth date or alphabetically from their name). We judged allocation concealment to be well done in eight RCTs (eight comparisons, <a href="./references#CD011737-bbs2-0004" title="LeySJ , MetcalfPA , ScraggRK , SwinburnBA . Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance. Diabetes Research and Clinical Practice2004;63(2):103-12. SwinburnBA , MetcalfPA , LeySJ . Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care2001;24(4):619-24. SwinburnBA , WoollardGA , ChangEC , WilsonMR . Effects of reduced-fat diets consumed ad libitum on intake of nutrients particularly antioxidant vitamins. Journal of the American Dietetic Association1999;99(11):1400-5. ">Ley 2004</a>; <a href="./references#CD011737-bbs2-0007" title="LerenP . Prevention of coronary heart disease, some results from the Oslo secondary and primary intervention studies. Journal of the American College of Nutrition1989;8(5):407-10. LerenP . The Oslo diet-heart study. Eleven year report. Circulation1970;42(5):935-42. LerenP . The effect of a cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial) [Virkningen av cholesterolsenkende diett hos menn som har gjennomgatt hjerteinfarkt. Et kontrollert klinisk fors/ok]. Nordisk Medicin1967;77(21):658-61. LerenP . The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Medica Scandinavia1966;466 Suppl:1-92. LerenP . The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Bulletin of the New York Academy of Medicine1968;44(8):1012-20. ">Oslo Diet‐Heart 1966</a>; <a href="./references#CD011737-bbs2-0008" title="CoppackSW , DollHA , PimB , HockadayTD . Intravenous glucose tolerance and mortality in non-insulin-dependant diabetes mellitus. Quarterly Journal of Medicine1990;75(277):451-60. HillsonRM , HockadayTD , MannJI , NewtonDJ . Hyperinsulinaemia is associated with development of ECG abnormalities in diabetics. Diabetes Research1984;1(3):143-9. HockadayTD , HockadayJM , MannJI , TurnerRC . Prospective comparison of modified fat-high-carbohydrate with standard low-carbohydrate dietary advice in the treatment of diabetes: one year follow-up study. British Journal of Nutrition1978;39(2):357-62. Howard-WilliamsJ , PatelP , JelfsR , CarterRD , AwdryP , BronA , et al. Polyunsaturated fatty acids and diabetic retinopathy. British Journal of Ophthalmology1985;69(1):15-8. Lopez-EspinozaI , HowardWJ , MannJI , CarterRD , HockadayTD . Fatty acid composition of platelet phospholipids in non-insulin-dependent diabetics randomized for dietary advice. British Journal of Nutrition1984;52(1):41-7. ">Oxford Retinopathy 1978</a>; <a href="./references#CD011737-bbs2-0012" title="BlannAD , JacksonP , BathPM , WattsGF . Von Willebrand factor, a possible indicator of endothelial cell damage, decreases during long-term compliance with a lipid-lowering diet. Journal of Internal Medicine1995;237(6):557-61. WattsGF , BruntJN , ColtartDJ , LewisB . The St. Thomas Atherosclerosis Regression Study (STARS). Atherosclerosis1992;97:231. WattsGF , JacksonP , BurkeV , LewisB . Dietary fatty acids and progression of coronary artery disease in men. American Journal of Clinical Nutrition1996;64(2):202-9. WattsGF , JacksonP , MandaliaS , BruntJN , LewisES , ColtartDJ , et al. Nutrient intake and progression of coronary artery disease. American Journal of Cardiology1994;73(5):328-32. WattsGF , LewisB , BruntJN , LewisES , ColtartDJ , SmithLD , et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet1992;339(8793):563-9. WattsGF , LewisB , BruntJNH , SwanAV . Coronary atheroma regression trials. Lancet1992;339(i):1241-3. WattsGF , LewisB , JacksonP , BurkeV , LewisES , BruntJN , et al. Relationships between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography. Canadian Journal of Cardiology1995;11(Suppl G):110G-4G. WattsGF , MandaliaS , BruntJN , SlavinBM , ColtartDJ , LewisB . Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism: Clinical and Experimental1993;42(11):1461-7. WattsGF , MandaliaS , SlavinBM , BruntJN , ColtartDJ , LewisB . Metabolic determinants of the course of coronary artery disease in men. Clinical Chemistry1994;40(12):2240-6. WattsGF . Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group. Journal of Cardiovascular Pharmacology1995;25(Suppl 4):S11-9. ">STARS 1992</a>; <a href="./references#CD011737-bbs2-0013" title="BlacketRB , LeelarthaepinB , McGilchristC , PalmerAJ , WoodhillJM . The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart disease. Australian and New Zealand Journal of Medicine1979;9(5):521-9. RamsdenCE , ZamoraD , LeelarthaepinB , Majchrzak-HongSF , FaurotKR , SuchindranCM , et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ2013;346:e8707. [DOI: 10.1136/bmj.e8707]WoodhillJM , PalmerAJ , LeelarthaepinB , McGilchristC , BlacketRB . Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Advances in Experimental Medicine and Biology1978;109:317-30. ">Sydney Diet‐Heart 1978</a>; <a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. ">Veterans Admin 1969</a>; <a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>; <a href="./references#CD011737-bbs2-0016" title="ChlebowskiRT , BlackburnGL , BuzzardIM , RoseDP , MartinoS , KhandekarJD , et al. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. Journal of Clinical Oncology1993;11(11):2072-80. ChlebowskiRT , BlackburnGL , ThomsonCA , NixonDW , ShapiroA , HoyMK , et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition study. Journal of the National Cancer Institute2006;98(24):1767-76. ChlebowskiRT , BlackburnGL . Final survival analysis from the randomized Womens Intervention Nutrition Study (WINS) evaluating dietary intervention as adjuvant breast cancer therapy. Cancer Research2015;75(9 Supplement):S5-08. ChlebowskiRT , RoseD , BlackburnG , BuzzardM , KhandekarJ , YorkR , et al. Feasibility of using dietary fat intake reduction in adjuvant breast cancer management. Proceedings of American Society of Clinical Oncology1991;86:86. ChlebowskiRT , RoseDP , BuzzardIM , BlackburnGL , YorkM , Insull W Jr, et al. Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues. Adjuvant: the Cancer Journal1990;6:357-63. HoyMK , WintersBL , ChlebowskiRT , PapoutsakisC , ShapiroA , LubinMP , et al. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study. Journal of the American Dietetic Association2009;109(4):688-96. RoseDP , ChlebowskiRT , ConnollyJM , JonesLA , WynderEL . Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Cancer Research1992;52(19):5386-90. RoseDP , ConnollyJM , ChlebowskiRT , BuzzardIM , WynderEL . The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Research &amp; Treatment1993;27(3):253-62. WynderEL , CohenLA , WintersBL . The challenges of assessing fat intake in cancer research investigations. Journal of the American Dietetic Association1997;97(7 Suppl):S5-8. ">WINS 2006</a>), and unclear in the remainder. </p> </section> <section id="CD011737-sec-0043"> <h4 class="title">Blinding</h4> <p>Blinding of participants is not easy in dietary studies, as the participants usually have to follow instructions to attain the specific dietary goals. However, it is feasible in some circumstances, including when food is provided via an institutional setting, or meals provided at a central setting and remaining meals packed to take away. It can also be achieved through use of a trial shop, where very specific food‐based dietary advice is provided for all participants, or where the same dietary advice is provided to both groups but a different supplement (e.g. dietary advice to reduce fats, then provision of different oils or fats) is provided. Where participants are not blinded, it is difficult to ensure that study staff, healthcare providers and outcome assessors are blinded. The single RCT that appears to have had adequate participant and study personnel blinding was <a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. ">Veterans Admin 1969</a>, and we judged blinding of participants to be inadequate in the remaining studies. </p> <p>Blinding of outcome assessment was assessed separately for mortality and CVD outcomes. Blinding is not relevant in assessing all‐cause mortality, so all trials were considered at low risk of bias for detection bias for this outcome. For CVD outcomes, nine trials were at low risk of detection bias, one was at high risk and the remainder were unclear. </p> </section> <section id="CD011737-sec-0044"> <h4 class="title">Incomplete outcome data</h4> <p>Assessing whether incomplete outcome data had been addressed was difficult, as the primary outcomes for this review (mortality and cardiovascular events) were often reported as dropouts and exclusions from the original studies, rather than as the primary outcomes of these trials<i>.</i> When mortality or cardiovascular events or both were noted in any one study, it is still feasible that some participants left that study feeling unwell or because the diet was inconvenient, so were simply lost to follow‐up from the perspective of the study, and later died or experienced a cardiovascular event. However, six of the studies checked medical records or death registers to ensure that such events were all collected (<a href="./references#CD011737-bbs2-0001" title="BlackHS , HerdJA , GoldbergLH , Wolf JE Jr, ThornbyJI , RosenT , et al. Effect of a low-fat diet on the incidence of actinic keratosis. New England Journal of Medicine1994;330(18):1272-5. BlackHS , ThornbyJI , Wolf JE Jr, GoldbergLH , HerdJA , RosenT , et al. Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer. International Journal of Cancer1995;62(2):165-9. JaaxS , ScottLW , Wolf JE Jr, ThornbyJI , BlackHS . General guidelines for a low-fat diet effective in the management and prevention of nonmelanoma skin cancer. Nutrition and Cancer1997;27(2):150-6. ">Black 1994</a>, <a href="./references#CD011737-bbs2-0002" title="BurrML , FehilyAM , GilbertJF , RogersS , HollidayRM , SweetnamPM , et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet1989;2(8666):757-61. BurrML , FehilyAM , RogersS , WelsbyE , KingS , SandhamS . Diet and reinfarction trial (DART): design, recruitment, and compliance. European Heart Journal1989;10(6):558-67. BurrML , FehilyAM . Fish and the heart. Lancet1989;ii:1450-2. BurrML , HollidayRM , FehilyAM , WhiteheadPJ . Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). European Heart Journal1992;13(2):166-70. BurrML , SweethamPM , FehilyAM . Diet and reinfarction [letter]. European Heart Journal1994;15(8):1152-3. FehilyAM , Vaughan-WilliamsE , ShielsK , WilliamsAH , HornerM , BinghamG , et al. The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART). Journal of Human Nutrition &amp; Dietetics1989;2(4):225-5. ">DART 1989</a>; <a href="./references#CD011737-bbs2-0007" title="LerenP . Prevention of coronary heart disease, some results from the Oslo secondary and primary intervention studies. Journal of the American College of Nutrition1989;8(5):407-10. LerenP . The Oslo diet-heart study. Eleven year report. Circulation1970;42(5):935-42. LerenP . The effect of a cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial) [Virkningen av cholesterolsenkende diett hos menn som har gjennomgatt hjerteinfarkt. Et kontrollert klinisk fors/ok]. Nordisk Medicin1967;77(21):658-61. LerenP . The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Medica Scandinavia1966;466 Suppl:1-92. LerenP . The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Bulletin of the New York Academy of Medicine1968;44(8):1012-20. ">Oslo Diet‐Heart 1966</a>; <a href="./references#CD011737-bbs2-0013" title="BlacketRB , LeelarthaepinB , McGilchristC , PalmerAJ , WoodhillJM . The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart disease. Australian and New Zealand Journal of Medicine1979;9(5):521-9. RamsdenCE , ZamoraD , LeelarthaepinB , Majchrzak-HongSF , FaurotKR , SuchindranCM , et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ2013;346:e8707. [DOI: 10.1136/bmj.e8707]WoodhillJM , PalmerAJ , LeelarthaepinB , McGilchristC , BlacketRB . Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Advances in Experimental Medicine and Biology1978;109:317-30. ">Sydney Diet‐Heart 1978</a>; <a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. ">Veterans Admin 1969</a>; <a href="./references#CD011737-bbs2-0016" title="ChlebowskiRT , BlackburnGL , BuzzardIM , RoseDP , MartinoS , KhandekarJD , et al. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. Journal of Clinical Oncology1993;11(11):2072-80. ChlebowskiRT , BlackburnGL , ThomsonCA , NixonDW , ShapiroA , HoyMK , et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition study. Journal of the National Cancer Institute2006;98(24):1767-76. ChlebowskiRT , BlackburnGL . Final survival analysis from the randomized Womens Intervention Nutrition Study (WINS) evaluating dietary intervention as adjuvant breast cancer therapy. Cancer Research2015;75(9 Supplement):S5-08. ChlebowskiRT , RoseD , BlackburnG , BuzzardM , KhandekarJ , YorkR , et al. Feasibility of using dietary fat intake reduction in adjuvant breast cancer management. Proceedings of American Society of Clinical Oncology1991;86:86. ChlebowskiRT , RoseDP , BuzzardIM , BlackburnGL , YorkM , Insull W Jr, et al. Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues. Adjuvant: the Cancer Journal1990;6:357-63. HoyMK , WintersBL , ChlebowskiRT , PapoutsakisC , ShapiroA , LubinMP , et al. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study. Journal of the American Dietetic Association2009;109(4):688-96. RoseDP , ChlebowskiRT , ConnollyJM , JonesLA , WynderEL . Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Cancer Research1992;52(19):5386-90. RoseDP , ConnollyJM , ChlebowskiRT , BuzzardIM , WynderEL . The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Research &amp; Treatment1993;27(3):253-62. WynderEL , CohenLA , WintersBL . The challenges of assessing fat intake in cancer research investigations. Journal of the American Dietetic Association1997;97(7 Suppl):S5-8. ">WINS 2006</a>). Within one study, there was extensive tracking of medical records, with assessment of health status by blinded trained adjudicators (<a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>), so few major events were likely to have been missed. In the other eight studies, it is not possible to know whether additional deaths or cardiovascular events occurred, that were not counted or ascertained within this review. </p> </section> <section id="CD011737-sec-0045"> <h4 class="title">Selective reporting</h4> <p>Assessment of selective reporting is difficult when the outcome of interest was simply considered a cause of dropouts in most included studies. We tried to contact all of the trialists to ask about deaths and outcome events, but it is possible that some trialists did not reply as they felt that their data did not reflect the expected or hoped‐for pattern of events. All of the included studies have either reported that the participants did not experience any of our primary outcomes, have published their outcome data, or have provided the data they did possess. For this reason, we have graded all the included studies as at low risk of selective reporting. </p> </section> <section id="CD011737-sec-0046"> <h4 class="title">Other potential sources of bias</h4> <p><b>Systematic differences in care</b>. We assessed the studies for risk of bias in relation to systematic differences in care. The three RCTs (four comparisons) that appeared at low risk of systematic differences in care between the study arms included <a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose corn oil 1965</a>; <a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose olive 1965</a>; <a href="./references#CD011737-bbs2-0008" title="CoppackSW , DollHA , PimB , HockadayTD . Intravenous glucose tolerance and mortality in non-insulin-dependant diabetes mellitus. Quarterly Journal of Medicine1990;75(277):451-60. HillsonRM , HockadayTD , MannJI , NewtonDJ . Hyperinsulinaemia is associated with development of ECG abnormalities in diabetics. Diabetes Research1984;1(3):143-9. HockadayTD , HockadayJM , MannJI , TurnerRC . Prospective comparison of modified fat-high-carbohydrate with standard low-carbohydrate dietary advice in the treatment of diabetes: one year follow-up study. British Journal of Nutrition1978;39(2):357-62. Howard-WilliamsJ , PatelP , JelfsR , CarterRD , AwdryP , BronA , et al. Polyunsaturated fatty acids and diabetic retinopathy. British Journal of Ophthalmology1985;69(1):15-8. Lopez-EspinozaI , HowardWJ , MannJI , CarterRD , HockadayTD . Fatty acid composition of platelet phospholipids in non-insulin-dependent diabetics randomized for dietary advice. British Journal of Nutrition1984;52(1):41-7. ">Oxford Retinopathy 1978</a>; <a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. ">Veterans Admin 1969</a>, while 11 RCTs clearly did have differences in care, such as differential time provided for those on the intervention to learn a new diet, and/or differential medical follow‐up, and one was unclear (<a href="./references#CD011737-bbs2-0003" title="HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Favourable influences of linoleic acid on the progression of diabetic micro- and macroangiopathy. Nutrition and Metabolism1980;24(Suppl 1):105-18. HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Influence of different diets on the progression of diabetic retinopathy. Progress in Food Nutritition and Science1980;4(5):41-6. HoutsmullerAJ , ZahnKJ , HenkesHE . Unsaturated fats and progression of diabetic retinopathy. Documenta Ophthalmologia1979;48(2):363-71. ">Houtsmuller 1979</a>). </p> <p><b>Aim to reduce saturated fat.</b> As several studies did not provide clear aims for their interventions (other than to alter specific dietary components, for example), we assessed whether the study stated an aim to reduce saturated fat. Ten RCTs (11 comparisons) clearly aimed to reduce saturated fat in their intervention arms, either directly or indirectly, for example, by stating food goals (<a href="./references#CD011737-bbs2-0002" title="BurrML , FehilyAM , GilbertJF , RogersS , HollidayRM , SweetnamPM , et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet1989;2(8666):757-61. BurrML , FehilyAM , RogersS , WelsbyE , KingS , SandhamS . Diet and reinfarction trial (DART): design, recruitment, and compliance. European Heart Journal1989;10(6):558-67. BurrML , FehilyAM . Fish and the heart. Lancet1989;ii:1450-2. BurrML , HollidayRM , FehilyAM , WhiteheadPJ . Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). European Heart Journal1992;13(2):166-70. BurrML , SweethamPM , FehilyAM . Diet and reinfarction [letter]. European Heart Journal1994;15(8):1152-3. FehilyAM , Vaughan-WilliamsE , ShielsK , WilliamsAH , HornerM , BinghamG , et al. The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART). Journal of Human Nutrition &amp; Dietetics1989;2(4):225-5. ">DART 1989</a>; <a href="./references#CD011737-bbs2-0003" title="HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Favourable influences of linoleic acid on the progression of diabetic micro- and macroangiopathy. Nutrition and Metabolism1980;24(Suppl 1):105-18. HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Influence of different diets on the progression of diabetic retinopathy. Progress in Food Nutritition and Science1980;4(5):41-6. HoutsmullerAJ , ZahnKJ , HenkesHE . Unsaturated fats and progression of diabetic retinopathy. Documenta Ophthalmologia1979;48(2):363-71. ">Houtsmuller 1979</a>; <a href="./references#CD011737-bbs2-0005" title="MoyTF , YanekLR , RaquenoJV , BezirdjianPJ , BlumenthalRS , WilderLB , et al. Dietary counseling for high blood cholesterol in families at risk of coronary disease. Preventive Cardiology2001;4(4):158-64. ">Moy 2001</a>; <a href="./references#CD011737-bbs2-0006" title="EdererF , LerenP , TurpeinenO , Frantz ID Jr. Cancer among men on cholesterol lowering diets: experience of five clinical trials. Lancet1971;2(7717):203-6. HeadyJA . Are PUFA harmful?British Medical Journal1974;1(898):115-6. MRC. Controlled trial of soya-bean oil in myocardial infarction. Lancet1968;2(570):693-9. ">MRC 1968</a>; <a href="./references#CD011737-bbs2-0007" title="LerenP . Prevention of coronary heart disease, some results from the Oslo secondary and primary intervention studies. Journal of the American College of Nutrition1989;8(5):407-10. LerenP . The Oslo diet-heart study. Eleven year report. Circulation1970;42(5):935-42. LerenP . The effect of a cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial) [Virkningen av cholesterolsenkende diett hos menn som har gjennomgatt hjerteinfarkt. Et kontrollert klinisk fors/ok]. Nordisk Medicin1967;77(21):658-61. LerenP . The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Medica Scandinavia1966;466 Suppl:1-92. LerenP . The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Bulletin of the New York Academy of Medicine1968;44(8):1012-20. ">Oslo Diet‐Heart 1966</a>; <a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose corn oil 1965</a>; <a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose olive 1965</a>; <a href="./references#CD011737-bbs2-0012" title="BlannAD , JacksonP , BathPM , WattsGF . Von Willebrand factor, a possible indicator of endothelial cell damage, decreases during long-term compliance with a lipid-lowering diet. Journal of Internal Medicine1995;237(6):557-61. WattsGF , BruntJN , ColtartDJ , LewisB . The St. Thomas Atherosclerosis Regression Study (STARS). Atherosclerosis1992;97:231. WattsGF , JacksonP , BurkeV , LewisB . Dietary fatty acids and progression of coronary artery disease in men. American Journal of Clinical Nutrition1996;64(2):202-9. WattsGF , JacksonP , MandaliaS , BruntJN , LewisES , ColtartDJ , et al. Nutrient intake and progression of coronary artery disease. American Journal of Cardiology1994;73(5):328-32. WattsGF , LewisB , BruntJN , LewisES , ColtartDJ , SmithLD , et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet1992;339(8793):563-9. WattsGF , LewisB , BruntJNH , SwanAV . Coronary atheroma regression trials. Lancet1992;339(i):1241-3. WattsGF , LewisB , JacksonP , BurkeV , LewisES , BruntJN , et al. Relationships between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography. Canadian Journal of Cardiology1995;11(Suppl G):110G-4G. WattsGF , MandaliaS , BruntJN , SlavinBM , ColtartDJ , LewisB . Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism: Clinical and Experimental1993;42(11):1461-7. WattsGF , MandaliaS , SlavinBM , BruntJN , ColtartDJ , LewisB . Metabolic determinants of the course of coronary artery disease in men. Clinical Chemistry1994;40(12):2240-6. WattsGF . Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group. Journal of Cardiovascular Pharmacology1995;25(Suppl 4):S11-9. ">STARS 1992</a>; <a href="./references#CD011737-bbs2-0013" title="BlacketRB , LeelarthaepinB , McGilchristC , PalmerAJ , WoodhillJM . The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart disease. Australian and New Zealand Journal of Medicine1979;9(5):521-9. RamsdenCE , ZamoraD , LeelarthaepinB , Majchrzak-HongSF , FaurotKR , SuchindranCM , et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ2013;346:e8707. [DOI: 10.1136/bmj.e8707]WoodhillJM , PalmerAJ , LeelarthaepinB , McGilchristC , BlacketRB . Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Advances in Experimental Medicine and Biology1978;109:317-30. ">Sydney Diet‐Heart 1978</a>; <a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. ">Veterans Admin 1969</a>; <a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>), while the remaining five did not (although they did achieve SFA reduction). </p> <p><b>Successful saturated fat reduction</b>. Eleven RCTs (11 comparisons) assessed SFA intake during the study period and showed that SFA intake in the intervention arm was statistically significantly lower than that in the control arm (<a href="./references#CD011737-bbs2-0001" title="BlackHS , HerdJA , GoldbergLH , Wolf JE Jr, ThornbyJI , RosenT , et al. Effect of a low-fat diet on the incidence of actinic keratosis. New England Journal of Medicine1994;330(18):1272-5. BlackHS , ThornbyJI , Wolf JE Jr, GoldbergLH , HerdJA , RosenT , et al. Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer. International Journal of Cancer1995;62(2):165-9. JaaxS , ScottLW , Wolf JE Jr, ThornbyJI , BlackHS . General guidelines for a low-fat diet effective in the management and prevention of nonmelanoma skin cancer. Nutrition and Cancer1997;27(2):150-6. ">Black 1994</a>; <a href="./references#CD011737-bbs2-0002" title="BurrML , FehilyAM , GilbertJF , RogersS , HollidayRM , SweetnamPM , et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet1989;2(8666):757-61. BurrML , FehilyAM , RogersS , WelsbyE , KingS , SandhamS . Diet and reinfarction trial (DART): design, recruitment, and compliance. European Heart Journal1989;10(6):558-67. BurrML , FehilyAM . Fish and the heart. Lancet1989;ii:1450-2. BurrML , HollidayRM , FehilyAM , WhiteheadPJ . Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). European Heart Journal1992;13(2):166-70. BurrML , SweethamPM , FehilyAM . Diet and reinfarction [letter]. European Heart Journal1994;15(8):1152-3. FehilyAM , Vaughan-WilliamsE , ShielsK , WilliamsAH , HornerM , BinghamG , et al. The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART). Journal of Human Nutrition &amp; Dietetics1989;2(4):225-5. ">DART 1989</a>; <a href="./references#CD011737-bbs2-0004" title="LeySJ , MetcalfPA , ScraggRK , SwinburnBA . Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance. Diabetes Research and Clinical Practice2004;63(2):103-12. SwinburnBA , MetcalfPA , LeySJ . Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care2001;24(4):619-24. SwinburnBA , WoollardGA , ChangEC , WilsonMR . Effects of reduced-fat diets consumed ad libitum on intake of nutrients particularly antioxidant vitamins. Journal of the American Dietetic Association1999;99(11):1400-5. ">Ley 2004</a>; <a href="./references#CD011737-bbs2-0005" title="MoyTF , YanekLR , RaquenoJV , BezirdjianPJ , BlumenthalRS , WilderLB , et al. Dietary counseling for high blood cholesterol in families at risk of coronary disease. Preventive Cardiology2001;4(4):158-64. ">Moy 2001</a>; <a href="./references#CD011737-bbs2-0008" title="CoppackSW , DollHA , PimB , HockadayTD . Intravenous glucose tolerance and mortality in non-insulin-dependant diabetes mellitus. Quarterly Journal of Medicine1990;75(277):451-60. HillsonRM , HockadayTD , MannJI , NewtonDJ . Hyperinsulinaemia is associated with development of ECG abnormalities in diabetics. Diabetes Research1984;1(3):143-9. HockadayTD , HockadayJM , MannJI , TurnerRC . Prospective comparison of modified fat-high-carbohydrate with standard low-carbohydrate dietary advice in the treatment of diabetes: one year follow-up study. British Journal of Nutrition1978;39(2):357-62. Howard-WilliamsJ , PatelP , JelfsR , CarterRD , AwdryP , BronA , et al. Polyunsaturated fatty acids and diabetic retinopathy. British Journal of Ophthalmology1985;69(1):15-8. Lopez-EspinozaI , HowardWJ , MannJI , CarterRD , HockadayTD . Fatty acid composition of platelet phospholipids in non-insulin-dependent diabetics randomized for dietary advice. British Journal of Nutrition1984;52(1):41-7. ">Oxford Retinopathy 1978</a>; <a href="./references#CD011737-bbs2-0011" title="DjuricZ , HeilbrunLK , ReadingBA , BoomerA , ValerioteFA , MartinoS . Effects of a low fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells. Journal of the National Cancer Institute1991;83(11):766-9. DjuricZ , MartinoS , HeilbrunLK , HartRW . Dietary modulation of oxidative DNA damage. Advances In Experimental Medicine and Biology1994;354:71-83. KasimSE , MartinoS , Kim P-N, KhilnaniS , BoomerA , DepperJ , et al. Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women. American Journal of Clinical Nutrition1993;57(2):146-53. SimonMS , HeilbrunLK , BoomerA , KresgeC , DepperJ , KimPN , et al. A randomised trial of a low-fat dietary intervention in women at high risk for breast cancer. Nutrition and Cancer1997;27(2):136-42. ">Simon 1997</a>; <a href="./references#CD011737-bbs2-0012" title="BlannAD , JacksonP , BathPM , WattsGF . Von Willebrand factor, a possible indicator of endothelial cell damage, decreases during long-term compliance with a lipid-lowering diet. Journal of Internal Medicine1995;237(6):557-61. WattsGF , BruntJN , ColtartDJ , LewisB . The St. Thomas Atherosclerosis Regression Study (STARS). Atherosclerosis1992;97:231. WattsGF , JacksonP , BurkeV , LewisB . Dietary fatty acids and progression of coronary artery disease in men. American Journal of Clinical Nutrition1996;64(2):202-9. WattsGF , JacksonP , MandaliaS , BruntJN , LewisES , ColtartDJ , et al. Nutrient intake and progression of coronary artery disease. American Journal of Cardiology1994;73(5):328-32. WattsGF , LewisB , BruntJN , LewisES , ColtartDJ , SmithLD , et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet1992;339(8793):563-9. WattsGF , LewisB , BruntJNH , SwanAV . Coronary atheroma regression trials. Lancet1992;339(i):1241-3. WattsGF , LewisB , JacksonP , BurkeV , LewisES , BruntJN , et al. Relationships between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography. Canadian Journal of Cardiology1995;11(Suppl G):110G-4G. WattsGF , MandaliaS , BruntJN , SlavinBM , ColtartDJ , LewisB . Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism: Clinical and Experimental1993;42(11):1461-7. WattsGF , MandaliaS , SlavinBM , BruntJN , ColtartDJ , LewisB . Metabolic determinants of the course of coronary artery disease in men. Clinical Chemistry1994;40(12):2240-6. WattsGF . Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group. Journal of Cardiovascular Pharmacology1995;25(Suppl 4):S11-9. ">STARS 1992</a>; <a href="./references#CD011737-bbs2-0013" title="BlacketRB , LeelarthaepinB , McGilchristC , PalmerAJ , WoodhillJM . The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart disease. Australian and New Zealand Journal of Medicine1979;9(5):521-9. RamsdenCE , ZamoraD , LeelarthaepinB , Majchrzak-HongSF , FaurotKR , SuchindranCM , et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ2013;346:e8707. [DOI: 10.1136/bmj.e8707]WoodhillJM , PalmerAJ , LeelarthaepinB , McGilchristC , BlacketRB . Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Advances in Experimental Medicine and Biology1978;109:317-30. ">Sydney Diet‐Heart 1978</a>; <a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. ">Veterans Admin 1969</a>; <a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>; <a href="./references#CD011737-bbs2-0016" title="ChlebowskiRT , BlackburnGL , BuzzardIM , RoseDP , MartinoS , KhandekarJD , et al. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. Journal of Clinical Oncology1993;11(11):2072-80. ChlebowskiRT , BlackburnGL , ThomsonCA , NixonDW , ShapiroA , HoyMK , et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition study. Journal of the National Cancer Institute2006;98(24):1767-76. ChlebowskiRT , BlackburnGL . Final survival analysis from the randomized Womens Intervention Nutrition Study (WINS) evaluating dietary intervention as adjuvant breast cancer therapy. Cancer Research2015;75(9 Supplement):S5-08. ChlebowskiRT , RoseD , BlackburnG , BuzzardM , KhandekarJ , YorkR , et al. Feasibility of using dietary fat intake reduction in adjuvant breast cancer management. Proceedings of American Society of Clinical Oncology1991;86:86. ChlebowskiRT , RoseDP , BuzzardIM , BlackburnGL , YorkM , Insull W Jr, et al. Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues. Adjuvant: the Cancer Journal1990;6:357-63. HoyMK , WintersBL , ChlebowskiRT , PapoutsakisC , ShapiroA , LubinMP , et al. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study. Journal of the American Dietetic Association2009;109(4):688-96. RoseDP , ChlebowskiRT , ConnollyJM , JonesLA , WynderEL . Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Cancer Research1992;52(19):5386-90. RoseDP , ConnollyJM , ChlebowskiRT , BuzzardIM , WynderEL . The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Research &amp; Treatment1993;27(3):253-62. WynderEL , CohenLA , WintersBL . The challenges of assessing fat intake in cancer research investigations. Journal of the American Dietetic Association1997;97(7 Suppl):S5-8. ">WINS 2006</a>). The remaining studies did not report SFA intake, so we rated them as unclear. </p> <p><b>Successful cholesterol reduction</b>. We would expect saturated fat reduction to be reflected in total or LDL cholesterol reductions, which may be more accurate assessments than self‐reported saturated fat intake. Nine RCTs (10 comparisons) provided information on serum total or LDL cholesterol levels in the intervention and control arms during the study, and found a reduction in the intervention arm compared to the control (P &lt; 0.05, or where variances were not provided showed a reduction of at least 0.2 mmol/L in the mean intervention measure compared with control). The studies that successfully reduced serum total cholesterol in lower saturated fat arms compared with higher saturated fat arms were <a href="./references#CD011737-bbs2-0002" title="BurrML , FehilyAM , GilbertJF , RogersS , HollidayRM , SweetnamPM , et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet1989;2(8666):757-61. BurrML , FehilyAM , RogersS , WelsbyE , KingS , SandhamS . Diet and reinfarction trial (DART): design, recruitment, and compliance. European Heart Journal1989;10(6):558-67. BurrML , FehilyAM . Fish and the heart. Lancet1989;ii:1450-2. BurrML , HollidayRM , FehilyAM , WhiteheadPJ . Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). European Heart Journal1992;13(2):166-70. BurrML , SweethamPM , FehilyAM . Diet and reinfarction [letter]. European Heart Journal1994;15(8):1152-3. FehilyAM , Vaughan-WilliamsE , ShielsK , WilliamsAH , HornerM , BinghamG , et al. The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART). Journal of Human Nutrition &amp; Dietetics1989;2(4):225-5. ">DART 1989</a>; <a href="./references#CD011737-bbs2-0003" title="HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Favourable influences of linoleic acid on the progression of diabetic micro- and macroangiopathy. Nutrition and Metabolism1980;24(Suppl 1):105-18. HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Influence of different diets on the progression of diabetic retinopathy. Progress in Food Nutritition and Science1980;4(5):41-6. HoutsmullerAJ , ZahnKJ , HenkesHE . Unsaturated fats and progression of diabetic retinopathy. Documenta Ophthalmologia1979;48(2):363-71. ">Houtsmuller 1979</a>; <a href="./references#CD011737-bbs2-0011" title="DjuricZ , HeilbrunLK , ReadingBA , BoomerA , ValerioteFA , MartinoS . Effects of a low fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells. Journal of the National Cancer Institute1991;83(11):766-9. DjuricZ , MartinoS , HeilbrunLK , HartRW . Dietary modulation of oxidative DNA damage. Advances In Experimental Medicine and Biology1994;354:71-83. KasimSE , MartinoS , Kim P-N, KhilnaniS , BoomerA , DepperJ , et al. Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women. American Journal of Clinical Nutrition1993;57(2):146-53. SimonMS , HeilbrunLK , BoomerA , KresgeC , DepperJ , KimPN , et al. A randomised trial of a low-fat dietary intervention in women at high risk for breast cancer. Nutrition and Cancer1997;27(2):136-42. ">Simon 1997</a>; <a href="./references#CD011737-bbs2-0012" title="BlannAD , JacksonP , BathPM , WattsGF . Von Willebrand factor, a possible indicator of endothelial cell damage, decreases during long-term compliance with a lipid-lowering diet. Journal of Internal Medicine1995;237(6):557-61. WattsGF , BruntJN , ColtartDJ , LewisB . The St. Thomas Atherosclerosis Regression Study (STARS). Atherosclerosis1992;97:231. WattsGF , JacksonP , BurkeV , LewisB . Dietary fatty acids and progression of coronary artery disease in men. American Journal of Clinical Nutrition1996;64(2):202-9. WattsGF , JacksonP , MandaliaS , BruntJN , LewisES , ColtartDJ , et al. Nutrient intake and progression of coronary artery disease. American Journal of Cardiology1994;73(5):328-32. WattsGF , LewisB , BruntJN , LewisES , ColtartDJ , SmithLD , et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet1992;339(8793):563-9. WattsGF , LewisB , BruntJNH , SwanAV . Coronary atheroma regression trials. Lancet1992;339(i):1241-3. WattsGF , LewisB , JacksonP , BurkeV , LewisES , BruntJN , et al. Relationships between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography. Canadian Journal of Cardiology1995;11(Suppl G):110G-4G. WattsGF , MandaliaS , BruntJN , SlavinBM , ColtartDJ , LewisB . Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism: Clinical and Experimental1993;42(11):1461-7. WattsGF , MandaliaS , SlavinBM , BruntJN , ColtartDJ , LewisB . Metabolic determinants of the course of coronary artery disease in men. Clinical Chemistry1994;40(12):2240-6. WattsGF . Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group. Journal of Cardiovascular Pharmacology1995;25(Suppl 4):S11-9. ">STARS 1992</a>; <a href="./references#CD011737-bbs2-0013" title="BlacketRB , LeelarthaepinB , McGilchristC , PalmerAJ , WoodhillJM . The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart disease. Australian and New Zealand Journal of Medicine1979;9(5):521-9. RamsdenCE , ZamoraD , LeelarthaepinB , Majchrzak-HongSF , FaurotKR , SuchindranCM , et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ2013;346:e8707. [DOI: 10.1136/bmj.e8707]WoodhillJM , PalmerAJ , LeelarthaepinB , McGilchristC , BlacketRB . Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Advances in Experimental Medicine and Biology1978;109:317-30. ">Sydney Diet‐Heart 1978</a>; <a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>, while <a href="./references#CD011737-bbs2-0005" title="MoyTF , YanekLR , RaquenoJV , BezirdjianPJ , BlumenthalRS , WilderLB , et al. Dietary counseling for high blood cholesterol in families at risk of coronary disease. Preventive Cardiology2001;4(4):158-64. ">Moy 2001</a> did not report total cholesterol (TC) but showed statistically significant reductions in LDL, and two studies (<a href="./references#CD011737-bbs2-0006" title="EdererF , LerenP , TurpeinenO , Frantz ID Jr. Cancer among men on cholesterol lowering diets: experience of five clinical trials. Lancet1971;2(7717):203-6. HeadyJA . Are PUFA harmful?British Medical Journal1974;1(898):115-6. MRC. Controlled trial of soya-bean oil in myocardial infarction. Lancet1968;2(570):693-9. ">MRC 1968</a>; <a href="./references#CD011737-bbs2-0007" title="LerenP . Prevention of coronary heart disease, some results from the Oslo secondary and primary intervention studies. Journal of the American College of Nutrition1989;8(5):407-10. LerenP . The Oslo diet-heart study. Eleven year report. Circulation1970;42(5):935-42. LerenP . The effect of a cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial) [Virkningen av cholesterolsenkende diett hos menn som har gjennomgatt hjerteinfarkt. Et kontrollert klinisk fors/ok]. Nordisk Medicin1967;77(21):658-61. LerenP . The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Medica Scandinavia1966;466 Suppl:1-92. LerenP . The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Bulletin of the New York Academy of Medicine1968;44(8):1012-20. ">Oslo Diet‐Heart 1966</a>) did not report variances but did reduce mean TC in the intervention arm compared with control by at least 0.2 mm0l/L. One study (<a href="./references#CD011737-bbs2-0001" title="BlackHS , HerdJA , GoldbergLH , Wolf JE Jr, ThornbyJI , RosenT , et al. Effect of a low-fat diet on the incidence of actinic keratosis. New England Journal of Medicine1994;330(18):1272-5. BlackHS , ThornbyJI , Wolf JE Jr, GoldbergLH , HerdJA , RosenT , et al. Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer. International Journal of Cancer1995;62(2):165-9. JaaxS , ScottLW , Wolf JE Jr, ThornbyJI , BlackHS . General guidelines for a low-fat diet effective in the management and prevention of nonmelanoma skin cancer. Nutrition and Cancer1997;27(2):150-6. ">Black 1994</a>) did not report lipid levels during the study, while five others did report lipid levels but did not suggest clear differences between lower and higher saturated fat arms (<a href="./references#CD011737-bbs2-0004" title="LeySJ , MetcalfPA , ScraggRK , SwinburnBA . Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance. Diabetes Research and Clinical Practice2004;63(2):103-12. SwinburnBA , MetcalfPA , LeySJ . Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care2001;24(4):619-24. SwinburnBA , WoollardGA , ChangEC , WilsonMR . Effects of reduced-fat diets consumed ad libitum on intake of nutrients particularly antioxidant vitamins. Journal of the American Dietetic Association1999;99(11):1400-5. ">Ley 2004</a>; <a href="./references#CD011737-bbs2-0008" title="CoppackSW , DollHA , PimB , HockadayTD . Intravenous glucose tolerance and mortality in non-insulin-dependant diabetes mellitus. Quarterly Journal of Medicine1990;75(277):451-60. HillsonRM , HockadayTD , MannJI , NewtonDJ . Hyperinsulinaemia is associated with development of ECG abnormalities in diabetics. Diabetes Research1984;1(3):143-9. HockadayTD , HockadayJM , MannJI , TurnerRC . Prospective comparison of modified fat-high-carbohydrate with standard low-carbohydrate dietary advice in the treatment of diabetes: one year follow-up study. British Journal of Nutrition1978;39(2):357-62. Howard-WilliamsJ , PatelP , JelfsR , CarterRD , AwdryP , BronA , et al. Polyunsaturated fatty acids and diabetic retinopathy. British Journal of Ophthalmology1985;69(1):15-8. Lopez-EspinozaI , HowardWJ , MannJI , CarterRD , HockadayTD . Fatty acid composition of platelet phospholipids in non-insulin-dependent diabetics randomized for dietary advice. British Journal of Nutrition1984;52(1):41-7. ">Oxford Retinopathy 1978</a>; <a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose corn oil 1965</a>; <a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose olive 1965</a>; <a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. ">Veterans Admin 1969</a>; <a href="./references#CD011737-bbs2-0016" title="ChlebowskiRT , BlackburnGL , BuzzardIM , RoseDP , MartinoS , KhandekarJD , et al. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. Journal of Clinical Oncology1993;11(11):2072-80. ChlebowskiRT , BlackburnGL , ThomsonCA , NixonDW , ShapiroA , HoyMK , et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition study. Journal of the National Cancer Institute2006;98(24):1767-76. ChlebowskiRT , BlackburnGL . Final survival analysis from the randomized Womens Intervention Nutrition Study (WINS) evaluating dietary intervention as adjuvant breast cancer therapy. Cancer Research2015;75(9 Supplement):S5-08. ChlebowskiRT , RoseD , BlackburnG , BuzzardM , KhandekarJ , YorkR , et al. Feasibility of using dietary fat intake reduction in adjuvant breast cancer management. Proceedings of American Society of Clinical Oncology1991;86:86. ChlebowskiRT , RoseDP , BuzzardIM , BlackburnGL , YorkM , Insull W Jr, et al. Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues. Adjuvant: the Cancer Journal1990;6:357-63. HoyMK , WintersBL , ChlebowskiRT , PapoutsakisC , ShapiroA , LubinMP , et al. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study. Journal of the American Dietetic Association2009;109(4):688-96. RoseDP , ChlebowskiRT , ConnollyJM , JonesLA , WynderEL . Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Cancer Research1992;52(19):5386-90. RoseDP , ConnollyJM , ChlebowskiRT , BuzzardIM , WynderEL . The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Research &amp; Treatment1993;27(3):253-62. WynderEL , CohenLA , WintersBL . The challenges of assessing fat intake in cancer research investigations. Journal of the American Dietetic Association1997;97(7 Suppl):S5-8. ">WINS 2006</a>). </p> <p><b>Dietary changes other than saturated fat</b>. Some trials were partially confounded by aiming to make dietary changes other than those directly related to dietary fat intakes; for example, some studies encouraged intervention participants to make changes to their fat intake as well as changes to fruit and vegetable or fibre or salt intakes. In these studies, any effect on outcomes could be a result of other dietary changes, not of changes in saturated fat intake. The 11 studies (12 comparisons) that appeared free of such differences included <a href="./references#CD011737-bbs2-0001" title="BlackHS , HerdJA , GoldbergLH , Wolf JE Jr, ThornbyJI , RosenT , et al. Effect of a low-fat diet on the incidence of actinic keratosis. New England Journal of Medicine1994;330(18):1272-5. BlackHS , ThornbyJI , Wolf JE Jr, GoldbergLH , HerdJA , RosenT , et al. Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer. International Journal of Cancer1995;62(2):165-9. JaaxS , ScottLW , Wolf JE Jr, ThornbyJI , BlackHS . General guidelines for a low-fat diet effective in the management and prevention of nonmelanoma skin cancer. Nutrition and Cancer1997;27(2):150-6. ">Black 1994</a>; <a href="./references#CD011737-bbs2-0002" title="BurrML , FehilyAM , GilbertJF , RogersS , HollidayRM , SweetnamPM , et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet1989;2(8666):757-61. BurrML , FehilyAM , RogersS , WelsbyE , KingS , SandhamS . Diet and reinfarction trial (DART): design, recruitment, and compliance. European Heart Journal1989;10(6):558-67. BurrML , FehilyAM . Fish and the heart. Lancet1989;ii:1450-2. BurrML , HollidayRM , FehilyAM , WhiteheadPJ . Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). European Heart Journal1992;13(2):166-70. BurrML , SweethamPM , FehilyAM . Diet and reinfarction [letter]. European Heart Journal1994;15(8):1152-3. FehilyAM , Vaughan-WilliamsE , ShielsK , WilliamsAH , HornerM , BinghamG , et al. The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART). Journal of Human Nutrition &amp; Dietetics1989;2(4):225-5. ">DART 1989</a>; <a href="./references#CD011737-bbs2-0003" title="HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Favourable influences of linoleic acid on the progression of diabetic micro- and macroangiopathy. Nutrition and Metabolism1980;24(Suppl 1):105-18. HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Influence of different diets on the progression of diabetic retinopathy. Progress in Food Nutritition and Science1980;4(5):41-6. HoutsmullerAJ , ZahnKJ , HenkesHE . Unsaturated fats and progression of diabetic retinopathy. Documenta Ophthalmologia1979;48(2):363-71. ">Houtsmuller 1979</a>; <a href="./references#CD011737-bbs2-0004" title="LeySJ , MetcalfPA , ScraggRK , SwinburnBA . Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance. Diabetes Research and Clinical Practice2004;63(2):103-12. SwinburnBA , MetcalfPA , LeySJ . Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care2001;24(4):619-24. SwinburnBA , WoollardGA , ChangEC , WilsonMR . Effects of reduced-fat diets consumed ad libitum on intake of nutrients particularly antioxidant vitamins. Journal of the American Dietetic Association1999;99(11):1400-5. ">Ley 2004</a>; <a href="./references#CD011737-bbs2-0006" title="EdererF , LerenP , TurpeinenO , Frantz ID Jr. Cancer among men on cholesterol lowering diets: experience of five clinical trials. Lancet1971;2(7717):203-6. HeadyJA . Are PUFA harmful?British Medical Journal1974;1(898):115-6. MRC. Controlled trial of soya-bean oil in myocardial infarction. Lancet1968;2(570):693-9. ">MRC 1968</a>; <a href="./references#CD011737-bbs2-0008" title="CoppackSW , DollHA , PimB , HockadayTD . Intravenous glucose tolerance and mortality in non-insulin-dependant diabetes mellitus. Quarterly Journal of Medicine1990;75(277):451-60. HillsonRM , HockadayTD , MannJI , NewtonDJ . Hyperinsulinaemia is associated with development of ECG abnormalities in diabetics. Diabetes Research1984;1(3):143-9. HockadayTD , HockadayJM , MannJI , TurnerRC . Prospective comparison of modified fat-high-carbohydrate with standard low-carbohydrate dietary advice in the treatment of diabetes: one year follow-up study. British Journal of Nutrition1978;39(2):357-62. Howard-WilliamsJ , PatelP , JelfsR , CarterRD , AwdryP , BronA , et al. Polyunsaturated fatty acids and diabetic retinopathy. British Journal of Ophthalmology1985;69(1):15-8. Lopez-EspinozaI , HowardWJ , MannJI , CarterRD , HockadayTD . Fatty acid composition of platelet phospholipids in non-insulin-dependent diabetics randomized for dietary advice. British Journal of Nutrition1984;52(1):41-7. ">Oxford Retinopathy 1978</a>; <a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose corn oil 1965</a>; <a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose olive 1965</a>; <a href="./references#CD011737-bbs2-0011" title="DjuricZ , HeilbrunLK , ReadingBA , BoomerA , ValerioteFA , MartinoS . Effects of a low fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells. Journal of the National Cancer Institute1991;83(11):766-9. DjuricZ , MartinoS , HeilbrunLK , HartRW . Dietary modulation of oxidative DNA damage. Advances In Experimental Medicine and Biology1994;354:71-83. KasimSE , MartinoS , Kim P-N, KhilnaniS , BoomerA , DepperJ , et al. Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women. American Journal of Clinical Nutrition1993;57(2):146-53. SimonMS , HeilbrunLK , BoomerA , KresgeC , DepperJ , KimPN , et al. A randomised trial of a low-fat dietary intervention in women at high risk for breast cancer. Nutrition and Cancer1997;27(2):136-42. ">Simon 1997</a>; <a href="./references#CD011737-bbs2-0013" title="BlacketRB , LeelarthaepinB , McGilchristC , PalmerAJ , WoodhillJM . The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart disease. Australian and New Zealand Journal of Medicine1979;9(5):521-9. RamsdenCE , ZamoraD , LeelarthaepinB , Majchrzak-HongSF , FaurotKR , SuchindranCM , et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ2013;346:e8707. [DOI: 10.1136/bmj.e8707]WoodhillJM , PalmerAJ , LeelarthaepinB , McGilchristC , BlacketRB . Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Advances in Experimental Medicine and Biology1978;109:317-30. ">Sydney Diet‐Heart 1978</a>; <a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. ">Veterans Admin 1969</a>; <a href="./references#CD011737-bbs2-0016" title="ChlebowskiRT , BlackburnGL , BuzzardIM , RoseDP , MartinoS , KhandekarJD , et al. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. Journal of Clinical Oncology1993;11(11):2072-80. ChlebowskiRT , BlackburnGL , ThomsonCA , NixonDW , ShapiroA , HoyMK , et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition study. Journal of the National Cancer Institute2006;98(24):1767-76. ChlebowskiRT , BlackburnGL . Final survival analysis from the randomized Womens Intervention Nutrition Study (WINS) evaluating dietary intervention as adjuvant breast cancer therapy. Cancer Research2015;75(9 Supplement):S5-08. ChlebowskiRT , RoseD , BlackburnG , BuzzardM , KhandekarJ , YorkR , et al. Feasibility of using dietary fat intake reduction in adjuvant breast cancer management. Proceedings of American Society of Clinical Oncology1991;86:86. ChlebowskiRT , RoseDP , BuzzardIM , BlackburnGL , YorkM , Insull W Jr, et al. Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues. Adjuvant: the Cancer Journal1990;6:357-63. HoyMK , WintersBL , ChlebowskiRT , PapoutsakisC , ShapiroA , LubinMP , et al. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study. Journal of the American Dietetic Association2009;109(4):688-96. RoseDP , ChlebowskiRT , ConnollyJM , JonesLA , WynderEL . Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Cancer Research1992;52(19):5386-90. RoseDP , ConnollyJM , ChlebowskiRT , BuzzardIM , WynderEL . The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Research &amp; Treatment1993;27(3):253-62. WynderEL , CohenLA , WintersBL . The challenges of assessing fat intake in cancer research investigations. Journal of the American Dietetic Association1997;97(7 Suppl):S5-8. ">WINS 2006</a>. This factor was not considered alongside others in the formal risk of bias assessment (<a href="#CD011737-fig-0002">Figure 2</a>) so is described here. We did not identify any further methodological issues. </p> <p><b>Summary risk of bias.</b> We considered dietary advice or all‐food‐provided type trials to be at low summary risk of bias where we judged randomisation, allocation concealment, and blinding of outcome assessors to be adequate. For CVD outcomes, five trials were assessed as at low summary risk of bias: <a href="./references#CD011737-bbs2-0004" title="LeySJ , MetcalfPA , ScraggRK , SwinburnBA . Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance. Diabetes Research and Clinical Practice2004;63(2):103-12. SwinburnBA , MetcalfPA , LeySJ . Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care2001;24(4):619-24. SwinburnBA , WoollardGA , ChangEC , WilsonMR . Effects of reduced-fat diets consumed ad libitum on intake of nutrients particularly antioxidant vitamins. Journal of the American Dietetic Association1999;99(11):1400-5. ">Ley 2004</a>; <a href="./references#CD011737-bbs2-0013" title="BlacketRB , LeelarthaepinB , McGilchristC , PalmerAJ , WoodhillJM . The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart disease. Australian and New Zealand Journal of Medicine1979;9(5):521-9. RamsdenCE , ZamoraD , LeelarthaepinB , Majchrzak-HongSF , FaurotKR , SuchindranCM , et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ2013;346:e8707. [DOI: 10.1136/bmj.e8707]WoodhillJM , PalmerAJ , LeelarthaepinB , McGilchristC , BlacketRB . Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Advances in Experimental Medicine and Biology1978;109:317-30. ">Sydney Diet‐Heart 1978</a>; <a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. ">Veterans Admin 1969</a>; <a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>; <a href="./references#CD011737-bbs2-0016" title="ChlebowskiRT , BlackburnGL , BuzzardIM , RoseDP , MartinoS , KhandekarJD , et al. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. Journal of Clinical Oncology1993;11(11):2072-80. ChlebowskiRT , BlackburnGL , ThomsonCA , NixonDW , ShapiroA , HoyMK , et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition study. Journal of the National Cancer Institute2006;98(24):1767-76. ChlebowskiRT , BlackburnGL . Final survival analysis from the randomized Womens Intervention Nutrition Study (WINS) evaluating dietary intervention as adjuvant breast cancer therapy. Cancer Research2015;75(9 Supplement):S5-08. ChlebowskiRT , RoseD , BlackburnG , BuzzardM , KhandekarJ , YorkR , et al. Feasibility of using dietary fat intake reduction in adjuvant breast cancer management. Proceedings of American Society of Clinical Oncology1991;86:86. ChlebowskiRT , RoseDP , BuzzardIM , BlackburnGL , YorkM , Insull W Jr, et al. Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues. Adjuvant: the Cancer Journal1990;6:357-63. HoyMK , WintersBL , ChlebowskiRT , PapoutsakisC , ShapiroA , LubinMP , et al. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study. Journal of the American Dietetic Association2009;109(4):688-96. RoseDP , ChlebowskiRT , ConnollyJM , JonesLA , WynderEL . Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Cancer Research1992;52(19):5386-90. RoseDP , ConnollyJM , ChlebowskiRT , BuzzardIM , WynderEL . The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Research &amp; Treatment1993;27(3):253-62. WynderEL , CohenLA , WintersBL . The challenges of assessing fat intake in cancer research investigations. Journal of the American Dietetic Association1997;97(7 Suppl):S5-8. ">WINS 2006</a>. For all‐cause mortality (and lipid outcomes) where blinding of outcome assessors is not important, a further three trials were also at low summary risk of bias, eight in total: <a href="./references#CD011737-bbs2-0004" title="LeySJ , MetcalfPA , ScraggRK , SwinburnBA . Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance. Diabetes Research and Clinical Practice2004;63(2):103-12. SwinburnBA , MetcalfPA , LeySJ . Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care2001;24(4):619-24. SwinburnBA , WoollardGA , ChangEC , WilsonMR . Effects of reduced-fat diets consumed ad libitum on intake of nutrients particularly antioxidant vitamins. Journal of the American Dietetic Association1999;99(11):1400-5. ">Ley 2004</a>; <a href="./references#CD011737-bbs2-0007" title="LerenP . Prevention of coronary heart disease, some results from the Oslo secondary and primary intervention studies. Journal of the American College of Nutrition1989;8(5):407-10. LerenP . The Oslo diet-heart study. Eleven year report. Circulation1970;42(5):935-42. LerenP . The effect of a cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial) [Virkningen av cholesterolsenkende diett hos menn som har gjennomgatt hjerteinfarkt. Et kontrollert klinisk fors/ok]. Nordisk Medicin1967;77(21):658-61. LerenP . The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Medica Scandinavia1966;466 Suppl:1-92. LerenP . The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Bulletin of the New York Academy of Medicine1968;44(8):1012-20. ">Oslo Diet‐Heart 1966</a>; <a href="./references#CD011737-bbs2-0008" title="CoppackSW , DollHA , PimB , HockadayTD . Intravenous glucose tolerance and mortality in non-insulin-dependant diabetes mellitus. Quarterly Journal of Medicine1990;75(277):451-60. HillsonRM , HockadayTD , MannJI , NewtonDJ . Hyperinsulinaemia is associated with development of ECG abnormalities in diabetics. Diabetes Research1984;1(3):143-9. HockadayTD , HockadayJM , MannJI , TurnerRC . Prospective comparison of modified fat-high-carbohydrate with standard low-carbohydrate dietary advice in the treatment of diabetes: one year follow-up study. British Journal of Nutrition1978;39(2):357-62. Howard-WilliamsJ , PatelP , JelfsR , CarterRD , AwdryP , BronA , et al. Polyunsaturated fatty acids and diabetic retinopathy. British Journal of Ophthalmology1985;69(1):15-8. Lopez-EspinozaI , HowardWJ , MannJI , CarterRD , HockadayTD . Fatty acid composition of platelet phospholipids in non-insulin-dependent diabetics randomized for dietary advice. British Journal of Nutrition1984;52(1):41-7. ">Oxford Retinopathy 1978</a>; <a href="./references#CD011737-bbs2-0012" title="BlannAD , JacksonP , BathPM , WattsGF . Von Willebrand factor, a possible indicator of endothelial cell damage, decreases during long-term compliance with a lipid-lowering diet. Journal of Internal Medicine1995;237(6):557-61. WattsGF , BruntJN , ColtartDJ , LewisB . The St. Thomas Atherosclerosis Regression Study (STARS). Atherosclerosis1992;97:231. WattsGF , JacksonP , BurkeV , LewisB . Dietary fatty acids and progression of coronary artery disease in men. American Journal of Clinical Nutrition1996;64(2):202-9. WattsGF , JacksonP , MandaliaS , BruntJN , LewisES , ColtartDJ , et al. Nutrient intake and progression of coronary artery disease. American Journal of Cardiology1994;73(5):328-32. WattsGF , LewisB , BruntJN , LewisES , ColtartDJ , SmithLD , et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet1992;339(8793):563-9. WattsGF , LewisB , BruntJNH , SwanAV . Coronary atheroma regression trials. Lancet1992;339(i):1241-3. WattsGF , LewisB , JacksonP , BurkeV , LewisES , BruntJN , et al. Relationships between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography. Canadian Journal of Cardiology1995;11(Suppl G):110G-4G. WattsGF , MandaliaS , BruntJN , SlavinBM , ColtartDJ , LewisB . Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism: Clinical and Experimental1993;42(11):1461-7. WattsGF , MandaliaS , SlavinBM , BruntJN , ColtartDJ , LewisB . Metabolic determinants of the course of coronary artery disease in men. Clinical Chemistry1994;40(12):2240-6. WattsGF . Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group. Journal of Cardiovascular Pharmacology1995;25(Suppl 4):S11-9. ">STARS 1992</a>; <a href="./references#CD011737-bbs2-0013" title="BlacketRB , LeelarthaepinB , McGilchristC , PalmerAJ , WoodhillJM . The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart disease. Australian and New Zealand Journal of Medicine1979;9(5):521-9. RamsdenCE , ZamoraD , LeelarthaepinB , Majchrzak-HongSF , FaurotKR , SuchindranCM , et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ2013;346:e8707. [DOI: 10.1136/bmj.e8707]WoodhillJM , PalmerAJ , LeelarthaepinB , McGilchristC , BlacketRB . Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Advances in Experimental Medicine and Biology1978;109:317-30. ">Sydney Diet‐Heart 1978</a>; <a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. ">Veterans Admin 1969</a>; <a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>; <a href="./references#CD011737-bbs2-0016" title="ChlebowskiRT , BlackburnGL , BuzzardIM , RoseDP , MartinoS , KhandekarJD , et al. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. Journal of Clinical Oncology1993;11(11):2072-80. ChlebowskiRT , BlackburnGL , ThomsonCA , NixonDW , ShapiroA , HoyMK , et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition study. Journal of the National Cancer Institute2006;98(24):1767-76. ChlebowskiRT , BlackburnGL . Final survival analysis from the randomized Womens Intervention Nutrition Study (WINS) evaluating dietary intervention as adjuvant breast cancer therapy. Cancer Research2015;75(9 Supplement):S5-08. ChlebowskiRT , RoseD , BlackburnG , BuzzardM , KhandekarJ , YorkR , et al. Feasibility of using dietary fat intake reduction in adjuvant breast cancer management. Proceedings of American Society of Clinical Oncology1991;86:86. ChlebowskiRT , RoseDP , BuzzardIM , BlackburnGL , YorkM , Insull W Jr, et al. Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues. Adjuvant: the Cancer Journal1990;6:357-63. HoyMK , WintersBL , ChlebowskiRT , PapoutsakisC , ShapiroA , LubinMP , et al. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study. Journal of the American Dietetic Association2009;109(4):688-96. RoseDP , ChlebowskiRT , ConnollyJM , JonesLA , WynderEL . Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Cancer Research1992;52(19):5386-90. RoseDP , ConnollyJM , ChlebowskiRT , BuzzardIM , WynderEL . The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Research &amp; Treatment1993;27(3):253-62. WynderEL , CohenLA , WintersBL . The challenges of assessing fat intake in cancer research investigations. Journal of the American Dietetic Association1997;97(7 Suppl):S5-8. ">WINS 2006</a>. </p> </section> </section> <section id="CD011737-sec-0047"> <h3 class="title" id="CD011737-sec-0047">Effects of interventions</h3> <p>See: <a href="./full#CD011737-tbl-0001"><b>Summary of findings 1</b> Effect of reducing saturated fat compared to usual saturated fat on CVD risk in adults (note: for the full set of GRADE tables see additional tables 24 to 28)</a> </p> <section id="CD011737-sec-0048"> <h4 class="title">Primary outcomes</h4> <section id="CD011737-sec-0049"> <h5 class="title">All‐cause mortality</h5> <p>GRADE assessment suggests that reducing saturated fat intake probably makes little or no difference to all‐cause mortality (moderate‐quality evidence, downgraded once for imprecision). </p> <p>There was little or no effect of lower saturated fat compared to higher saturated fat intake on mortality (risk ratio (RR) 0.96, 95% confidence interval (CI) 0.90 to 1.03, I² = 2%, 55,858 participants, 3518 deaths, 11 RCTs, P<sub>effect</sub> = 0.42, <a href="./references#CD011737-fig-0007" title="">Analysis 1.1</a>). This lack of effect was confirmed in sensitivity analyses including only trials at low summary risk of bias (<a href="./references#CD011737-fig-0008" title="">Analysis 1.2</a>), that aimed to reduce saturated fat (<a href="./references#CD011737-fig-0009" title="">Analysis 1.3</a>), that significantly reduced saturated fat intake (<a href="./references#CD011737-fig-0010" title="">Analysis 1.4</a>), that achieved a reduction in total or LDL cholesterol (<a href="./references#CD011737-fig-0011" title="">Analysis 1.5</a>), excluding the largest trial (<a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>, <a href="./references#CD011737-fig-0012" title="">Analysis 1.6</a>), or analysing using Mantel‐Haenszel or Peto fixed‐effect analysis (<a href="./references#CD011737-fig-0013" title="">Analysis 1.7</a>; <a href="./references#CD011737-fig-0014" title="">Analysis 1.8</a>). </p> <p>Small study bias was assessed using a funnel plot and comparing the results of fixed‐ and random‐effects meta‐analysis. The funnel plot did not suggest any small study bias (<a href="#CD011737-fig-0003">Figure 3</a>), and the results of fixed‐ and random‐effects meta‐analyses were very similar, suggesting that small study bias was not an issue. </p> <div class="figure" id="CD011737-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: fat modification or reduction vs usual diet ‐ total mortality." data-id="CD011737-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-03.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: fat modification or reduction vs usual diet ‐ total mortality.</p> </div> </div> </div> <p>There was little or no effect, regardless of what nutrients were used to replace the saturated fat removed, including replacement with PUFA, MUFA, CHO and/or protein (<a href="./references#CD011737-fig-0015" title="">Analysis 1.9</a>). Effects did not differ by main substitution (<a href="./references#CD011737-fig-0016" title="">Analysis 1.10</a>), study duration (<a href="./references#CD011737-fig-0017" title="">Analysis 1.11</a>), baseline saturated fat intake (<a href="./references#CD011737-fig-0018" title="">Analysis 1.12</a>), degree of difference in saturated fat between arms (<a href="./references#CD011737-fig-0019" title="">Analysis 1.13</a>), participant sex (<a href="./references#CD011737-fig-0020" title="">Analysis 1.14</a>), by baseline CVD risk (<a href="./references#CD011737-fig-0021" title="">Analysis 1.15</a>), by degree of cholesterol reduction (<a href="./references#CD011737-fig-0022" title="">Analysis 1.16</a>) or by decade of publication (<a href="./references#CD011737-fig-0023" title="">Analysis 1.17</a>, Chi² test for differences between subgroups all P &gt; 0.05). </p> </section> <section id="CD011737-sec-0050"> <h5 class="title">Cardiovascular mortality</h5> <p>GRADE assessment suggests that reducing saturated fat intake probably makes little or no difference to cardiovascular mortality (moderate‐quality evidence, downgraded once for imprecision). </p> <p>There was little or no effect of SFA reduction on cardiovascular mortality (RR 0.95, 95% CI 0.80 to 1.12, I² = 30%, 10 RCTs, 53,421 participants, 1096 cardiovascular deaths, <a href="./references#CD011737-fig-0024" title="">Analysis 1.18</a>). This lack of effect was confirmed in sensitivity analyses limiting to trials at low summary risk of bias (<a href="./references#CD011737-fig-0025" title="">Analysis 1.19</a>), explicitly aiming to reduce saturated fat (<a href="./references#CD011737-fig-0026" title="">Analysis 1.20</a>), achieving statistically significant saturated fat reduction (<a href="./references#CD011737-fig-0027" title="">Analysis 1.21</a>), achieving cholesterol reduction (<a href="./references#CD011737-fig-0028" title="">Analysis 1.22</a>), or running fixed‐effect analysis (<a href="./references#CD011737-fig-0030" title="">Analysis 1.24</a>; <a href="./references#CD011737-fig-0031" title="">Analysis 1.25</a>). However, excluding the largest single trial (<a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>) suggested that reducing saturated fat intake reduced the risk of CVD mortality (<a href="./references#CD011737-fig-0029" title="">Analysis 1.23</a>). </p> <p>The funnel plot did not suggest small study bias (<a href="#CD011737-fig-0004">Figure 4</a>), and the similarity in effect sizes between fixed‐ and random‐effects analysis suggests that small study bias is not important here. </p> <div class="figure" id="CD011737-fig-0004"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 4</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: fat modification or reduction vs usual diet ‐ cardiovascular mortality" data-id="CD011737-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-04.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: fat modification or reduction vs usual diet ‐ cardiovascular mortality </p> </div> </div> </div> <p>Subgrouping did not suggest important effects of reduced SFA on cardiovascular mortality, regardless of what was substituted for SFA (<a href="./references#CD011737-fig-0032" title="">Analysis 1.26</a>). When subgrouping by main substitution (<a href="./references#CD011737-fig-0033" title="">Analysis 1.27</a>), duration (<a href="./references#CD011737-fig-0034" title="">Analysis 1.28</a>), baseline SFA intake (<a href="./references#CD011737-fig-0035" title="">Analysis 1.29</a>), by difference in SFA (<a href="./references#CD011737-fig-0036" title="">Analysis 1.30</a>), participant sex (<a href="./references#CD011737-fig-0037" title="">Analysis 1.31</a>), baseline CVD risk (<a href="./references#CD011737-fig-0038" title="">Analysis 1.32</a>), or degree of cholesterol reduction (<a href="./references#CD011737-fig-0039" title="">Analysis 1.33</a>), there were no statistically significant differences between subgroups. There was a marginally significant difference between subgroups when ordered by decade of publication, but no clear pattern of effect, so we assumed the effect was probably spurious (<a href="./references#CD011737-fig-0040" title="">Analysis 1.34</a>). Additionally, effects did not appear to relate to statin use, as there was a reduction in risk of CVD mortality in studies published in the 1960s and a marginal increase in risk in the one trial published during the 1970s (although the 95% confidence interval did include 1.0), both well before statins were in common use (the 4S trial which first showed that use of statins reduced mortality was published in 1994, <a href="./references#CD011737-bbs2-0347" title="Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet1994;344(8934):1383-9.">4S 1994</a>). </p> </section> <section id="CD011737-sec-0051"> <h5 class="title">Cardiovascular events</h5> <p>GRADE assessment suggests that reducing SFA intake probably reduces cardiovascular events, to a greater extent with greater cholesterol reduction (moderate‐quality evidence, downgraded once for risk of bias and publication bias combined). </p> <p>There was a 17% reduction in cardiovascular events in people who had reduced SFA compared with those on higher SFA (RR 0.83, 95% CI 0.70 to 0.98, I² = 67%, 12 RCTs, 53,758 participants, 4538 people with cardiovascular events, P<sub>effect</sub> = 0.03, <a href="./references#CD011737-fig-0041" title="">Analysis 1.35</a>). This protective effect was confirmed in sensitivity analyses including only trials that aimed to reduce saturated fat (<a href="./references#CD011737-fig-0043" title="">Analysis 1.37</a>), that significantly reduced saturated fat intake (<a href="./references#CD011737-fig-0044" title="">Analysis 1.38</a>), that achieved a reduction in total or LDL cholesterol (<a href="./references#CD011737-fig-0045" title="">Analysis 1.39</a>), or excluding the largest trial (<a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>, <a href="./references#CD011737-fig-0046" title="">Analysis 1.40</a>). Analysing including only trials at low summary risk of bias, or using Mantel‐Haenszel or Peto fixed‐effect analysis suggested more marginal protection(<a href="./references#CD011737-fig-0042" title="">Analysis 1.36</a>; <a href="./references#CD011737-fig-0047" title="">Analysis 1.41</a>; <a href="./references#CD011737-fig-0048" title="">Analysis 1.42</a>). </p> <p>A funnel plot did not suggest severe small‐study bias (<a href="#CD011737-fig-0005">Figure 5</a>), but fixed‐effect analyses suggested slightly smaller effects (<a href="./references#CD011737-fig-0047" title="">Analysis 1.41</a>; <a href="./references#CD011737-fig-0048" title="">Analysis 1.42</a>), suggesting that smaller studies with more cardiovascular events in the intervention groups may be missing. Adding any such studies back would tend to moderate the protective effect of reducing SFA. </p> <div class="figure" id="CD011737-fig-0005"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 5</div> </div> <hr class="top"/><img alt="Funnel plot of comparison: fat modification or reduction vs usual diet ‐ combined cardiovascular events." data-id="CD011737-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-05.svg"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Funnel plot of comparison: fat modification or reduction vs usual diet ‐ combined cardiovascular events. </p> </div> </div> </div> <p>Sensitivity analysis omitting trials which included dietary interventions in addition to changes to dietary fat (for example, changes to fruit and vegetable or fibre intake) we excluded three trials (<a href="./references#CD011737-bbs2-0007" title="LerenP . Prevention of coronary heart disease, some results from the Oslo secondary and primary intervention studies. Journal of the American College of Nutrition1989;8(5):407-10. LerenP . The Oslo diet-heart study. Eleven year report. Circulation1970;42(5):935-42. LerenP . The effect of a cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial) [Virkningen av cholesterolsenkende diett hos menn som har gjennomgatt hjerteinfarkt. Et kontrollert klinisk fors/ok]. Nordisk Medicin1967;77(21):658-61. LerenP . The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Medica Scandinavia1966;466 Suppl:1-92. LerenP . The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Bulletin of the New York Academy of Medicine1968;44(8):1012-20. ">Oslo Diet‐Heart 1966</a>; <a href="./references#CD011737-bbs2-0012" title="BlannAD , JacksonP , BathPM , WattsGF . Von Willebrand factor, a possible indicator of endothelial cell damage, decreases during long-term compliance with a lipid-lowering diet. Journal of Internal Medicine1995;237(6):557-61. WattsGF , BruntJN , ColtartDJ , LewisB . The St. Thomas Atherosclerosis Regression Study (STARS). Atherosclerosis1992;97:231. WattsGF , JacksonP , BurkeV , LewisB . Dietary fatty acids and progression of coronary artery disease in men. American Journal of Clinical Nutrition1996;64(2):202-9. WattsGF , JacksonP , MandaliaS , BruntJN , LewisES , ColtartDJ , et al. Nutrient intake and progression of coronary artery disease. American Journal of Cardiology1994;73(5):328-32. WattsGF , LewisB , BruntJN , LewisES , ColtartDJ , SmithLD , et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet1992;339(8793):563-9. WattsGF , LewisB , BruntJNH , SwanAV . Coronary atheroma regression trials. Lancet1992;339(i):1241-3. WattsGF , LewisB , JacksonP , BurkeV , LewisES , BruntJN , et al. Relationships between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography. Canadian Journal of Cardiology1995;11(Suppl G):110G-4G. WattsGF , MandaliaS , BruntJN , SlavinBM , ColtartDJ , LewisB . Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism: Clinical and Experimental1993;42(11):1461-7. WattsGF , MandaliaS , SlavinBM , BruntJN , ColtartDJ , LewisB . Metabolic determinants of the course of coronary artery disease in men. Clinical Chemistry1994;40(12):2240-6. WattsGF . Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group. Journal of Cardiovascular Pharmacology1995;25(Suppl 4):S11-9. ">STARS 1992</a>; <a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>). This analysis also suggested that reducing saturated fat (rather than other dietary changes) reduced risk of cardiovascular events: RR 0.86 (95% CI 0.67 to 1.09, <a href="./references#CD011737-fig-0049" title="">Analysis 1.43</a>). </p> <p>When we subgrouped according to replacement for SFA, the PUFA replacement group suggested a 21% reduction in cardiovascular events, a 16% reduction in studies replacing SFA with carbohydrate, and little or no effect of other replacements, but without statistically significant effects between subgroups (<a href="./references#CD011737-fig-0050" title="">Analysis 1.44</a>). Similarly, there were no statistically significant differences between subgroups by main replacement (<a href="./references#CD011737-fig-0051" title="">Analysis 1.45</a>), by study duration (<a href="./references#CD011737-fig-0052" title="">Analysis 1.46</a>), in men or women (<a href="./references#CD011737-fig-0055" title="">Analysis 1.49</a>) or by baseline CVD risk (<a href="./references#CD011737-fig-0056" title="">Analysis 1.50</a>). When subgrouping, there was a suggestion of greater effects when baseline SFA was higher (<a href="./references#CD011737-fig-0053" title="">Analysis 1.47</a>), with greater reduction of SFA (<a href="./references#CD011737-fig-0054" title="">Analysis 1.48</a>), and with greater cholesterol reduction (<a href="./references#CD011737-fig-0057" title="">Analysis 1.51</a>). There were different effects by decade of publication, but no suggestion of a trend or a change following wider introduction of statins in the mid‐1990s (<a href="./references#CD011737-fig-0058" title="">Analysis 1.52</a>). </p> <p>We further explored the effects of dietary fats on cardiovascular events, by using meta‐regression of the difference between the control and intervention of total fat intake, SFA intake, MUFA intake, PUFA intake, CHO intake (all by percentage of energy (%E)), serum total cholesterol (in mmol/L) achieved in trials, as well as baseline SFA intake, sex, study duration in months, and CVD risk of participants at baseline (<a href="#CD011737-tbl-0005">Table 4</a>). As we included only 13 studies for this outcome, we ran meta‐regressions exploring single explanatory factors at once, and as data were limited, with many studies not reporting dietary intake data, these analyses were limited in power to assess outcomes. The data suggested that greater reductions in total serum cholesterol levels reduced CVD events more. Greater baseline SFA intake and greater reduction in SFA were also associated with greater improvement in CVD events with SFA reduction, and increases in PUFA and MUFA intakes were slightly protective of CVD events, but none of these relationships were statistically significant. Overall, the relationship with serum total cholesterol was clearest (P = 0.04, accounting for 99% of between‐study variation). Sex, study duration and baseline cardiovascular risk did not appear to influence effect size. Apparent heterogeneity was accounted for by a dose‐effect; where SFA reduction resulted in greater serum cholesterol reduction, the reduction in CVD events was greater. </p> <div class="table" id="CD011737-tbl-0005"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Meta‐regression of effects of SFA reduction on cardiovascular events</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Regression factor</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No. of studies</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Constant</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Coefficient (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>P value</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Proportion of between study variation explained</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Change in SFA as %E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.05 (‐0.03 to 0.13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Change in SFA as % of control</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.01 (‐0.01 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Baseline SFA as %E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.06 (‐0.15 to 0.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Change in TC, mmol/L</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69 (0.05 to 1.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.04</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Change in PUFA as %E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.02 (‐0.08 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Change in MUFA as %E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.03 (‐0.14 to 0.09)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐87%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Change in CHO as %E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.00 (‐0.05 to 0.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐273%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Change in total fat intake as %E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.01 (‐0.03 to 0.01)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gender*</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.14 (‐0.63 to 0.35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐13%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study duration</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.00 (‐0.01 to 0.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐24.8%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>CVD risk at baseline**</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.03 (‐0.48 to 0.55)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐39%</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p><sup>*Gender was coded as follows: 0 = women, 1 = mixed, 2 = men<br/><b>**</b>CVD risk at baseline was coded as follows: 1 = Low CVD risk, 2 = Moderate CVD risk, 3 = existing CVD</sup><br/><sup>CHO: carbohydrate<br/>CI: confidence interval<br/>CVD: cardiovascular disease<br/>E: energy<br/>MUFA: monounsaturated fatty acid<br/>PUFA: polyunsaturated fatty fat<br/>SFA: saturated fatty acid<br/>TC: total cholesterol</sup> </p> </div> </div> <p>This 17% reduction in risk of CVD events translated into a number needed to treat for an additional beneficial outcome (NNTB) of 56 in primary prevention trials, so that 56 people need to reduce their saturated fat intake over around four years for one person to avoid experiencing a CVD event. In secondary prevention trials, the NNTB was 53. </p> </section> </section> <section id="CD011737-sec-0052"> <h4 class="title">Secondary outcomes ‐ health events</h4> <section id="CD011737-sec-0053"> <h5 class="title">Myocardial Infarction (fatal and non‐fatal)</h5> <p>GRADE assessment suggested that the effect of reducing saturated fat intake on risk of myocardial infarction is unclear as the evidence was of very low‐quality (downgraded once each for risk of bias, imprecision and publication bias). </p> <p>There was a small protective effect of SFA reduction on myocardial infarction (fatal and non‐fatal, RR 0.90, 95% CI 0.80 to 1.01, I² = 10%, 10 RCTs (11 comparisons) including 53,167 participants, 1714 people experiencing MI, <a href="./references#CD011737-fig-0059" title="">Analysis 2.1</a>). This protective effect was slightly modified in sensitivity analyses, and confirmed in analyses limited to trials that aimed to reduce saturated fat (<a href="./references#CD011737-fig-0061" title="">Analysis 2.3</a>), that achieved a reduction in total or LDL cholesterol (<a href="./references#CD011737-fig-0063" title="">Analysis 2.5</a>), and excluding the largest trial (<a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>, <a href="./references#CD011737-fig-0064" title="">Analysis 2.6</a>). Sensitivity analyses including only trials at low summary risk of bias (RR 0.93, 95% CI 0.81 to 1.08, <a href="./references#CD011737-fig-0060" title="">Analysis 2.2</a>), that significantly reduced saturated fat intake (<a href="./references#CD011737-fig-0062" title="">Analysis 2.4</a>), analysed using Mantel‐Haenszel or Peto fixed‐effect analysis (<a href="./references#CD011737-fig-0065" title="">Analysis 2.7</a>; <a href="./references#CD011737-fig-0066" title="">Analysis 2.8</a>) suggested little or no effect, though risk ratios were still all &lt; 1.0. </p> <p>The funnel plot was difficult to interpret, but did not raise major concerns about small‐study bias (not shown). While effects of random‐ and fixed‐effect meta‐analysis were only slightly different, they fell each side of the line suggesting an effect (<a href="./references#CD011737-fig-0065" title="">Analysis 2.7</a>; <a href="./references#CD011737-fig-0066" title="">Analysis 2.8</a>). There may be a small amount of small study bias. </p> <p>The protective effect of replacing SFA with PUFA appeared to explain the reduction in MI (<a href="./references#CD011737-fig-0067" title="">Analysis 2.9</a>), but there were no statistically significant differences between subgroups by replacement (<a href="./references#CD011737-fig-0068" title="">Analysis 2.10</a>), duration (<a href="./references#CD011737-fig-0069" title="">Analysis 2.11</a>), baseline SFA intake (<a href="./references#CD011737-fig-0070" title="">Analysis 2.12</a>), change in SFA intake (<a href="./references#CD011737-fig-0071" title="">Analysis 2.13</a>), participant sex (<a href="./references#CD011737-fig-0072" title="">Analysis 2.14</a>), baseline CVD risk (<a href="./references#CD011737-fig-0073" title="">Analysis 2.15</a>), cholesterol reduction (<a href="./references#CD011737-fig-0074" title="">Analysis 2.16</a>) or decade of publication (<a href="./references#CD011737-fig-0075" title="">Analysis 2.17</a>). </p> </section> <section id="CD011737-sec-0054"> <h5 class="title">Myocardial Infarction (non‐fatal only)</h5> <p>GRADE assessment suggests that reducing saturated fat may have little or no effect on risk of non‐fatal myocardial infarction (low‐quality evidence, downgraded once each for risk of bias and imprecision). </p> <p>There was no clear effect of SFA reduction compared to usual diet on non‐fatal myocardial infarction (RR 0.97, 95% CI 0.87 to 1.07, I² = 0%, 7 RCTs, 52,834 participants, 1385 people with at least one non‐fatal MI, <a href="./references#CD011737-fig-0076" title="">Analysis 2.18</a>). This lack of effect was not altered in sensitivity analyses retaining only those that aimed to reduce SFA (<a href="./references#CD011737-fig-0078" title="">Analysis 2.20</a>), those showing a reduction in serum cholesterol (<a href="./references#CD011737-fig-0080" title="">Analysis 2.22</a>), or fixed‐effect analysis (<a href="./references#CD011737-fig-0082" title="">Analysis 2.24</a>; <a href="./references#CD011737-fig-0083" title="">Analysis 2.25</a>). However, sensitivity analyses retaining only trials at low summary risk of bias (RR 0.89, 95% CI 0.58 to 1.35, <a href="./references#CD011737-fig-0077" title="">Analysis 2.19</a>), those showing a significant reduction in SFA (<a href="./references#CD011737-fig-0079" title="">Analysis 2.21</a>), and omitting the largest trial (<a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>, <a href="./references#CD011737-fig-0081" title="">Analysis 2.23</a>) all suggested a reduction in non‐fatal MI with reduced SFA. </p> <p>The funnel plot did not raise major concerns about small‐study bias (not shown), and effects of fixed‐ and random‐effects analyses were very similar, reinforcing the lack of small study bias. </p> <p>Subgrouping by any replacement for SFA suggested reductions in non‐fatal MI when replaced by PUFA, but not other replacements (<a href="./references#CD011737-fig-0084" title="">Analysis 2.26</a>). Subgrouping by main substitution (<a href="./references#CD011737-fig-0085" title="">Analysis 2.27</a>), duration (<a href="./references#CD011737-fig-0086" title="">Analysis 2.28</a>), baseline SFA intake (<a href="./references#CD011737-fig-0087" title="">Analysis 2.29</a>), degree of SFA reduction (<a href="./references#CD011737-fig-0088" title="">Analysis 2.30</a>), sex (<a href="./references#CD011737-fig-0089" title="">Analysis 2.31</a>), baseline CVD risk (<a href="./references#CD011737-fig-0090" title="">Analysis 2.32</a>), degree of cholesterol reduction (<a href="./references#CD011737-fig-0091" title="">Analysis 2.33</a>) and decade of publication (<a href="./references#CD011737-fig-0092" title="">Analysis 2.34</a>) did not suggest significant differences between subgroups. </p> </section> <section id="CD011737-sec-0055"> <h5 class="title">Stroke (any type, fatal or non‐fatal)</h5> <p>GRADE assessment suggests that the effect of reducing SFA intake on stroke is unclear as the evidence is of very low‐quality (downgraded twice for imprecision and once for risk of bias). </p> <p>As data on stroke were sparse, it was not possible to tease out differential effects on ischaemic or haemorrhagic strokes, or whether a stroke was fatal. For this analysis, we combined all stroke data from any study. There was little or no effect of SFA reduction compared to usual diet on stroke of any type with any outcome (RR 0.92, 95% CI 0.68 to 1.25, I² = 9%, 7 RCTs, 50,952 participants, 1118 people with stroke, <a href="./references#CD011737-fig-0093" title="">Analysis 2.35</a>). This lack of effect was not altered in sensitivity analyses retaining only those that aimed to reduce SFA (<a href="./references#CD011737-fig-0095" title="">Analysis 2.37</a>), those showing a reduction in serum cholesterol (<a href="./references#CD011737-fig-0097" title="">Analysis 2.39</a>), or fixed‐effect analysis (<a href="./references#CD011737-fig-0099" title="">Analysis 2.41</a>; <a href="./references#CD011737-fig-0100" title="">Analysis 2.42</a>). However, for sensitivity analyses retaining only trials at low summary risk of bias (RR 0.76, 95% CI 0.42 to 1.38, <a href="./references#CD011737-fig-0094" title="">Analysis 2.36</a>), those showing a significant reduction in SFA (<a href="./references#CD011737-fig-0096" title="">Analysis 2.38</a>), and omitting the largest trial (<a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>, <a href="./references#CD011737-fig-0098" title="">Analysis 2.40</a>) the best estimate of effect always suggested a reduction in stroke with reduced SFA, though they were not statistically significant. </p> <p>We did not create a funnel plot as the analysis only included data from seven RCTs, however RRs generated using fixed‐effect analyses were much closer to 1.0 than the random‐effects meta‐analysis (suggesting a small amount of publication bias), though both suggested little or no effect. </p> <p>Subgrouping by any substitution for SFA suggested reduction in risk of stroke whether SFA was replaced by PUFA, CHO or protein (<a href="./references#CD011737-fig-0101" title="">Analysis 2.43</a>). Subgrouping did not suggest significant differences between subgroups by main substitution (<a href="./references#CD011737-fig-0102" title="">Analysis 2.44</a>), duration (<a href="./references#CD011737-fig-0120" title="">Analysis 2.62</a>), baseline SFA (<a href="./references#CD011737-fig-0104" title="">Analysis 2.46</a>), SFA change (<a href="./references#CD011737-fig-0105" title="">Analysis 2.47</a>), sex (<a href="./references#CD011737-fig-0106" title="">Analysis 2.48</a>), CVD risk (<a href="./references#CD011737-fig-0107" title="">Analysis 2.49</a>), cholesterol reduction (<a href="./references#CD011737-fig-0108" title="">Analysis 2.50</a>) or decade of publication (<a href="./references#CD011737-fig-0109" title="">Analysis 2.51</a>). </p> </section> <section id="CD011737-sec-0056"> <h5 class="title">Coronary heart disease (CHD) mortality</h5> <p>GRADE assessment suggests that reducing saturated fat intake may have little or no effect on CHD mortality (low‐quality evidence, downgraded twice for imprecision). </p> <p>Eight RCTs (9 comparisons) suggest little or no effect of reducing saturated fat on risk of CHD mortality (RR 0.97, 95% CI 0.82 to 1.16, I² = 28%, 53,159 participants, 927 people died of coronary heart disease, <a href="./references#CD011737-fig-0110" title="">Analysis 2.52</a>), and this was not altered in any sensitivity analyses (<a href="./references#CD011737-fig-0111" title="">Analysis 2.53</a>; <a href="./references#CD011737-fig-0112" title="">Analysis 2.54</a>; <a href="./references#CD011737-fig-0113" title="">Analysis 2.55</a>; <a href="./references#CD011737-fig-0114" title="">Analysis 2.56</a>; <a href="./references#CD011737-fig-0115" title="">Analysis 2.57</a>; <a href="./references#CD011737-fig-0116" title="">Analysis 2.58</a>; <a href="./references#CD011737-fig-0117" title="">Analysis 2.59</a>). </p> <p>We did not create a funnel plot as the analysis only included data from seven RCTs, but the results of fixed‐ and random‐effects analyses were nearly identical, suggesting that small study bias is not an issue here. </p> <p>There was no suggestion of an effect of reducing SFA on CHD mortality regardless of what replaced the SFA (<a href="./references#CD011737-fig-0118" title="">Analysis 2.60</a>). There were no statistically significant differences between subgrouping in any analysis (<a href="./references#CD011737-fig-0119" title="">Analysis 2.61</a>; <a href="./references#CD011737-fig-0120" title="">Analysis 2.62</a>; <a href="./references#CD011737-fig-0121" title="">Analysis 2.63</a>; <a href="./references#CD011737-fig-0122" title="">Analysis 2.64</a>; <a href="./references#CD011737-fig-0123" title="">Analysis 2.65</a>; <a href="./references#CD011737-fig-0124" title="">Analysis 2.66</a>; <a href="./references#CD011737-fig-0125" title="">Analysis 2.67</a>; <a href="./references#CD011737-fig-0126" title="">Analysis 2.68</a>). </p> </section> <section id="CD011737-sec-0057"> <h5 class="title">Coronary heart disease events</h5> <p>GRADE assessment suggested that the effect of reducing saturated fat on CHD events is unclear as the evidence is of very low‐quality (downgraded once each for imprecision, risk of bias and inconsistency). </p> <p>There was the suggestion of a 17% reduction in CHD events as a result of saturated fat reduction in the main analysis (RR 0.83, 95% CI 0.68 to 1.01, I² = 62%, 53,199 participants, 2261 people had at least one coronary heart disease event in 10 RCTs, <a href="./references#CD011737-fig-0127" title="">Analysis 2.69</a>). This did not differ in sensitivity analyses (<a href="./references#CD011737-fig-0132" title="">Analysis 2.74</a>; <a href="./references#CD011737-fig-0130" title="">Analysis 2.72</a>; <a href="./references#CD011737-fig-0131" title="">Analysis 2.73</a>; <a href="./references#CD011737-fig-0129" title="">Analysis 2.71</a>; <a href="./references#CD011737-fig-0133" title="">Analysis 2.75</a>; <a href="./references#CD011737-fig-0134" title="">Analysis 2.76</a>) except when limiting to trials at low summary risk of bias (RR 0.92, 95% CI 0.77 to 1.10, <a href="./references#CD011737-fig-0128" title="">Analysis 2.70</a>). </p> <p>The funnel plot did not appear unbalanced, and the results of fixed‐ and random‐effects analyses were different, though both suggested that reducing SFA resulted in lower risk of CHD. </p> <p>Subgrouping by any replacement for SFA suggested that replacement by PUFA may lead to reduced risk of CHD events (<a href="./references#CD011737-fig-0135" title="">Analysis 2.77</a>). There were no statistically significant differences between any other subgroups (<a href="./references#CD011737-fig-0136" title="">Analysis 2.78</a>; <a href="./references#CD011737-fig-0137" title="">Analysis 2.79</a>; <a href="./references#CD011737-fig-0138" title="">Analysis 2.80</a>; <a href="./references#CD011737-fig-0139" title="">Analysis 2.81</a>; <a href="./references#CD011737-fig-0140" title="">Analysis 2.82</a>; <a href="./references#CD011737-fig-0141" title="">Analysis 2.83</a>; <a href="./references#CD011737-fig-0142" title="">Analysis 2.84</a>) except by decade of publication, though this did not suggest any sequence or step change (<a href="./references#CD011737-fig-0143" title="">Analysis 2.85</a>). </p> </section> <section id="CD011737-sec-0058"> <h5 class="title">Type 2 diabetes, new diagnoses</h5> <p>Only one RCT reported on diagnosis of diabetes (<a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>). There was little or no effect of reducing SFA intakes on diagnosis of diabetes in this study (RR 0.96, 95% CI 0.90 to 1.02, 48,835 participants, 3342 developed diabetes, <a href="./references#CD011737-fig-0144" title="">Analysis 2.86</a>). <a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a> was assessed at low summary risk of bias, aimed to reduce SFA, and demonstrated significant SFA and cholesterol reduction. With only one trial, we were not able to assess publication bias or carry out subgrouping. </p> </section> </section> <section id="CD011737-sec-0059"> <h4 class="title">Secondary outcomes ‐ blood levels</h4> <section id="CD011737-sec-0060"> <h5 class="title">Serum blood lipids</h5> <p><b>Total cholesterol (TC):</b> There was a reduction in TC in participants with reduced SFA compared to higher SFA (mean difference (MD) ‐0.24 mmol/L, 95% CI ‐0.36 to ‐0.13, I² = 60%, 13 RCTs, 7115 participants, <a href="./references#CD011737-fig-0145" title="">Analysis 3.1</a>). We did not conduct sensitivity analyses or most subgroupings on secondary outcomes, but there was no clear differential effect on TC depending on the replacement for SFA (PUFA, MUFA, CHO or a mixture, <a href="./references#CD011737-fig-0146" title="">Analysis 3.2</a>; <a href="./references#CD011737-fig-0147" title="">Analysis 3.3</a>). The funnel plot did not raise concerns about small‐study bias (not shown). </p> <p><b>Low‐density lipoprotein (LDL):</b> There was a reduction in LDL in participants with reduced SFA compared to higher SFA (MD ‐0.19 mmol/L, 95% CI ‐0.33 to ‐0.05, I² = 37%, 5 RCTs, 3291 participants, <a href="./references#CD011737-fig-0148" title="">Analysis 3.4</a>). There was no clear differential effect on LDL depending on the replacement for SFA (PUFA, MUFA, CHO or a mixture, <a href="./references#CD011737-fig-0149" title="">Analysis 3.5</a>; <a href="./references#CD011737-fig-0150" title="">Analysis 3.6</a>). We could not interpret the funnel plot due to sparsity of studies (not shown). </p> <p><b>High‐density lipoprotein (HDL):</b> There was little or no effect of reducing SFA intakes on HDL (MD ‐0.01 mmol/L, 95% CI ‐0.02 to 0.01, I² = 0%, 7 RCTs, 5147 participants, <a href="./references#CD011737-fig-0151" title="">Analysis 3.7</a>). There was no clear differential effect on HDL depending on the replacement for SFA (PUFA, MUFA, CHO or a mixture, <a href="./references#CD011737-fig-0152" title="">Analysis 3.8</a>; <a href="./references#CD011737-fig-0153" title="">Analysis 3.9</a>). We could not interpret the funnel plot due to sparsity of studies (not shown). </p> <p><b>Triglycerides (TG):</b> There was little or no effect of reducing SFA intakes on TG (MD ‐0.08 mmol/L, 95% CI ‐0.21 to 0.04, I² = 51%, 7 RCTs, 3845 participants, <a href="./references#CD011737-fig-0154" title="">Analysis 3.10</a>). There was no clear differential effect on TG depending on the replacement for SFA (PUFA, MUFA, CHO or a mixture, <a href="./references#CD011737-fig-0155" title="">Analysis 3.11</a>; <a href="./references#CD011737-fig-0156" title="">Analysis 3.12</a>). We could not interpret the funnel plot due to sparsity of studies (not shown). </p> <p><b>TG/HDL ratio:</b> We did not find any studies that reported TG/HDL ratio. </p> <p><b>TC/HDL ratio:</b> Only three RCTs reported on TC/HDL ratio. There was little or no effect of reducing SFA intakes on TC/HDL (MD ‐0.10, 95% CI ‐0.33 to 0.13, I² = 24%, 2985 participants, <a href="./references#CD011737-fig-0157" title="">Analysis 3.13</a>). There were no clear differential effects of replacement on TC/HDL (<a href="./references#CD011737-fig-0158" title="">Analysis 3.14</a>; <a href="./references#CD011737-fig-0159" title="">Analysis 3.15</a>). We could not interpret the funnel plot due to sparsity of studies (not shown). </p> <p><b>LDL/HDL ratio:</b> Only one RCT reported on LDL/HDL ratio. There was no clear effect of reducing SFA intakes on LDL/HDL in this study (MD ‐0.36, 95% CI ‐0.92 to 0.20, 50 participants, <a href="./references#CD011737-fig-0160" title="">Analysis 3.16</a>). This study replaced SFA with CHO (mainly) and PUFA. </p> <p><b>Lipoprotein (a) (Lp(a)):</b> Only two RCTs reported on lipoprotein (a), but these included 28,820 participants. There was little or no effect of reducing SFA intakes on Lp(a) (MD 0.00, 95% CI ‐0.00 to 0.00, I² = 0%, <a href="./references#CD011737-fig-0161" title="">Analysis 3.17</a>). There was no suggestion of differential effects of replacement on Lp(a) (<a href="./references#CD011737-fig-0162" title="">Analysis 3.18</a>; <a href="./references#CD011737-fig-0163" title="">Analysis 3.19</a>). We could not interpret the funnel plot due to sparsity of studies (not shown). </p> <p><b>Homeostatic model assessment (HOMA):</b> Only one RCT reported on the effects of reducing SFA on insulin resistance using HOMA. There was little or no effect of reducing SFA intakes compared to usual diet on HOMA in this study (MD ‐0.00, 95% CI ‐0.04 to 0.04, 2832 participants, <a href="./references#CD011737-fig-0164" title="">Analysis 3.20</a>). </p> <p><b>Glucose at two hours post‐glucose tolerance test (GTT):</b> Only three RCTs reported on glucose two hours post‐GTT. There was a reduction in glucose after reducing SFA intakes compared to usual diet (MD ‐1.69 mmol/L, 95% CI ‐2.55 to ‐0.82, I² = 45%, 249 participants, <a href="./references#CD011737-fig-0164" title="">Analysis 3.20</a>). We could not interpret the funnel plot due to sparsity of studies (not shown). </p> <p><b>HbA1c (glycosylated haemoglobin):</b> HbA1c was not measured in any included RCT. </p> </section> </section> <section id="CD011737-sec-0061"> <h4 class="title">Secondary outcomes ‐ other outcomes and potential harms</h4> <p>There was little or no effect of reducing SFA intakes on <b>cancer diagnoses</b> of any type (RR 0.94, 95% CI 0.83 to 1.07, I² = 33%, 4 RCTs, 52,294 participants, 5476 cancer diagnoses, <a href="./references#CD011737-fig-0165" title="">Analysis 4.1</a>); <b>cancer deaths</b> (RR 1.00, 95% CI 0.61 to 1.64, I² = 49%, 5 RCTs, 52,283 participants, 2472 cancer deaths, <a href="./references#CD011737-fig-0166" title="">Analysis 4.2</a>); <b>systolic blood pressure</b> (MD ‐0.19 mmHg, 95% CI ‐1.36 to 0.97, I² = 0%, 5 RCTs, 3812 participants, <a href="./references#CD011737-fig-0169" title="">Analysis 4.5</a>); <b>diastolic blood pressure</b> (MD ‐0.36 mmHg, 95% CI ‐1.03 to 0.32, I² = 0%, 5 RCTs, 3812 participants, <a href="./references#CD011737-fig-0170" title="">Analysis 4.6</a>). </p> <p>There was evidence that reducing SFA intake resulted in small reductions in <b>body weight</b> (MD ‐1.97 kg, 95% CI ‐3.67 to ‐0.27, I² = 72%, 6 RCTs, 4541 participants, <a href="./references#CD011737-fig-0167" title="">Analysis 4.3</a>), and <b>body mass index</b> (MD ‐0.50, 95% CI ‐0.82 to ‐0.19, I² = 55%, 6 RCTs, 5553 participants, <a href="./references#CD011737-fig-0168" title="">Analysis 4.4</a>). </p> <p>Only one RCT reported assessing <b>quality of life</b>. The Women's Health Initiative (<a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>) assessed quality of life at baseline using the SF‐36 tool). They found that being in the lower SFA arm resulted in a small improvement in Global Quality of Life at trial close‐out (on a scale of 0 worst to 10 best, MD 0.04, 95% CI 0.01 to 0.07, <a href="./references#CD011737-fig-0171" title="">Analysis 4.7</a>). This very small effect (less than 1% change) was statistically significant but unlikely to be relevant to individuals. However, it suggests no reduction in quality of life in those reducing their saturated fat. </p> </section> <section id="CD011737-sec-0062"> <h4 class="title">Other results</h4> <p>To assess the effect in the population of consuming &lt; 10%E as SFA relative to &gt; 10%E as SFA for reduction in risk of noncommunicable diseases (NCDs), we combined studies with a control group saturated fat intake of &gt; 10%E and an intervention group saturated fat intake of &lt; 10%E for all‐cause mortality, cardiovascular and coronary heart disease mortality and events, myocardial infarctions, non‐fatal myocardial infarctions, and stroke. To assess the effect in the population of a reduction in %E from SFA from 10% in gradual increments relative to higher intake we repeated this with saturated fat cut‐offs between 7%E and 13%E. The data for these cut‐offs are shown in <a href="#CD011737-tbl-0006">Table 5</a>, and were plotted for a visual overview (<a href="#CD011737-fig-0006">Figure 6</a>). The figure suggests reductions in cardiovascular outcomes in studies where saturated fat intake was greater than 10%E in control groups, and less than 10%E in intervention groups. </p> <div class="table" id="CD011737-tbl-0006"> <table><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">SFA cut‐off data</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Cut‐ off</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR of all‐cause mortality</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR of CVD mortality</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR of CVD events</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR of MI</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR of non‐fatal MI</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR of stroke</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR of CHD mortality</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR of CHD events</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>7%E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (0.66 to 1.20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.01 to 4.15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.01 to 4.15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>8%E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (0.66 to 1.20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.01 to 4.15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.01 to 4.15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>9%E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.96 (0.83 to 1.10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69 (0.51 to 0.94)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.79 (0.62 to 0.99)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76 (0.55 to 1.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62 (0.31 to 1.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.59 (0.30 to 1.15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82 (0.55 to 1.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.77 (0.56 to 1.04)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>10%E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.99 (0.90 to 1.09)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.95 (0.67 to 1.35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.88 (0.66 to 1.18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (0.80 to 1.08)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (0.58 to 1.35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87 (0.58 to 1.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.05 (0.77 to 1.43)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82 (0.60 to 1.13)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>11%E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.99 (0.88 to 1.12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92 (0.65 to 1.31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.86 (0.66 to 1.13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.94 (0.84 to 1.06)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (0.58 to 1.35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76 (0.45 to 1.30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.02 (0.84 to 1.24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.85 (0.63 to 1.15)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>12%E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98 (0.91 to 1.07)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.95 (0.75 to 1.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (0.74 to 1.08)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.94 (0.85 to 1.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (0.72 to 1.14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (0.55 to 1.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.02 (0.84 to 1.24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (0.77 to 1.06)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>13%E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.02 (0.83 to 1.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (0.63 to 1.38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87 (0.65 to 1.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87 (0.73 to 1.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.72 (0.50 to 1.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.54 (0.29 to 1.00)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.06 (0.76 to 1.48)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.84 (0.63 to 1.12)</p> </td> </tr> </tbody> </table> <div class="table-footnote"> <p>CHD: coronary heart disease<br/>CVD: cardiovascular disease<br/>E: energy<br/>MI: myocardial infarction<br/>N/A: not applicable (no relevant studies)<br/>RR: risk ratio<br/>SFA: saturated fat, as percentage of energy </p> </div> </div> <div class="figure" id="CD011737-fig-0006"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 6</div> </div> <hr class="top"/><img alt="Exploration of saturated fat cut‐offs" data-id="CD011737-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-06.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Exploration of saturated fat cut‐offs</p> </div> </div> </div> </section> <section id="CD011737-sec-0063"> <h4 class="title">Additional WHO NUGAG specific questions:</h4> <section id="CD011737-sec-0064"> <h5 class="title">In adults what is the effect in the population of reduced percentage of energy (%E) intake from saturated fatty acids (SFA) relative to higher intake for reduction in risk of noncommunicable diseases (NCDs)? </h5> <p>We found that reducing saturated fat for at least two years suggested no clear effects on all‐cause or cardiovascular mortality, but a 17% reduction in combined cardiovascular events. Heterogeneity in this result was partially explained by greater reductions in cardiovascular events in studies with greater serum total cholesterol reductions (implying greater reductions in SFA intake). Effects of reducing SFA on other cardiovascular and cancer outcomes were either very small or unclear (as the evidence was of very low quality), but it should be noted that risk ratios were all 1.0 or lower ‐ no harm was indicated. Effects on NCD risk factors were small but positive (serum total cholesterol, LDL cholesterol, systolic and diastolic blood pressure, weight and BMI) or neutral (HDL cholesterol and TGs). </p> </section> <section id="CD011737-sec-0065"> <h5 class="title">What is the effect of reducing SFA on coronary heart disease mortality and coronary heart disease events? </h5> <p>We found little or no effect of reducing SFA on non‐fatal MI and CHD events, but the evidence on MI, stroke and CHD events was of very low quality. However, all risk ratios were less than 1.0. </p> </section> <section id="CD011737-sec-0066"> <h5 class="title">What is the effect in the population of replacing SFA with PUFAs, MUFAs, CHO (refined versus unrefined), protein or trans fatty acids (TFAs) relative to no replacement for reduction in risk of NCDs? </h5> <p>We found greater reductions in cardiovascular events in studies that replaced saturated fats by PUFAs or CHO than in studies with replacement with MUFAs or protein, where there was little evidence of any effect. </p> <p><b><i>What is the effect of replacing some saturated fat with PUFA on risk of CVD in adults?</i> </b> </p> <p>There is moderate‐quality evidence that replacing saturated fat with PUFA probably reduces the risk of CVD events. Replacing SFA with PUFA also appears to reduce the risk of total MI, non‐fatal MI, stroke and CHD events, but has little or no effect on all‐cause mortality, CVD mortality and CHD mortality. </p> <p><b><i>What is the effect of replacing some saturated fat with MUFA on risk of CVD in adults?</i> </b> </p> <p>The evidence for effects of replacing SFA with MUFA was very limited, so assessment of health effects was not possible. </p> <p><b><i>What is the effect of replacing some saturated fat with CHO on risk of CVD in adults?</i> </b> </p> <p>While studies that replaced SFA with CHO reduced CVD events and stroke, effects on all‐cause mortality and other CVD outcomes suggested little or no effect. </p> <p><b><i>What is the effect of replacing some saturated fat with protein on risk of CVD in adults?</i> </b> </p> <p>There was no evidence suggesting that replacing SFA with protein reduced all‐cause mortality or any CVD outcomes, but the evidence was limited. </p> </section> <section id="CD011737-sec-0067"> <h5 class="title">What is the effect in the population of consuming &lt; 10%E as SFA relative to &gt; 10%E as SFA for reduction in risk of NCDs? </h5> <p>Cut‐off data were difficult to interpret, and confidence intervals were wide, but they suggested greater reductions in cardiovascular events in studies where saturated fat intake was greater than 10%E in control groups, and less than 10%E in intervention groups (see <a href="#CD011737-fig-0006">Figure 6</a>). </p> </section> <section id="CD011737-sec-0068"> <h5 class="title">What is the effect in the population of a reduction in %E from SFA from 10% in gradual increments relative to higher intake for reduction in risk of NCDs? </h5> <p>The data from RCTs are too limited to be able to address this question.</p> </section> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD011737-sec-0069" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD011737-sec-0069"></div> <section id="CD011737-sec-0070"> <h3 class="title" id="CD011737-sec-0070">Summary of main results</h3> <p>This systematic review of long‐term randomised controlled trials of SFA reduction suggests that reducing saturated fat for at least two years probably has little or no effect on all‐cause or cardiovascular mortality, but probably caused a 17% (95% CI 2 to 30%, I<sup>2</sup> = 67%, moderate‐quality evidence) reduction in people experiencing cardiovascular events. The heterogeneity in this relationship was explained by greater reduction in CVD events in trials with greater serum cholesterol lowering. This effect on cardiovascular events was retained in most sensitivity analyses, but not when limiting to studies at low summary risk of bias. Subgrouping suggested that there was a 21% (95% CI 0 to 38%) reduction in cardiovascular events in studies that replaced saturated fats by PUFAs, and a 16% (95% CI ‐6 to 33%) reduction in studies replacing with CHO, with little information on the effect of replacing with MUFAs or protein. The difference between subgroups was not statistically significant. We could not explore data on trans fats due to lack of data. Meta‐regression and subgrouping suggested that greater reductions in SFA intake, greater reductions in total serum cholesterol levels, higher baseline SFA intake and greater increases in PUFA and MUFA intakes reduced CVD events more, but the strongest factor was the degree of cholesterol lowering. This suggests that the cardiovascular effects of reducing saturated fat rely on changes in atherosclerosis via serum cholesterol. The degree of cholesterol lowering reflects greater reduction in SFA and greater increase in PUFA (<a href="./references#CD011737-bbs2-0380" title="HegstedDM . From chick nutrition to nutrition policy. Annual Review of Nutrition2000;20:1-19.">Hegsted 2000</a>). </p> <p>There may be little or no effect of SFA reduction on non‐fatal MI or CHD mortality (both low‐quality evidence), and effects on fatal and non‐fatal MI, stroke and CHD events were unclear (as the evidence was of very low‐quality). However, risk ratios were less than 1.00 for all of these. While we found small reductions in body weight and body mass index with advice to reduce saturated fats, there was little or no effect on diabetes diagnoses, cancer diagnoses or cancer deaths, or on systolic or diastolic blood pressure. </p> <p>Reducing saturated fat caused reductions in serum total and LDL cholesterol, which did not differ according to type of replacement. There was little or no effect of saturated fat reduction on serum HDL cholesterol or triglyceride. Data on lipid ratios, Lp(a) and HOMA were very limited and effects unclear, but SFA reduction appears to reduce glucose two hours after a glucose load. </p> </section> <section id="CD011737-sec-0071"> <h3 class="title" id="CD011737-sec-0071">Overall completeness and applicability of evidence</h3> <p>The review included adult participants at varying levels of risk of cardiovascular disease, men and women, with mean ages from 46 to 66 years at baseline, in free‐living and institutional settings, and across the past 50 years. All the studies were conducted in industrialised countries, and no data were available from developing or transitional countries. The effectiveness of SFA reduction has been well assessed, with trials of at least 24 months including more than 50,000 participants for all primary and secondary CVD outcomes. Three thousand five hundred and eighteen participants in the included trials died, 1096 died of a cardiovascular cause, and 4538 experienced at least one cardiovascular event. </p> <p>The external validity of the review in industrialised countries, men and women, people with low, moderate and high risk of cardiovascular disease was high, but it is not clear how this evidence relates to diets in developing and transitional countries. </p> </section> <section id="CD011737-sec-0072"> <h3 class="title" id="CD011737-sec-0072">Quality of the evidence</h3> <p>All 15 trials (16 comparisons) included were randomised controlled trials, allocation concealment was judged well done in eight RCTs and blinding of outcome assessors adequate in nine trials assessing CVD outcomes (and all trials assessing all‐cause mortality). Blinding of participants is difficult and expensive in dietary fat trials, but was adequate in one trial. We judged incomplete outcome data not to be a problem in seven RCTs, and selective reporting was not a problem in any trial. Three trials were free of differences in care between the intervention and control arms, 10 RCTs stated an aim to reduce saturated fat, 11 showed evidence they had reduced SFA intake (all studies did one or the other), and nine studies showed clear reductions in total cholesterol. Five trials were at low summary risk of bias. </p> <p>The lack of blinding of participants in most dietary trials is unlikely to alter outcome assessment when outcomes include death and cardiovascular events (although it could potentially affect assessment of worsening of angina, or increased dose of antianginals), but lack of blinding in participants may have led those in the control groups to alter their lifestyle and dietary practices (for example, feeling that they have not been helped to reduce their cardiovascular risk, they may act to reduce their own risk by altering other lifestyle behaviours such as smoking or exercise, leading to a potential lessening of the apparent effect of the dietary intervention). Systematic differences in care between arms may have led to intervention groups receiving additional support in areas like self efficacy and gaining support from new social circles, potentially beneficial to health regardless of dietary fat intake, or gaining additional healthcare professional time, possibly leading to earlier diagnosis and treatment of other risk factors such as raised blood pressure. Additional dietary messages such as those around fruit and vegetable intake, fibre, alcohol and sugars, present in many studies, may have been protective, or may have diluted the effect or attainability or both of the saturated fat goals. </p> <p>The quality of evidence balances the uncertainty over allocation concealment, lack of blinding and presence of systematic differences in care and additional dietary differences between arms (<a href="#CD011737-fig-0002">Figure 2</a>) with the scale and consistency of the evidence across studies and across decades, despite very different designs and design flaws. For this reason, there is moderate‐quality evidence that interventions that reduced dietary saturated fat intake reduced the risk of cardiovascular events. </p> <section id="CD011737-sec-0073"> <h4 class="title">Complex interventions</h4> <p>With complex interventions, such as dietary interventions, there are additional questions that need to be asked about included studies. Important issues to consider include defining the intervention, searching for and identifying all relevant studies, selecting studies for inclusion and data synthesis (<a href="./references#CD011737-bbs2-0398" title="LenzM , SteckelbergA , RichterB , MühlhauserI . Meta-analysis does not allow appraisal of complex interventions in diabetes and hypertension self-management: a methodological review. Diabetologia2007;50(7):1375–83.">Lenz 2007</a>; <a href="./references#CD011737-bbs2-0431" title="ShepperdS , LewinS , StrausS , ClarkeM , EcclesMP , FitzpatrickR , et al. Can we systematically review studies that evaluate complex interventions?PLOS Medicine2009;6(8):e1000086.">Sheppherd 2009</a>), as well as questions around whether the intended intervention was realised in study participants during the study. </p> <p>For this review, we have worked to define the interventions clearly (see <a href="./references#CD011737-sec-0108" title="">Characteristics of included studies</a>), providing information on the type of intervention, stating the study aims and methods for each arm and the assessed total and saturated fat intakes attained within the study. However, while we have characterised the interventions, no two studies that reduced SFA had exactly the same dietary goals for the intervention groups. Methods of attaining the dietary goals varied from providing a whole diet over several years (in studies based in institutions) to providing advice on diet alongside supplementary foods such as margarines or oils, to providing dietary advice with or without supplementary support in the way of group sessions, cooking classes, shopping tours, feedback, self‐efficacy sessions and/or individual counselling. We aimed to use this variety to support generalisability for the effects of the interventions. </p> <p>We aimed to identify all the relevant studies through use of a broad search strategy, which was time‐consuming. However, we believe that we have included most relevant trials. We also carefully defined acceptable interventions for each arm, to simplify decisions on inclusion, and the two independent assessors often agreed. We augmented data synthesis by subgrouping and meta‐regression, to help us understand the effects of individual elements of dietary fat changes. </p> <p>A study that sets out to assess the effect of a 30% reduction in saturated fat intake may attain this level of reduction in some participants, exceed it in some and not achieve it at all in others. The actual mean change attained in the intervention group may be less dramatic than that aimed for, and the participants in the control group may also reduce their saturated fat intake by a small amount, narrowing the difference in saturated fat between the groups further and so reducing the scale of any outcome. This can be dealt with in the systematic review if we meta‐regress the difference in saturated fat intake between the intervention and control group with the scale of the outcome (assuming a linear dose response), still allowing us to understand the effect of altering saturated fat intake. However, it is difficult to measure actual saturated fat intake achieved. Some trials did not report it, either because they did not assess it, or did assess it but didn't report this relatively uninteresting outcome. Other trials did report the results of asking people what they were eating, using a food frequency questionnaire or several 24‐hour food recalls. However, there is good evidence to believe that asking people how they are eating may produce somewhat biased information (<a href="./references#CD011737-bbs2-0394" title="KristalAR , PetersU , PotterJD . Is it time to abandon the food frequency questionnaire?Cancer Epidemiology, Biomarkers and Prevention2005;14(12):2826-8.">Kristal 2005</a>; <a href="./references#CD011737-bbs2-0426" title="SchatzkinA , KipnisV , CarrollRJ , MidthuneD , SubarAF , BinghamS , et al. A comparison of a food frequency questionnaire with a 24-hour recall for use in an epidemiological cohort study: results from the biomarker-based Observing Protein and Energy Nutrition (OPEN) Study. International Journal of Epidemiology2003;32(6):1054-62.">Schatzkin 2003</a>), and this may be a greater problem where the participant has been recently urged to eat in a particular way, as in a dietary trial. Assessment of change in total cholesterol is a way to get over self‐reporting of dietary intake as reducing saturated fat reduces total and LDL cholesterol. This review suggests that the relationship between saturated fat reduction and CVD events is moderated by the degree of cholesterol lowering, which is exactly what would be expected of a true effect. </p> <p>The interventions used in the studies included in this review were varied, with some participants given all their food over a long period of time in an institutional setting, while most participants were given advice on how to achieve dietary changes, with or without the support of supplements such as oils and foods (<a href="#CD011737-tbl-0002">Table 1</a>). Advice was provided by a variety of health professionals, and with different levels of intensity. The effect of this was that different degrees of saturated fat reduction were achieved in different studies. The level of compliance with interventions involving long‐term behaviour change, such as those used in these studies, can vary widely. This is likely to attenuate the pooled effect and bias it towards the null. Insofar as we were able to understand this issue, subgrouping and meta‐regression suggested that greater reductions in saturated fats were associated with greater reductions in the risk of cardiovascular disease events. This suggestion of a dose response strengthens our belief that there is a true effect of reducing saturated fat on CVD events. </p> </section> </section> <section id="CD011737-sec-0074"> <h3 class="title" id="CD011737-sec-0074">Potential biases in the review process</h3> <p>In compiling the included studies, we worked hard to locate randomised studies that altered dietary SFA intake for at least 24 months, even when cardiovascular events were not reported in study publications, or where such events were reported incidentally as reasons for participant dropouts. We attempted to contact all authors of potentially includable studies to verify the presence or absence of our outcomes. In many studies, no outcomes relevant to this review occurred or were recorded, and the numbers of events occurring within single studies varied from none to over 2500 deaths, over 500 cardiovascular deaths, and over 3000 participants experiencing at least one cardiovascular event (all within <a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>, the largest single study with almost 50,000 female participants for many years). </p> <p>The number of cardiovascular deaths across the review was relatively small (1096), so while we can be quite confident in reporting a reduction in participants experiencing cardiovascular events (4476 events) with SFA reduction, and a lack of effect on total mortality (3518 deaths) within the studies' time scales, the effect on cardiovascular mortality is less clear. The risk ratio of 0.94 (95% CI 0.78 to 1.13, <a href="./references#CD011737-fig-0024" title="">Analysis 1.18</a>) may translate into a small protective effect, but this is unclear. </p> <p>The lack of effect on individual cardiovascular events is harder to explain; there were 1714 people experiencing MIs, 1118 strokes and 1385 non‐fatal MIs, 2472 cancer deaths, 3342 diabetes diagnoses and 5476 cancer diagnoses. Lack of clear effects on any of these outcomes is surprising, given the effects on total cardiovascular events, but may be due to the relatively short timescale of the included studies, compared to a usual lifespan during which risks of chronic illnesses develop over decades, and to relatively small reductions in saturated fat (and serum cholesterol) in some trials. Some of the events included within combined cardiovascular events, such as new or worsening angina or increased anti‐anginal treatment, could potentially be influenced by allocated study arm, and so might increase bias within unblinded trials (although they also add power to see potential effects). There are difficulties in finding data on the number of people experiencing composite end points such as cardiovascular events. This end point represents the number of people experiencing any of the following: cardiovascular death, cardiovascular morbidity (non‐fatal myocardial infarction, angina, stroke, heart failure, peripheral vascular events, atrial fibrillation) and unplanned cardiovascular interventions (coronary artery bypass surgery or angioplasty). Adding up the number of events is easy, but a single participant may have experienced a stroke, an MI and atrial fibrillation during a trial ‐ and we need to take care not to count this individual three times. So finding such composite end point data involves using the best published composite end point data and supplementing this with author contact where possible. We have underestimated such composite end points rather than overestimated them where exact data are not available. Added to this complex picture, it needs to be remembered that definitions and diagnoses of some end points have altered over time. </p> <p>Where the funnel plots and comparison of fixed‐ and random‐effects meta‐analyses suggest small‐study bias, we have downgraded the quality of the evidence in GRADE, but effects of any such small study bias appear small. </p> <p>Some trials were partially confounded by aiming to make dietary changes other than those directly related to dietary fat intakes; for example, some studies encouraged intervention participants to make changes to their fat intake as well as changes to fruit and vegetable, fibre or salt intakes. In these studies, any effect on outcomes could be a result of other dietary changes, not of changes in saturated fat intake. The 11 studies (12 comparisons) that appeared free of such differences included <a href="./references#CD011737-bbs2-0001" title="BlackHS , HerdJA , GoldbergLH , Wolf JE Jr, ThornbyJI , RosenT , et al. Effect of a low-fat diet on the incidence of actinic keratosis. New England Journal of Medicine1994;330(18):1272-5. BlackHS , ThornbyJI , Wolf JE Jr, GoldbergLH , HerdJA , RosenT , et al. Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer. International Journal of Cancer1995;62(2):165-9. JaaxS , ScottLW , Wolf JE Jr, ThornbyJI , BlackHS . General guidelines for a low-fat diet effective in the management and prevention of nonmelanoma skin cancer. Nutrition and Cancer1997;27(2):150-6. ">Black 1994</a>; <a href="./references#CD011737-bbs2-0002" title="BurrML , FehilyAM , GilbertJF , RogersS , HollidayRM , SweetnamPM , et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet1989;2(8666):757-61. BurrML , FehilyAM , RogersS , WelsbyE , KingS , SandhamS . Diet and reinfarction trial (DART): design, recruitment, and compliance. European Heart Journal1989;10(6):558-67. BurrML , FehilyAM . Fish and the heart. Lancet1989;ii:1450-2. BurrML , HollidayRM , FehilyAM , WhiteheadPJ . Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). European Heart Journal1992;13(2):166-70. BurrML , SweethamPM , FehilyAM . Diet and reinfarction [letter]. European Heart Journal1994;15(8):1152-3. FehilyAM , Vaughan-WilliamsE , ShielsK , WilliamsAH , HornerM , BinghamG , et al. The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART). Journal of Human Nutrition &amp; Dietetics1989;2(4):225-5. ">DART 1989</a>; <a href="./references#CD011737-bbs2-0003" title="HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Favourable influences of linoleic acid on the progression of diabetic micro- and macroangiopathy. Nutrition and Metabolism1980;24(Suppl 1):105-18. HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Influence of different diets on the progression of diabetic retinopathy. Progress in Food Nutritition and Science1980;4(5):41-6. HoutsmullerAJ , ZahnKJ , HenkesHE . Unsaturated fats and progression of diabetic retinopathy. Documenta Ophthalmologia1979;48(2):363-71. ">Houtsmuller 1979</a>; <a href="./references#CD011737-bbs2-0004" title="LeySJ , MetcalfPA , ScraggRK , SwinburnBA . Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance. Diabetes Research and Clinical Practice2004;63(2):103-12. SwinburnBA , MetcalfPA , LeySJ . Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care2001;24(4):619-24. SwinburnBA , WoollardGA , ChangEC , WilsonMR . Effects of reduced-fat diets consumed ad libitum on intake of nutrients particularly antioxidant vitamins. Journal of the American Dietetic Association1999;99(11):1400-5. ">Ley 2004</a>; <a href="./references#CD011737-bbs2-0006" title="EdererF , LerenP , TurpeinenO , Frantz ID Jr. Cancer among men on cholesterol lowering diets: experience of five clinical trials. Lancet1971;2(7717):203-6. HeadyJA . Are PUFA harmful?British Medical Journal1974;1(898):115-6. MRC. Controlled trial of soya-bean oil in myocardial infarction. Lancet1968;2(570):693-9. ">MRC 1968</a>; <a href="./references#CD011737-bbs2-0008" title="CoppackSW , DollHA , PimB , HockadayTD . Intravenous glucose tolerance and mortality in non-insulin-dependant diabetes mellitus. Quarterly Journal of Medicine1990;75(277):451-60. HillsonRM , HockadayTD , MannJI , NewtonDJ . Hyperinsulinaemia is associated with development of ECG abnormalities in diabetics. Diabetes Research1984;1(3):143-9. HockadayTD , HockadayJM , MannJI , TurnerRC . Prospective comparison of modified fat-high-carbohydrate with standard low-carbohydrate dietary advice in the treatment of diabetes: one year follow-up study. British Journal of Nutrition1978;39(2):357-62. Howard-WilliamsJ , PatelP , JelfsR , CarterRD , AwdryP , BronA , et al. Polyunsaturated fatty acids and diabetic retinopathy. British Journal of Ophthalmology1985;69(1):15-8. Lopez-EspinozaI , HowardWJ , MannJI , CarterRD , HockadayTD . Fatty acid composition of platelet phospholipids in non-insulin-dependent diabetics randomized for dietary advice. British Journal of Nutrition1984;52(1):41-7. ">Oxford Retinopathy 1978</a>; <a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose corn oil 1965</a>; <a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose olive 1965</a>; <a href="./references#CD011737-bbs2-0011" title="DjuricZ , HeilbrunLK , ReadingBA , BoomerA , ValerioteFA , MartinoS . Effects of a low fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells. Journal of the National Cancer Institute1991;83(11):766-9. DjuricZ , MartinoS , HeilbrunLK , HartRW . Dietary modulation of oxidative DNA damage. Advances In Experimental Medicine and Biology1994;354:71-83. KasimSE , MartinoS , Kim P-N, KhilnaniS , BoomerA , DepperJ , et al. Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women. American Journal of Clinical Nutrition1993;57(2):146-53. SimonMS , HeilbrunLK , BoomerA , KresgeC , DepperJ , KimPN , et al. A randomised trial of a low-fat dietary intervention in women at high risk for breast cancer. Nutrition and Cancer1997;27(2):136-42. ">Simon 1997</a>; <a href="./references#CD011737-bbs2-0013" title="BlacketRB , LeelarthaepinB , McGilchristC , PalmerAJ , WoodhillJM . The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart disease. Australian and New Zealand Journal of Medicine1979;9(5):521-9. RamsdenCE , ZamoraD , LeelarthaepinB , Majchrzak-HongSF , FaurotKR , SuchindranCM , et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ2013;346:e8707. [DOI: 10.1136/bmj.e8707]WoodhillJM , PalmerAJ , LeelarthaepinB , McGilchristC , BlacketRB . Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Advances in Experimental Medicine and Biology1978;109:317-30. ">Sydney Diet‐Heart 1978</a>; <a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. ">Veterans Admin 1969</a>; <a href="./references#CD011737-bbs2-0016" title="ChlebowskiRT , BlackburnGL , BuzzardIM , RoseDP , MartinoS , KhandekarJD , et al. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. Journal of Clinical Oncology1993;11(11):2072-80. ChlebowskiRT , BlackburnGL , ThomsonCA , NixonDW , ShapiroA , HoyMK , et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition study. Journal of the National Cancer Institute2006;98(24):1767-76. ChlebowskiRT , BlackburnGL . Final survival analysis from the randomized Womens Intervention Nutrition Study (WINS) evaluating dietary intervention as adjuvant breast cancer therapy. Cancer Research2015;75(9 Supplement):S5-08. ChlebowskiRT , RoseD , BlackburnG , BuzzardM , KhandekarJ , YorkR , et al. Feasibility of using dietary fat intake reduction in adjuvant breast cancer management. Proceedings of American Society of Clinical Oncology1991;86:86. ChlebowskiRT , RoseDP , BuzzardIM , BlackburnGL , YorkM , Insull W Jr, et al. Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues. Adjuvant: the Cancer Journal1990;6:357-63. HoyMK , WintersBL , ChlebowskiRT , PapoutsakisC , ShapiroA , LubinMP , et al. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study. Journal of the American Dietetic Association2009;109(4):688-96. RoseDP , ChlebowskiRT , ConnollyJM , JonesLA , WynderEL . Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Cancer Research1992;52(19):5386-90. RoseDP , ConnollyJM , ChlebowskiRT , BuzzardIM , WynderEL . The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Research &amp; Treatment1993;27(3):253-62. WynderEL , CohenLA , WintersBL . The challenges of assessing fat intake in cancer research investigations. Journal of the American Dietetic Association1997;97(7 Suppl):S5-8. ">WINS 2006</a>. On the basis of reviewer comments, we assessed effects of reducing saturated fat intake on combined CVD events including only these trials free of additional interventions. Omitting trials with additional interventions (<a href="./references#CD011737-bbs2-0007" title="LerenP . Prevention of coronary heart disease, some results from the Oslo secondary and primary intervention studies. Journal of the American College of Nutrition1989;8(5):407-10. LerenP . The Oslo diet-heart study. Eleven year report. Circulation1970;42(5):935-42. LerenP . The effect of a cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial) [Virkningen av cholesterolsenkende diett hos menn som har gjennomgatt hjerteinfarkt. Et kontrollert klinisk fors/ok]. Nordisk Medicin1967;77(21):658-61. LerenP . The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Medica Scandinavia1966;466 Suppl:1-92. LerenP . The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Bulletin of the New York Academy of Medicine1968;44(8):1012-20. ">Oslo Diet‐Heart 1966</a>; <a href="./references#CD011737-bbs2-0012" title="BlannAD , JacksonP , BathPM , WattsGF . Von Willebrand factor, a possible indicator of endothelial cell damage, decreases during long-term compliance with a lipid-lowering diet. Journal of Internal Medicine1995;237(6):557-61. WattsGF , BruntJN , ColtartDJ , LewisB . The St. Thomas Atherosclerosis Regression Study (STARS). Atherosclerosis1992;97:231. WattsGF , JacksonP , BurkeV , LewisB . Dietary fatty acids and progression of coronary artery disease in men. American Journal of Clinical Nutrition1996;64(2):202-9. WattsGF , JacksonP , MandaliaS , BruntJN , LewisES , ColtartDJ , et al. Nutrient intake and progression of coronary artery disease. American Journal of Cardiology1994;73(5):328-32. WattsGF , LewisB , BruntJN , LewisES , ColtartDJ , SmithLD , et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet1992;339(8793):563-9. WattsGF , LewisB , BruntJNH , SwanAV . Coronary atheroma regression trials. Lancet1992;339(i):1241-3. WattsGF , LewisB , JacksonP , BurkeV , LewisES , BruntJN , et al. Relationships between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography. Canadian Journal of Cardiology1995;11(Suppl G):110G-4G. WattsGF , MandaliaS , BruntJN , SlavinBM , ColtartDJ , LewisB . Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism: Clinical and Experimental1993;42(11):1461-7. WattsGF , MandaliaS , SlavinBM , BruntJN , ColtartDJ , LewisB . Metabolic determinants of the course of coronary artery disease in men. Clinical Chemistry1994;40(12):2240-6. WattsGF . Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group. Journal of Cardiovascular Pharmacology1995;25(Suppl 4):S11-9. ">STARS 1992</a>; <a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>) leaves nine studies (ten arms) randomising 4456 participants of whom 812 experienced a CVD event, suggesting a similar reduction in CVD events (RR 0.86, 95% CI 0.67 to 1.09, I<sup>2</sup> = 59%, <a href="./references#CD011737-fig-0049" title="">Analysis 1.43</a>) to the main analysis (RR 0.83, 95% CI 0.70 to 0.98, I<sup>2</sup> = 67%, &gt; 53,000 participants randomised, <a href="./references#CD011737-fig-0041" title="">Analysis 1.35</a>). This suggests that effects on combined CVD events are not driven by interventions other than reductions in saturated fats and any energy replacements. </p> <p>One surprising element of this review is the lack of new trials identified in the 2019 update, and small numbers of potential ongoing trials. This is likely to be because well‐powered trials on cardiovascular end points will need to be large and carried out over several years, so expensive. As the effects of saturated fats are felt to be established and understood, trialists and funders may feel that the money would be better invested in answering other questions. For most of the ongoing trials, information is limited and these trials may or may not be included when fully published. Perhaps the current evidence set is as definitive as we will achieve during the 'statin era'. </p> </section> <section id="CD011737-sec-0075"> <h3 class="title" id="CD011737-sec-0075">Agreements and disagreements with other studies or reviews</h3> <p>In this review, saturated fat reduction had little or no effect on all‐cause or cardiovascular mortality but did appear to reduce the risk of cardiovascular events by 17%, although effects on MI and stroke individually were less clear. This result was rather different from those of <a href="./references#CD011737-bbs2-0433" title="Siri-TarinoPW , SunQ , HuFB , KraussRM . Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. American Journal of Clinical Nutrition2010;91(3):535-46.">Siri‐Tarino 2010</a>, who systematically reviewed cohort studies that assessed relationships between saturated fat and cardiovascular events. They included 21 studies and did not find associations between saturated fat intake and cardiovascular disease (RR 1.0, 95% CI 0.89 to 1.11). This meta‐analysis has been criticised (<a href="./references#CD011737-bbs2-0390" title="KatanMB , BrouwerIA , ClarkeR , GeleijnseJM , MensinkRP . Saturated fat and heart disease. American Journal of Clinical Nutrition2010;92(2):459-60; author reply 460-1.">Katan 2010</a>; <a href="./references#CD011737-bbs2-0425" title="ScarboroughP , RaynerM , Van DisI , NorumK . Meta-analysis of effect of saturated fat intake on cardiovascular disease: overadjustment obscures true associations. American Journal of Clinical Nutrition2010;92(2):458-9; author reply 459.">Scarborough 2010</a>; <a href="./references#CD011737-bbs2-0435" title="StamlerJ . Diet-heart: a problematic revisit. American Journal of Clinical Nutrition2010;91(3):497-9.">Stamler 2010</a>), as results of half of the studies included in their meta‐analysis were adjusted for serum cholesterol concentrations, while there is an established relation between saturated fat intake and cholesterol level. The issue of what factors should be adjusted for, and what not adjusted for, in observational studies when dietary factors are very tightly correlated is a thorny one, and one of the reasons why trial data may be helpful. The studies included in the meta‐analysis also varied widely in the method used to assess intake, as half of the studies collected one‐day intake data. However, as with our review, they found little or no relationship between saturated fat intake and coronary heart disease (RR 1.07, 95% CI 0.96 to 1.19) though their data did suggest a (non‐statistically significant) reduction in stroke risk with higher saturated fat intake (RR 0.81, 95% CI 0.62 to 1.05, <a href="./references#CD011737-bbs2-0433" title="Siri-TarinoPW , SunQ , HuFB , KraussRM . Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. American Journal of Clinical Nutrition2010;91(3):535-46.">Siri‐Tarino 2010</a>). </p> <p>In this review, we found that replacing saturated fat with PUFAs (a modified‐fat diet) appeared more protective of cardiovascular events than replacement with carbohydrates (a low‐fat diet, <a href="./references#CD011737-fig-0050" title="">Analysis 1.44</a>; <a href="./references#CD011737-fig-0051" title="">Analysis 1.45</a>). This was similar to results within our closely allied systematic review assessing health effects of total fat reduction, where modified‐fat diets were protective and low‐fat diets were not (<a href="./references#CD011737-bbs2-0448" title="HooperL , SummerbellCD , ThompsonR , SillsD , RobertsFG , MooreHJ , et al. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database of Systematic Reviews2012, Issue 5. Art. No: CD002137. [DOI: 10.1002/14651858.CD002137.pub3]">Hooper 2012</a>). Meta‐regression did not suggest any relationship between either PUFAs or MUFAs and cardiovascular events in this review, although the analysis was underpowered. <a href="./references#CD011737-bbs2-0351" title="Alonso Á, Ruiz-GutierrezV , Martínez-González MÁ. Monounsaturated fatty acids, olive oil and blood pressure: epidemiological, clinical and experimental evidence. Public Health Nutrition2006;9(2):251-7.">Alonso 2006</a> suggested a protective role for MUFA from olive oil, but not from meat sources (the main source of MUFA in the USA and Northern Europe). Our systematic review was not able to explore this issue as we included only one small study (underpowered to assess health outcomes on its own) that replaced SFA with MUFA, using an olive oil supplement (<a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose olive 1965</a>). A review by <a href="./references#CD011737-bbs2-0407" title="MozaffarianD , MichaR , WallaceS . Effects of coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials. PLOS Medicine2010;7(3):e1000252.">Mozaffarian 2010</a>, which again included very similar studies to the last version of this review, with the Finnish Mental Hospital study and Women's Health Initiative data added, stated that their findings provided evidence that consuming PUFAs in place of saturated fat would reduce coronary heart disease. However, their evidence for this was limited, as they found that modifying fat reduced the risk of myocardial infarction or coronary heart disease death (combined) by 19% (similar to our result). As the mean increase in PUFAs in these studies was 9.9% of energy, they infer an effect of increasing PUFAs by 5% of energy of 10% reduction in risk of myocardial infarction or coronary heart disease death. They provided no suggestion or evidence of a relationship between degree of PUFAs increase and level of risk reduction. Another review carried out during updating of the Nordic Nutritional Recommendations (<a href="./references#CD011737-bbs2-0428" title="SchwabU , LauritzenL , TholstrupT , HaldorssoniT , RiserusU , UusitupaM , et al. Effect of the amount and type of dietary fat on cardiometabolic risk factors and risk of developing type-2 diabetes, cardiovascular disease, and cancer: a systematic review. Food &amp; Nutrition Research2014;58:25145. [DOI: 10.3402/fnr.v58.25145]">Schwab 2014</a>) included observational as well as intervention studies, and concluded that there was convincing evidence that partial replacement of SFA with PUFA decreases risk of CVD while replacement with CHO is associated with increased CVD risk. The review included studies performed solely in white participants or with a clear white majority. </p> <p>Within the meta‐regression, we hoped to combine studies that effectively altered saturated fat by different degrees, so that studies that reduced saturated fat very little and studies that reduced it a great deal would all offer data points for the meta‐regression against mortality and morbidity end points, and similarly for total fat, polyunsaturated, monounsaturated and trans fats. Unfortunately many of the included studies did not report data on assessed dietary intake during the trial, reducing the quantity of data available to understand the relationships. Another limitation in understanding effects of individual classes of fatty acids on mortality and morbidity (both in trials and in observational studies) was our ability to correctly assess participants' intake. We could overcome this by using biomarkers such as serum LDL cholesterol (differences between the LDL concentration in the intervention and control arms could be seen as a reasonable and independent approximation of saturated fat intake); however, as many studies were carried out in the 1960s to 1990s, few measured and reported LDL cholesterol. We used meta‐regression with serum total cholesterol (although this is a composite marker and so less related to saturated fat intake), but although this was available for more studies than LDL it was not available for all studies. Despite the limited data, there was a clear suggestion from meta‐regression that there was greater reduction of risk of cardiovascular events in studies with greater total serum cholesterol reduction, supporting the central role of serum lipids in the link between dietary saturated fats and cardiovascular events. </p> <section id="CD011737-sec-0076"> <h4 class="title">Participants' level of risk</h4> <p>As the rate of events is higher in high‐risk groups (by definition), it should require smaller sample sizes and shorter follow‐up to observe an effect of an intervention in a high‐risk group of participants (<a href="./references#CD011737-bbs2-0363" title="Davey SmithG , SongF , SheldonTA . Cholesterol lowering and mortality: the importance of considering initial level of risk. BMJ1993;306(6889):1367-73.">Davey Smith 1993</a>). There have been suggestions that randomised controlled trials are unsuitable for assessing the effectiveness of interventions with very modest levels of effect in low‐risk populations, because of the huge numbers of person‐years of observation needed to gain sufficient statistical power to avoid Type II errors (<a href="./references#CD011737-bbs2-0368" title="EbrahimS , Davey SmithG . Systematic review of randomised controlled trials of multiple risk factor interventions for preventing coronary heart disease. BMJ1997;314(7095):1666.">Ebrahim 1997</a>). However, with the publication of the Women's Health Initiative trial (<a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>) we now have data on more people experiencing cardiovascular events who were originally at low risk of cardiovascular disease than in people with moderate or high risk. The same is true for cardiovascular deaths and total mortality. </p> <p>When end points such as total mortality are used, the situation becomes more difficult, as in low‐risk groups the proportion of deaths which are unrelated to cardiovascular disease (and perhaps unlikely to be influenced by dietary fat changes) rises, again diluting any differences in the numbers of deaths between intervention and control groups. It is more likely that changes in cardiovascular deaths will be seen than in total mortality. The trend is certainly in this direction, with the pooled risk ratio for total mortality 0.96 (95% CI 0.90 to 1.03, <a href="./references#CD011737-fig-0007" title="">Analysis 1.1</a>), and for cardiovascular mortality RR 0.94 (95% CI 0.78 to 1.13, <a href="./references#CD011737-fig-0024" title="">Analysis 1.18</a>). Our best estimate is that SFA reduction results in a reduction of 6% in deaths due to cardiovascular disease, and a reduction of 4% in total deaths, but these are small effects with wide confidence intervals. </p> <p>The high‐risk participants all showed evidence of cardiovascular disease at baseline. Under current guidelines, most high‐risk participants with raised lipid levels should be on lipid‐lowering medication (<a href="./references#CD011737-bbs2-0375" title="GrundySM , StoneNJ , BaileyAL , BeamC , BirtcherKK , BlumenthalRS , et al. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol. Journal of the American College of Cardiology2019;73(24):e285-350.">Grundy 2019</a>; <a href="./references#CD011737-bbs2-0410" title="National Institute of Health and Care Excellence. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. www.nice.org.uk/guidance/cg181/resources/guidance-lipid-modification-cardiovascular-risk-assessment-and-the-modification-of-blood-lipids-for-the-primary-and-secondary-prevention-of-cardiovascular-disease-pdf (accessed 29th Dec 2019).">NICE 2014</a>; <a href="./references#CD011737-bbs2-0411" title="O'GaraPT , KushnerFG , AscheimDD , Casey DE Jr, ChungMK , De LemosJA , et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Circulation2013;127(4):e362-e425. [DOI: 10.1161/CIR.0b013e3182742cf6 ]">O'Gara 2014</a>). This raises the question of whether there is any additional advantage of adherence to a reduced SFA diet in addition to statin therapy. Little evidence exists at present to answer this question. However, in all parts of the world where drug budgets are restricted and use of lipid‐lowering medication remains rationed even for those at high risk, the use of reduced SFA diets would appear to be a cost‐effective option leading to considerable reductions in cardiovascular events for populations (and so in health budgets) in only a few years. </p> <p>Low‐risk participants are unlikely to be on lipid‐lowering medication under current guidelines. The suggestion of protection of low‐risk individuals from cardiovascular events with a reduction of roughly 17% of events in just a few years of intervention, as there is no evidence that effects in the low‐CVD‐risk group are different from effects in the higher‐risk groups, would appear to merit continued public health action. Recent guidelines recommend saturated fat reduction in general populations (<a href="./references#CD011737-bbs2-0423" title="Scientific Advisory Committee on Nutrition. Saturated fat and health. www.gov.uk/government/publications/saturated-fats-and-health-sacn-report (accessed prior to 30 April 2020).">SACN 2019</a>). </p> <p>A factor that may affect participant risk of cardiovascular disease, and also the effectiveness of reducing saturated fat intake, that has altered over time is the level of use of statins to control serum lipids in people at moderate and high risk of CVD. The <a href="./references#CD011737-bbs2-0347" title="Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet1994;344(8934):1383-9.">4S 1994</a> trial, which was the first trial to show that use of statins could reduce mortality in people with coronary heart disease, was published in 1994 and led to an explosion of the use of statins. For most health outcomes, we saw no clear effect of a decade of publication on risk, but for combined CVD events and CHD events, there were differences between subgroups. For combined CVD events, there were reductions in risk with reduced saturated fat intakes in the 1960s, 1970s and 1990s (both trials published early in the decade), but no clear effect of reducing saturated fat in the 1980s (one trial with 283 events) or 2000s (three large trials). It is possible (but not clear) that participants in the trials published in the 2000s were protected by higher levels of statin use (statins were allowed in participants in the largest trial, <a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. ">WHI 2006</a>). </p> </section> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD011737-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-FIG-01" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram for this systematic review (update searches run October 2019)." data-id="CD011737-fig-0001" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-01.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-FIG-01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram for this systematic review (update searches run October 2019).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-FIG-02" target="_blank"><b></b></a></p> </div><img alt="Methodological quality summary: review authors' judgements about each methodological quality item for each included study. Please note that while Rose 1965 (Rose corn oil 1965; Rose olive 1965) appears twice in this summary, it is a single trial. Rose 1965 was a 3‐arm trial and we have used the two intervention arms separately in the review." data-id="CD011737-fig-0002" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-FIG-02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>Methodological quality summary: review authors' judgements about each methodological quality item for each included study. Please note that while Rose 1965 (<a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose corn oil 1965</a>; <a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. ">Rose olive 1965</a>) appears twice in this summary, it is a single trial. Rose 1965 was a 3‐arm trial and we have used the two intervention arms separately in the review. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-FIG-03" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: fat modification or reduction vs usual diet ‐ total mortality." data-id="CD011737-fig-0003" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-FIG-03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>Funnel plot of comparison: fat modification or reduction vs usual diet ‐ total mortality.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-FIG-04" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: fat modification or reduction vs usual diet ‐ cardiovascular mortality" data-id="CD011737-fig-0004" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-FIG-04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 4</div> <div class="figure-caption"> <p>Funnel plot of comparison: fat modification or reduction vs usual diet ‐ cardiovascular mortality </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-FIG-05" target="_blank"><b></b></a></p> </div><img alt="Funnel plot of comparison: fat modification or reduction vs usual diet ‐ combined cardiovascular events." data-id="CD011737-fig-0005" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-FIG-05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 5</div> <div class="figure-caption"> <p>Funnel plot of comparison: fat modification or reduction vs usual diet ‐ combined cardiovascular events. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-FIG-06" target="_blank"><b></b></a></p> </div><img alt="Exploration of saturated fat cut‐offs" data-id="CD011737-fig-0006" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-06.png"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-FIG-06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 6</div> <div class="figure-caption"> <p>Exploration of saturated fat cut‐offs</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-FIG-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 1: ALL‐CAUSE MORTALITY" data-id="CD011737-fig-0007" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 1: ALL‐CAUSE MORTALITY </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 2: All‐cause mortality, SA low summary risk of bias" data-id="CD011737-fig-0008" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 2: All‐cause mortality, SA low summary risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 3: All‐cause mortality, SA aim to reduce SFA" data-id="CD011737-fig-0009" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 3: All‐cause mortality, SA aim to reduce SFA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 4: All‐cause mortality, SA statistically significant SFA reduction" data-id="CD011737-fig-0010" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 4: All‐cause mortality, SA statistically significant SFA reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 5: All‐cause mortality, SA TC reduction" data-id="CD011737-fig-0011" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 5: All‐cause mortality, SA TC reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 6: All‐cause mortality, SA excluding WHI" data-id="CD011737-fig-0012" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 6: All‐cause mortality, SA excluding WHI </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 7: All‐cause mortality, SA Mantel‐Haenszel fixed‐effect" data-id="CD011737-fig-0013" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 7: All‐cause mortality, SA Mantel‐Haenszel fixed‐effect </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 8: All‐cause mortality, SA Peto fixed‐effect" data-id="CD011737-fig-0014" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 8: All‐cause mortality, SA Peto fixed‐effect </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 9: All‐cause mortality, subgroup by any substitution" data-id="CD011737-fig-0015" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 9: All‐cause mortality, subgroup by any substitution </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 10: All‐cause mortality, subgroup by main substitution" data-id="CD011737-fig-0016" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.10</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 10: All‐cause mortality, subgroup by main substitution </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 11: All‐cause mortality, subgroup by duration" data-id="CD011737-fig-0017" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.11</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 11: All‐cause mortality, subgroup by duration </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 12: All‐cause mortality, subgroup by baseline SFA" data-id="CD011737-fig-0018" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.12</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 12: All‐cause mortality, subgroup by baseline SFA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 13: All‐cause mortality, subgroup by SFA change" data-id="CD011737-fig-0019" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.13</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 13: All‐cause mortality, subgroup by SFA change </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 14: All‐cause mortality, subgroup by sex" data-id="CD011737-fig-0020" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.14</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 14: All‐cause mortality, subgroup by sex </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 15: All‐cause mortality, subgroup by CVD risk" data-id="CD011737-fig-0021" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.15</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 15: All‐cause mortality, subgroup by CVD risk </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 16: All‐cause mortality, subgroup by TC reduction" data-id="CD011737-fig-0022" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.16</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 16: All‐cause mortality, subgroup by TC reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 17: All‐cause mortality, subgroup decade of publication" data-id="CD011737-fig-0023" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.17</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 17: All‐cause mortality, subgroup decade of publication </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 18: CARDIOVASCULAR MORTALITY" data-id="CD011737-fig-0024" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.18</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 18: CARDIOVASCULAR MORTALITY </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 19: CVD mortality, SA low summary risk of bias" data-id="CD011737-fig-0025" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.19</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 19: CVD mortality, SA low summary risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.20" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 20: CVD mortality, SA aim to reduce SFA" data-id="CD011737-fig-0026" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.20.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.20.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.20</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 20: CVD mortality, SA aim to reduce SFA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.20.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.21" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 21: CVD mortality, SA statistically significant SFA reduction" data-id="CD011737-fig-0027" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.21.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.21.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.21</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 21: CVD mortality, SA statistically significant SFA reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.21.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.22" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 22: CVD mortality, SA TC reduction" data-id="CD011737-fig-0028" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.22.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.22.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.22</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 22: CVD mortality, SA TC reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.22.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.23" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 23: CVD mortality, SA excluding WHI" data-id="CD011737-fig-0029" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.23.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.23.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.23</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 23: CVD mortality, SA excluding WHI </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.23.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.24" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 24: CVD mortality, SA Mantel‐Haenszel fixed‐effect" data-id="CD011737-fig-0030" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.24.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.24.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.24</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 24: CVD mortality, SA Mantel‐Haenszel fixed‐effect </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.24.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.25" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 25: CVD mortality, SA Peto fixed‐effect" data-id="CD011737-fig-0031" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.25.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.25.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.25</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 25: CVD mortality, SA Peto fixed‐effect </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.25.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.26" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 26: CVD mortality, subgroup by any substitution" data-id="CD011737-fig-0032" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.26.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.26.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.26</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 26: CVD mortality, subgroup by any substitution </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.26.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.27" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 27: CVD mortality, subgroup by main substitution" data-id="CD011737-fig-0033" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.27.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.27.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.27</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 27: CVD mortality, subgroup by main substitution </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.27.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.28" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 28: CVD mortality, subgroup by duration" data-id="CD011737-fig-0034" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.28.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.28.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.28</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 28: CVD mortality, subgroup by duration </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.28.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.29" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 29: CVD mortality, subgroup by baseline SFA" data-id="CD011737-fig-0035" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.29.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.29.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.29</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 29: CVD mortality, subgroup by baseline SFA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.29.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.30" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 30: CVD mortality, subgroup by SFA change" data-id="CD011737-fig-0036" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.30.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.30.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.30</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 30: CVD mortality, subgroup by SFA change </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.30.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.31" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 31: CVD mortality, subgroup by sex" data-id="CD011737-fig-0037" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.31.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.31.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.31</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 31: CVD mortality, subgroup by sex </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.31.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.32" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 32: CVD mortality, subgroup by CVD risk" data-id="CD011737-fig-0038" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.32.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.32.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.32</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 32: CVD mortality, subgroup by CVD risk </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.32.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.33" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 33: CVD mortality, subgroup by TC reduction" data-id="CD011737-fig-0039" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.33.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.33.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.33</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 33: CVD mortality, subgroup by TC reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.33.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.34" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 34: CVD mortality, subgroup decade of publication" data-id="CD011737-fig-0040" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.34.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.34.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.34</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 34: CVD mortality, subgroup decade of publication </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.34.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.35" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 35: COMBINED CARDIOVASCULAR EVENTS" data-id="CD011737-fig-0041" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.35.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.35.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.35</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 35: COMBINED CARDIOVASCULAR EVENTS </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.35.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.36" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 36: CVD events, SA low summary risk of bias" data-id="CD011737-fig-0042" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.36.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.36.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.36</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 36: CVD events, SA low summary risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.36.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.37" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 37: CVD events, SA aim to reduce SFA" data-id="CD011737-fig-0043" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.37.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.37.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.37</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 37: CVD events, SA aim to reduce SFA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.37.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.38" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 38: CVD events, SA statistically significant SFA reduction" data-id="CD011737-fig-0044" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.38.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.38.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.38</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 38: CVD events, SA statistically significant SFA reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.38.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.39" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 39: CVD events, SA TC reduction" data-id="CD011737-fig-0045" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.39.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.39.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.39</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 39: CVD events, SA TC reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.39.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.40" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 40: CVD events, SA excluding WHI" data-id="CD011737-fig-0046" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.40.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.40.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.40</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 40: CVD events, SA excluding WHI </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.40.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.41" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 41: CVD events, SA Mantel‐Haenszel fixed‐effect" data-id="CD011737-fig-0047" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.41.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.41.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.41</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 41: CVD events, SA Mantel‐Haenszel fixed‐effect </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.41.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.42" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 42: CVD events, SA Peto fixed‐effect" data-id="CD011737-fig-0048" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.42.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.42.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.42</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 42: CVD events, SA Peto fixed‐effect </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.42.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.43" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 43: CVD events, SA excluding trials with additional interventions" data-id="CD011737-fig-0049" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.43.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.43.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.43</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 43: CVD events, SA excluding trials with additional interventions </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.43.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.44" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 44: CVD events, subgroup by any substitution" data-id="CD011737-fig-0050" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.44.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.44.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.44</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 44: CVD events, subgroup by any substitution </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.44.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.45" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 45: CVD events, subgroup by main substitution" data-id="CD011737-fig-0051" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.45.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.45.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.45</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 45: CVD events, subgroup by main substitution </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.45.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.46" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 46: CVD events, subgroup by duration" data-id="CD011737-fig-0052" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.46.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.46.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.46</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 46: CVD events, subgroup by duration </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.46.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.47" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 47: CVD events, subgroup by baseline SFA" data-id="CD011737-fig-0053" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.47.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.47.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.47</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 47: CVD events, subgroup by baseline SFA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.47.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.48" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 48: CVD events, subgroup by SFA change" data-id="CD011737-fig-0054" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.48.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.48.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.48</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 48: CVD events, subgroup by SFA change </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.48.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.49" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 49: CVD events, subgroup by sex" data-id="CD011737-fig-0055" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.49.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.49.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.49</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 49: CVD events, subgroup by sex </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.49.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.50" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 50: CVD events, subgroup by CVD risk" data-id="CD011737-fig-0056" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.50.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.50.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.50</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 50: CVD events, subgroup by CVD risk </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.50.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.51" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 51: CVD events, subgroup by TC reduction" data-id="CD011737-fig-0057" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.51.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.51.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.51</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 51: CVD events, subgroup by TC reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.51.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-001.52" target="_blank"><b></b></a></p> </div><img alt="Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 52: CVD events, subgroup decade of publication" data-id="CD011737-fig-0058" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.52.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-001.52.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.52</div> <div class="figure-caption"> <p>Comparison 1: SFA reduction vs usual diet ‐ primary outcomes, Outcome 52: CVD events, subgroup decade of publication </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-001.52.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 1: MYOCARDIAL INFARCTION" data-id="CD011737-fig-0059" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 1: MYOCARDIAL INFARCTION </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 2: MI, SA by low summary risk of bias" data-id="CD011737-fig-0060" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 2: MI, SA by low summary risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 3: MI, SA aim to reduce SFA" data-id="CD011737-fig-0061" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.3</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 3: MI, SA aim to reduce SFA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 4: MI, SA statistically significant SFA reduction" data-id="CD011737-fig-0062" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.4</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 4: MI, SA statistically significant SFA reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 5: MI, SA by TC reduction" data-id="CD011737-fig-0063" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.5</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 5: MI, SA by TC reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 6: MI, SA excluding WHI" data-id="CD011737-fig-0064" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.6</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 6: MI, SA excluding WHI </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 7: MI, SA Mantel‐Haenszel fixed‐effect" data-id="CD011737-fig-0065" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.7</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 7: MI, SA Mantel‐Haenszel fixed‐effect </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 8: MI, SA Peto fixed‐effect" data-id="CD011737-fig-0066" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.8</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 8: MI, SA Peto fixed‐effect </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 9: MI, subgroup by any substitution" data-id="CD011737-fig-0067" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.9</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 9: MI, subgroup by any substitution </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 10: MI, subgroup by main substitution" data-id="CD011737-fig-0068" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.10</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 10: MI, subgroup by main substitution </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 11: MI, subgroup by duration" data-id="CD011737-fig-0069" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.11</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 11: MI, subgroup by duration </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 12: MI, subgroup by baseline SFA" data-id="CD011737-fig-0070" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.12</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 12: MI, subgroup by baseline SFA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 13: MI, subgroup by SFA change" data-id="CD011737-fig-0071" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.13</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 13: MI, subgroup by SFA change </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 14: MI, subgroup by sex" data-id="CD011737-fig-0072" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.14</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 14: MI, subgroup by sex </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 15: MI, subgroup by CVD risk" data-id="CD011737-fig-0073" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.15</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 15: MI, subgroup by CVD risk </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 16: MI, subgroup by TC reduction" data-id="CD011737-fig-0074" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.16</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 16: MI, subgroup by TC reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 17: MI, subgroup decade of publication" data-id="CD011737-fig-0075" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.17</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 17: MI, subgroup decade of publication </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 18: NON‐FATAL MYOCARDIAL INFARCTION" data-id="CD011737-fig-0076" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.18</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 18: NON‐FATAL MYOCARDIAL INFARCTION </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 19: Non‐fatal MI, SA by low summary risk of bias" data-id="CD011737-fig-0077" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.19</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 19: Non‐fatal MI, SA by low summary risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.20" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 20: Non‐fatal MI, SA aim to reduce SFA" data-id="CD011737-fig-0078" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.20.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.20.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.20</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 20: Non‐fatal MI, SA aim to reduce SFA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.20.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.21" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 21: Non‐fatal MI, SA statistically significant SFA reduction" data-id="CD011737-fig-0079" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.21.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.21.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.21</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 21: Non‐fatal MI, SA statistically significant SFA reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.21.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.22" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 22: Non‐fatal MI, SA by TC reduction" data-id="CD011737-fig-0080" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.22.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.22.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.22</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 22: Non‐fatal MI, SA by TC reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.22.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.23" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 23: Non‐fatal MI, SA excluding WHI" data-id="CD011737-fig-0081" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.23.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.23.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.23</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 23: Non‐fatal MI, SA excluding WHI </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.23.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.24" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 24: Non‐fatal MI, SA Mantel‐Haenszel fixed‐effect" data-id="CD011737-fig-0082" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.24.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.24.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.24</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 24: Non‐fatal MI, SA Mantel‐Haenszel fixed‐effect </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.24.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.25" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 25: Non‐fatal MI, SA Peto fixed‐effect" data-id="CD011737-fig-0083" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.25.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.25.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.25</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 25: Non‐fatal MI, SA Peto fixed‐effect </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.25.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.26" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 26: Non‐fatal MI, subgroup by any substitution" data-id="CD011737-fig-0084" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.26.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.26.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.26</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 26: Non‐fatal MI, subgroup by any substitution </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.26.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.27" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 27: Non‐fatal MI, subgroup by main substitution" data-id="CD011737-fig-0085" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.27.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.27.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.27</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 27: Non‐fatal MI, subgroup by main substitution </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.27.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.28" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 28: Non‐fatal MI, subgroup by duration" data-id="CD011737-fig-0086" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.28.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.28.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.28</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 28: Non‐fatal MI, subgroup by duration </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.28.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.29" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 29: Non‐fatal MI, subgroup by baseline SFA" data-id="CD011737-fig-0087" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.29.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.29.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.29</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 29: Non‐fatal MI, subgroup by baseline SFA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.29.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.30" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 30: Non‐fatal MI, subgroup by SFA change" data-id="CD011737-fig-0088" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.30.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.30.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.30</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 30: Non‐fatal MI, subgroup by SFA change </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.30.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.31" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 31: Non‐fatal MI, subgroup by sex" data-id="CD011737-fig-0089" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.31.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.31.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.31</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 31: Non‐fatal MI, subgroup by sex </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.31.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.32" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 32: Non‐fatal MI, subgroup by CVD risk" data-id="CD011737-fig-0090" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.32.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.32.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.32</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 32: Non‐fatal MI, subgroup by CVD risk </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.32.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.33" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 33: Non‐fatal MI, subgroup by TC reduction" data-id="CD011737-fig-0091" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.33.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.33.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.33</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 33: Non‐fatal MI, subgroup by TC reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.33.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.34" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 34: Non‐fatal MI, subgroup decade of publication" data-id="CD011737-fig-0092" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.34.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.34.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.34</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 34: Non‐fatal MI, subgroup decade of publication </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.34.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.35" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 35: STROKE" data-id="CD011737-fig-0093" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.35.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.35.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.35</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 35: STROKE</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.35.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.36" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 36: Stroke, SA by low summary risk of bias" data-id="CD011737-fig-0094" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.36.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.36.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.36</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 36: Stroke, SA by low summary risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.36.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.37" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 37: Stroke, SA aim to reduce SFA" data-id="CD011737-fig-0095" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.37.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.37.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.37</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 37: Stroke, SA aim to reduce SFA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.37.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.38" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 38: Stroke, SA statistically significant SFA reduction" data-id="CD011737-fig-0096" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.38.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.38.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.38</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 38: Stroke, SA statistically significant SFA reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.38.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.39" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 39: Stroke, SA by TC reduction" data-id="CD011737-fig-0097" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.39.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.39.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.39</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 39: Stroke, SA by TC reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.39.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.40" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 40: Stroke, SA excluding WHI" data-id="CD011737-fig-0098" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.40.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.40.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.40</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 40: Stroke, SA excluding WHI </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.40.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.41" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 41: Stroke, SA Mantel‐Haenszel fixed‐effect" data-id="CD011737-fig-0099" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.41.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.41.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.41</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 41: Stroke, SA Mantel‐Haenszel fixed‐effect </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.41.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.42" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 42: Stroke, SA Peto fixed‐effect" data-id="CD011737-fig-0100" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.42.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.42.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.42</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 42: Stroke, SA Peto fixed‐effect </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.42.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.43" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 43: Stroke, subgroup by any substitution" data-id="CD011737-fig-0101" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.43.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.43.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.43</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 43: Stroke, subgroup by any substitution </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.43.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.44" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 44: Stroke, subgroup by main substitution" data-id="CD011737-fig-0102" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.44.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.44.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.44</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 44: Stroke, subgroup by main substitution </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.44.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.45" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 45: Stroke, subgroup by duration" data-id="CD011737-fig-0103" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.45.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.45.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.45</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 45: Stroke, subgroup by duration </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.45.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.46" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 46: Stroke, subgroup by baseline SFA" data-id="CD011737-fig-0104" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.46.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.46.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.46</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 46: Stroke, subgroup by baseline SFA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.46.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.47" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 47: Stroke, subgroup by SFA change" data-id="CD011737-fig-0105" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.47.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.47.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.47</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 47: Stroke, subgroup by SFA change </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.47.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.48" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 48: Stroke, subgroup by sex" data-id="CD011737-fig-0106" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.48.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.48.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.48</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 48: Stroke, subgroup by sex </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.48.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.49" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 49: Stroke, subgroup by CVD risk" data-id="CD011737-fig-0107" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.49.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.49.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.49</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 49: Stroke, subgroup by CVD risk </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.49.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.50" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 50: Stroke, subgroup by TC reduction" data-id="CD011737-fig-0108" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.50.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.50.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.50</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 50: Stroke, subgroup by TC reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.50.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.51" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 51: Stroke, subgroup decade of publication" data-id="CD011737-fig-0109" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.51.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.51.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.51</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 51: Stroke, subgroup decade of publication </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.51.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.52" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 52: CORONARY HEART DISEASE MORTALITY" data-id="CD011737-fig-0110" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.52.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.52.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.52</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 52: CORONARY HEART DISEASE MORTALITY </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.52.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.53" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 53: CHD mortality, SA by low summary risk of bias" data-id="CD011737-fig-0111" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.53.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.53.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.53</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 53: CHD mortality, SA by low summary risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.53.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.54" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 54: CHD mortality, SA aim to reduce SFA" data-id="CD011737-fig-0112" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.54.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.54.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.54</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 54: CHD mortality, SA aim to reduce SFA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.54.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.55" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 55: CHD mortality, SA statistically significant SFA reduction" data-id="CD011737-fig-0113" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.55.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.55.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.55</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 55: CHD mortality, SA statistically significant SFA reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.55.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.56" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 56: CHD mortality, SA by TC reduction" data-id="CD011737-fig-0114" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.56.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.56.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.56</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 56: CHD mortality, SA by TC reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.56.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.57" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 57: CHD mortality, SA excluding WHI" data-id="CD011737-fig-0115" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.57.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.57.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.57</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 57: CHD mortality, SA excluding WHI </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.57.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.58" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 58: CHD mortality, SA Mantel‐Haenszel fixed‐effect" data-id="CD011737-fig-0116" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.58.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.58.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.58</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 58: CHD mortality, SA Mantel‐Haenszel fixed‐effect </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.58.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0117"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.59" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 59: CHD mortality, SA Peto fixed‐effect" data-id="CD011737-fig-0117" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.59.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.59.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.59</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 59: CHD mortality, SA Peto fixed‐effect </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0117">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.59.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0118"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.60" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 60: CHD mortality, subgroup by any substitution" data-id="CD011737-fig-0118" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.60.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.60.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.60</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 60: CHD mortality, subgroup by any substitution </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0118">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.60.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0119"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.61" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 61: CHD mortality, subgroup by main substitution" data-id="CD011737-fig-0119" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.61.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.61.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.61</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 61: CHD mortality, subgroup by main substitution </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0119">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.61.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0120"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.62" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 62: CHD mortality, subgroup by duration" data-id="CD011737-fig-0120" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.62.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.62.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.62</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 62: CHD mortality, subgroup by duration </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0120">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.62.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0121"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.63" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 63: CHD mortality, subgroup by baseline SFA" data-id="CD011737-fig-0121" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.63.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.63.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.63</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 63: CHD mortality, subgroup by baseline SFA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0121">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.63.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0122"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.64" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 64: CHD mortality, subgroup by SFA change" data-id="CD011737-fig-0122" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.64.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.64.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.64</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 64: CHD mortality, subgroup by SFA change </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0122">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.64.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0123"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.65" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 65: CHD mortality, subgroup by sex" data-id="CD011737-fig-0123" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.65.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.65.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.65</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 65: CHD mortality, subgroup by sex </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0123">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.65.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0124"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.66" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 66: CHD mortality, subgroup by CVD risk" data-id="CD011737-fig-0124" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.66.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.66.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.66</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 66: CHD mortality, subgroup by CVD risk </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0124">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.66.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0125"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.67" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 67: CHD mortality, subgroup by TC reduction" data-id="CD011737-fig-0125" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.67.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.67.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.67</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 67: CHD mortality, subgroup by TC reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0125">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.67.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0126"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.68" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 68: CHD mortality, subgroup decade of publication" data-id="CD011737-fig-0126" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.68.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.68.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.68</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 68: CHD mortality, subgroup decade of publication </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0126">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.68.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0127"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.69" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 69: CORONARY HEART DISEASE EVENTS" data-id="CD011737-fig-0127" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.69.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.69.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.69</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 69: CORONARY HEART DISEASE EVENTS </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0127">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.69.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0128"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.70" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 70: CHD events, SA by low summary risk of bias" data-id="CD011737-fig-0128" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.70.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.70.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.70</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 70: CHD events, SA by low summary risk of bias </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0128">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.70.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0129"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.71" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 71: CHD events, SA excluding WHI" data-id="CD011737-fig-0129" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.71.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.71.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.71</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 71: CHD events, SA excluding WHI </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0129">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.71.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0130"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.72" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 72: CHD events, SA statistically significant SFA reduction" data-id="CD011737-fig-0130" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.72.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.72.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.72</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 72: CHD events, SA statistically significant SFA reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0130">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.72.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0131"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.73" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 73: CHD events, SA by TC reduction" data-id="CD011737-fig-0131" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.73.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.73.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.73</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 73: CHD events, SA by TC reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0131">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.73.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0132"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.74" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 74: CHD events, SA aim to reduce SFA" data-id="CD011737-fig-0132" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.74.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.74.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.74</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 74: CHD events, SA aim to reduce SFA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0132">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.74.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0133"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.75" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 75: CHD events, SA Mantel‐Haenszel fixed‐effect" data-id="CD011737-fig-0133" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.75.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.75.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.75</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 75: CHD events, SA Mantel‐Haenszel fixed‐effect </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0133">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.75.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0134"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.76" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 76: CHD events, SA Peto fixed‐effect" data-id="CD011737-fig-0134" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.76.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.76.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.76</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 76: CHD events, SA Peto fixed‐effect </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0134">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.76.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0135"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.77" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 77: CHD events, subgroup by any substitution" data-id="CD011737-fig-0135" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.77.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.77.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.77</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 77: CHD events, subgroup by any substitution </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0135">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.77.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0136"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.78" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 78: CHD events, subgroup by main substitution" data-id="CD011737-fig-0136" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.78.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.78.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.78</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 78: CHD events, subgroup by main substitution </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0136">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.78.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0137"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.79" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 79: CHD events, subgroup by duration" data-id="CD011737-fig-0137" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.79.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.79.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.79</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 79: CHD events, subgroup by duration </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0137">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.79.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0138"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.80" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 80: CHD events, subgroup by baseline SFA" data-id="CD011737-fig-0138" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.80.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.80.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.80</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 80: CHD events, subgroup by baseline SFA </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0138">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.80.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0139"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.81" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 81: CHD events, subgroup by SFA change" data-id="CD011737-fig-0139" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.81.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.81.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.81</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 81: CHD events, subgroup by SFA change </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0139">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.81.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0140"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.82" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 82: CHD events, subgroup by sex" data-id="CD011737-fig-0140" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.82.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.82.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.82</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 82: CHD events, subgroup by sex </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0140">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.82.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0141"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.83" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 83: CHD events, subgroup by CVD risk" data-id="CD011737-fig-0141" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.83.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.83.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.83</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 83: CHD events, subgroup by CVD risk </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0141">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.83.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0142"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.84" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 84: CHD events, subgroup by TC reduction" data-id="CD011737-fig-0142" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.84.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.84.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.84</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 84: CHD events, subgroup by TC reduction </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0142">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.84.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0143"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.85" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 85: CHD events, subgroup decade of publication" data-id="CD011737-fig-0143" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.85.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.85.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.85</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 85: CHD events, subgroup decade of publication </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0143">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.85.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0144"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-002.86" target="_blank"><b></b></a></p> </div><img alt="Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 86: DIABETES DIAGNOSES" data-id="CD011737-fig-0144" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.86.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-002.86.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.86</div> <div class="figure-caption"> <p>Comparison 2: SFA reduction vs usual diet ‐ secondary health events, Outcome 86: DIABETES DIAGNOSES </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0144">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-002.86.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0145"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 1: Total cholesterol, mmol/L" data-id="CD011737-fig-0145" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 1: Total cholesterol, mmol/L </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0145">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0146"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 2: TC, mmol/L, subgroup by any replacement" data-id="CD011737-fig-0146" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 2: TC, mmol/L, subgroup by any replacement </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0146">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0147"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 3: TC, mmol/L, subgroup by main replacement" data-id="CD011737-fig-0147" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 3: TC, mmol/L, subgroup by main replacement </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0147">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0148"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 4: LDL cholesterol, mmol/L" data-id="CD011737-fig-0148" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 4: LDL cholesterol, mmol/L </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0148">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0149"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 5: LDL, mmol/L, subgroup by any replacement" data-id="CD011737-fig-0149" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 5: LDL, mmol/L, subgroup by any replacement </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0149">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0150"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 6: LDL, mmol/L, subgroup by main replacement" data-id="CD011737-fig-0150" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 6: LDL, mmol/L, subgroup by main replacement </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0150">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0151"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 7: HDL cholesterol, mmol/L" data-id="CD011737-fig-0151" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 7: HDL cholesterol, mmol/L </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0151">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.07.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0152"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.08" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 8: HDL, mmol/L, subgroup by any replacement" data-id="CD011737-fig-0152" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.08.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.08.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 8: HDL, mmol/L, subgroup by any replacement </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0152">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.08.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0153"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.09" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 9: HDL, mmol/L, subgroup by main replacement" data-id="CD011737-fig-0153" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.09.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.09.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.9</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 9: HDL, mmol/L, subgroup by main replacement </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0153">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.09.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0154"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.10" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 10: Triglycerides, mmol/L" data-id="CD011737-fig-0154" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.10.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.10.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.10</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 10: Triglycerides, mmol/L </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0154">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.10.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0155"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.11" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 11: TG, mmol/L, subgroup by any replacement" data-id="CD011737-fig-0155" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.11.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.11.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.11</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 11: TG, mmol/L, subgroup by any replacement </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0155">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.11.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0156"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.12" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 12: TG, mmol/L, subgroup by main replacement" data-id="CD011737-fig-0156" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.12.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.12.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.12</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 12: TG, mmol/L, subgroup by main replacement </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0156">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.12.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0157"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.13" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 13: total cholesterol /HDL ratio" data-id="CD011737-fig-0157" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.13.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.13.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.13</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 13: total cholesterol /HDL ratio </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0157">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.13.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0158"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.14" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 14: TC /HDL ratio, subgroup by any replacement" data-id="CD011737-fig-0158" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.14.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.14.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.14</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 14: TC /HDL ratio, subgroup by any replacement </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0158">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.14.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0159"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.15" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 15: TC /HDL ratio, subgroup by main replacement" data-id="CD011737-fig-0159" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.15.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.15.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.15</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 15: TC /HDL ratio, subgroup by main replacement </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0159">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.15.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0160"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.16" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 16: LDL /HDL ratio" data-id="CD011737-fig-0160" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.16.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.16.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.16</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 16: LDL /HDL ratio </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0160">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.16.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0161"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.17" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 17: Lp(a), mmol/L" data-id="CD011737-fig-0161" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.17.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.17.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.17</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 17: Lp(a), mmol/L </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0161">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.17.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0162"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.18" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 18: Lp(a), mmol/L, subgroup by any replacement" data-id="CD011737-fig-0162" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.18.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.18.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.18</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 18: Lp(a), mmol/L, subgroup by any replacement </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0162">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.18.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0163"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.19" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 19: Lp(a), mmol/L, subgroup by main replacement" data-id="CD011737-fig-0163" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.19.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.19.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.19</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 19: Lp(a), mmol/L, subgroup by main replacement </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0163">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.19.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0164"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-003.20" target="_blank"><b></b></a></p> </div><img alt="Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 20: Insulin sensitivity" data-id="CD011737-fig-0164" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.20.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-003.20.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.20</div> <div class="figure-caption"> <p>Comparison 3: SFA reduction vs usual diet ‐ secondary blood outcomes, Outcome 20: Insulin sensitivity </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0164">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-003.20.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0165"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-004.01" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: SFA reduction vs usual diet ‐ secondary outcomes including potential adverse effects, Outcome 1: Cancer diagnoses" data-id="CD011737-fig-0165" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-004.01.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-004.01.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4: SFA reduction vs usual diet ‐ secondary outcomes including potential adverse effects, Outcome 1: Cancer diagnoses </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0165">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-004.01.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0166"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-004.02" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: SFA reduction vs usual diet ‐ secondary outcomes including potential adverse effects, Outcome 2: Cancer deaths" data-id="CD011737-fig-0166" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-004.02.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-004.02.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4: SFA reduction vs usual diet ‐ secondary outcomes including potential adverse effects, Outcome 2: Cancer deaths </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0166">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-004.02.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0167"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-004.03" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: SFA reduction vs usual diet ‐ secondary outcomes including potential adverse effects, Outcome 3: Weight, kg" data-id="CD011737-fig-0167" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-004.03.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-004.03.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4: SFA reduction vs usual diet ‐ secondary outcomes including potential adverse effects, Outcome 3: Weight, kg </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0167">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-004.03.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0168"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-004.04" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: SFA reduction vs usual diet ‐ secondary outcomes including potential adverse effects, Outcome 4: BMI, kg/m2" data-id="CD011737-fig-0168" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-004.04.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-004.04.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4: SFA reduction vs usual diet ‐ secondary outcomes including potential adverse effects, Outcome 4: BMI, kg/m2 </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0168">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-004.04.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0169"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-004.05" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: SFA reduction vs usual diet ‐ secondary outcomes including potential adverse effects, Outcome 5: Systolic Blood Pressure, mmHg" data-id="CD011737-fig-0169" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-004.05.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-004.05.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.5</div> <div class="figure-caption"> <p>Comparison 4: SFA reduction vs usual diet ‐ secondary outcomes including potential adverse effects, Outcome 5: Systolic Blood Pressure, mmHg </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0169">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-004.05.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0170"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-004.06" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: SFA reduction vs usual diet ‐ secondary outcomes including potential adverse effects, Outcome 6: Diastolic Blood Pressure, mmHg" data-id="CD011737-fig-0170" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-004.06.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-004.06.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.6</div> <div class="figure-caption"> <p>Comparison 4: SFA reduction vs usual diet ‐ secondary outcomes including potential adverse effects, Outcome 6: Diastolic Blood Pressure, mmHg </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0170">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-004.06.svg" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD011737-fig-0171"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/urn:x-wiley:14651858:media:CD011737:CD011737-CMP-004.07" target="_blank"><b></b></a></p> </div><img alt="Comparison 4: SFA reduction vs usual diet ‐ secondary outcomes including potential adverse effects, Outcome 7: Quality of Life" data-id="CD011737-fig-0171" src="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-004.07.svg"/><div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_t/tCD011737-CMP-004.07.png" target="_blank"><b></b></a></p> </div> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.7</div> <div class="figure-caption"> <p>Comparison 4: SFA reduction vs usual diet ‐ secondary outcomes including potential adverse effects, Outcome 7: Quality of Life </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-fig-0171">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/media/CDSR/CD011737/image_n/nCD011737-CMP-004.07.svg" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD011737-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Effect of reducing saturated fat compared to usual saturated fat on CVD risk in adults (note: for the full set of GRADE tables see additional tables 24 to 28)</span></div> <tbody> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Low saturated fat compared with usual saturated fat for CVD risk</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>Patient or population: people at any baseline risk of CVD</b> </p> <p><b>Intervention: lower saturated fat intake</b> </p> <p><b>Comparison: higher saturated fat intake</b> </p> <p><b>Settings: Any, including community‐dwelling and institutions. Included RCTs were conducted in North America, Europe and Australia/New Zealand, no studies were carried out in industrialising or developing countries.</b> </p> </td> </tr> <tr class="separated"> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Outcomes</b> </p> </th> <th align="" class="headercell table-tint" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Relative effect<br/>(95% CI)</b> </p> </th> <td align="" class="table-tint table-highlight" colspan="2" rowspan="1" valign=""> <p><b>Anticipated absolute effects (95% CI)</b> </p> </td> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>No of Participants<br/>(studies)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Quality of the evidence<br/>(GRADE)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="2" scope="col" valign="top"> <p><b>Comments</b> </p> </th> </tr> <tr class="separated"> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p><b>Risk with higher SFA intake</b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p><b>Risk with lower SFA intake</b> </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>All‐cause mortality</b> </p> <p>follow‐up mean duration 56 months<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.96</b> (0.90 to 1.03) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>62 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60 per 1000</p> <p>(56 to 64)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>55,858<br/>(12) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>2,3,4,5,6</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical importance. Reducing saturated fat intake probably makes little or no difference to all‐cause mortality. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Cardiovascular mortality</b> </p> <p>follow‐up mean duration 53 months<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.94</b> (0.78 to 1.13) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>19 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18 per 1000<br/>(15 to 22) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53,421<br/>(11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>2,3,4,6,7</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical importance. Reducing saturated fat intake probably makes little or no difference to cardiovascular mortality. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Combined cardiovascular events</b> </p> <p>follow‐up mean duration 52 months<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.83</b> (0.70 to 0.98) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>85 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>70 per 1000</p> <p>(59 to 83)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53,758<br/>(13) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊕⊝<br/><b>Moderate<sup>4,8,9,10,11</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical importance. Reducing saturated fat intake probably reduces cardiovascular events (to a greater extent with greater cholesterol reduction). </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Myocardial infarctions</b> </p> <p>follow‐up mean duration 55 months</p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.90</b> (0.80 to 1.01) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>32 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>29 per 1000</p> <p>(25 to 32)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53,167<br/>(11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very</b> <b>Low <sup>3,4,5,11,12</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical importance. The effect of reducing saturated fat intake on risk of myocardial infarction is unclear as the evidence is of very low quality. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Non‐fatal MI</b> </p> <p>follow‐up mean duration 55 months<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.97</b> (0.87 to 1.07) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>26 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>25 per 1000</p> <p>(23 to 28)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>52,834<br/>(8) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>3,4,5,6,13</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical importance. Reducing saturated fat may have little or no effect on risk of non‐fatal myocardial infarction. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>Stroke</b> </p> <p>follow‐up mean duration 59 months<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.92</b> (0.68 to 1.25) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>22 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>20 per 1000</p> <p>(15 to 27)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50,952<br/>(7) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very</b> <b>Low <sup>3,4,6,13,14</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical importance. The effect of reducing saturated fat on the risk of stroke is unclear as the evidence was of very low quality. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CHD mortality</b> </p> <p>follow‐up mean duration 65 months<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.97</b> (0.82 to 1.16) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>16 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>16 per 1000</p> <p>(13 to 19)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53,159<br/>(9) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/><b>Low<sup>2,3,4,6,14</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical importance. Reducing saturated fat intake may have little or no effect on CHD mortality. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p><b>CHD events</b> </p> <p>follow‐up mean duration 59 months<sup>1</sup> </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>RR 0.83</b> (0.68 to 1.01) </p> </td> <td align="" class="table-tint table-highlight" colspan="1" rowspan="1" valign=""> <p>42 per 1000</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>35 per 1000</p> <p>(29 to 43)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>53,199<br/>(11) </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊝⊝⊝<br/><b>Very</b> <b>low <sup>4,5,6,12,15</sup> </b> </p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Critical importance. The effect of reducing saturated fat on risk of CHD events is unclear as the evidence is of very low quality. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/><b>CI:</b> Confidence interval; <b>RR:</b> Risk Ratio; CHD: coronary heart disease. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>GRADE Working Group grades of evidence<br/><b>High quality:</b> Further research is very unlikely to change our confidence in the estimate of effect.<br/><b>Moderate quality:</b> Further research is likely to have an important impact on our confidence in the estimate of effect and may change the estimate.<br/><b>Low quality:</b> Further research is very likely to have an important impact on our confidence in the estimate of effect and is likely to change the estimate.<br/><b>Very low quality:</b> We are very uncertain about the estimate. </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup>Minimum study duration was 24 months. </p> <p><sup>2</sup><b>Risk of bias.</b> Limiting trials to those at low summary risk of bias also suggested little or no effect. Not downgraded. </p> <p><sup>3</sup><b>Inconsistency</b>. We found no important heterogeneity; I² ≤ 30%. Not downgraded. </p> <p><sup>4</sup><b>Indirectness</b>. These RCTs directly assessed the effect of lower vs higher saturated fat intake on health outcomes of interest. Participants included men and women with and without CVD at baseline (also some participants with CVD risk factors like diabetes, or at risk of cancers). However, no trials included participants from developing countries. Not downgraded. </p> <p><sup>5</sup><b>Imprecision</b>. The 95% CI includes both no effect and a benefit. Downgraded once. </p> <p><sup>6</sup><b>Publication bias</b>. The funnel plot, and comparison of fixed‐ and random‐effects meta‐analyses did not suggest major small‐study (publication) bias. Not downgraded. </p> <p><sup>7</sup><b>Imprecision</b>. The 95% CI includes both harm and benefit. Downgraded once. </p> <p><sup>8</sup><b>Risk of bias.</b> Limiting trials to those at low summary risk of bias suggested a smaller and non‐statistically significant effect (RR 0.96, 95% CI 0.76 to 1.20) suggesting little or no effect on risk of CVD events. Downgraded once (along with publication bias). </p> <p><sup>9</sup><b>Inconsistency</b>. Although heterogeneity was high, I² = 65%, this was mostly explained by the degree of cholesterol‐lowering (a dose effect). Not downgraded. </p> <p><sup>10</sup><b>Imprecision</b>. The 95% CI includes only benefit or minimal effect. Not downgraded. </p> <p><sup>11</sup><b>Publication bias</b>. The funnel plot did not suggest publication bias, but comparison of fixed‐ and random‐effects meta‐analyses suggested possible small‐study (publication) bias. Downgraded once (along with risk of bias, downgraded once in total). </p> <p><sup>12</sup><b>Risk of bias.</b> Limiting trials to those at low summary risk of bias moved the RR slightly towards 1.0, suggesting little or no effect on total MI. Downgraded once. </p> <p><sup>13</sup><b>Risk of bias.</b> Limiting trials to those at low summary risk of bias moved the RR slightly away from 1.0, suggesting that reducing SFA reduces the risk of non‐fatal MI. This was also seen in several other sensitivity analyses. Downgraded once. </p> <p><sup>14</sup><b>Imprecision</b>. The 95% CI includes both important benefits and important harms. Downgraded twice. </p> <p><sup>15</sup><b>Inconsistency</b>. Heterogeneity was high, I² = 65%. Downgraded once. </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 1.</span> <span class="table-title">Effect of reducing saturated fat compared to usual saturated fat on CVD risk in adults (note: for the full set of GRADE tables see additional tables 24 to 28)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011737-tbl-0002"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Comparison of study interventions for included RCTs</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Reference</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Population</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>CVD risk category</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Is intervention delivered to Individual or group?</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>intervention given by?</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Face‐to‐face or other?</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Number of visits</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Is intervention advice only or other intervention?</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0001" title="BlackHS , HerdJA , GoldbergLH , Wolf JE Jr, ThornbyJI , RosenT , et al. Effect of a low-fat diet on the incidence of actinic keratosis. New England Journal of Medicine1994;330(18):1272-5. BlackHS , ThornbyJI , Wolf JE Jr, GoldbergLH , HerdJA , RosenT , et al. Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer. International Journal of Cancer1995;62(2):165-9. JaaxS , ScottLW , Wolf JE Jr, ThornbyJI , BlackHS . General guidelines for a low-fat diet effective in the management and prevention of nonmelanoma skin cancer. Nutrition and Cancer1997;27(2):150-6. "><b>Black 1994</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>People with non‐melanoma skin cancer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 x weekly classes then monthly follow‐up sessions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice (behaviour techniques learning)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0002" title="BurrML , FehilyAM , GilbertJF , RogersS , HollidayRM , SweetnamPM , et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet1989;2(8666):757-61. BurrML , FehilyAM , RogersS , WelsbyE , KingS , SandhamS . Diet and reinfarction trial (DART): design, recruitment, and compliance. European Heart Journal1989;10(6):558-67. BurrML , FehilyAM . Fish and the heart. Lancet1989;ii:1450-2. BurrML , HollidayRM , FehilyAM , WhiteheadPJ . Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). European Heart Journal1992;13(2):166-70. BurrML , SweethamPM , FehilyAM . Diet and reinfarction [letter]. European Heart Journal1994;15(8):1152-3. FehilyAM , Vaughan-WilliamsE , ShielsK , WilliamsAH , HornerM , BinghamG , et al. The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART). Journal of Human Nutrition &amp; Dietetics1989;2(4):225-5. "><b>DART 1989</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Men recovering from a MI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice (diet advice, recipes and encouragement)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0003" title="HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Favourable influences of linoleic acid on the progression of diabetic micro- and macroangiopathy. Nutrition and Metabolism1980;24(Suppl 1):105-18. HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Influence of different diets on the progression of diabetic retinopathy. Progress in Food Nutritition and Science1980;4(5):41-6. HoutsmullerAJ , ZahnKJ , HenkesHE . Unsaturated fats and progression of diabetic retinopathy. Documenta Ophthalmologia1979;48(2):363-71. "><b>Houtsmuller 1979</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Adults with newly‐diagnosed diabetes</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice?</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0004" title="LeySJ , MetcalfPA , ScraggRK , SwinburnBA . Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance. Diabetes Research and Clinical Practice2004;63(2):103-12. SwinburnBA , MetcalfPA , LeySJ . Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care2001;24(4):619-24. SwinburnBA , WoollardGA , ChangEC , WilsonMR . Effects of reduced-fat diets consumed ad libitum on intake of nutrients particularly antioxidant vitamins. Journal of the American Dietetic Association1999;99(11):1400-5. "><b>Ley 2004</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>People with impaired glucose intolerance or high normal blood glucose</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Small group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Monthly meetings</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice (education, personal goal‐setting, self‐monitoring)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0005" title="MoyTF , YanekLR , RaquenoJV , BezirdjianPJ , BlumenthalRS , WilderLB , et al. Dietary counseling for high blood cholesterol in families at risk of coronary disease. Preventive Cardiology2001;4(4):158-64. "><b>Moy 2001</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Middle‐aged siblings of people with early CHD, with at least 1 CVD risk factor</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Trained nurse</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6 ‐ 8 weekly for 2 years</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice (individualised counselling sessions)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0006" title="EdererF , LerenP , TurpeinenO , Frantz ID Jr. Cancer among men on cholesterol lowering diets: experience of five clinical trials. Lancet1971;2(7717):203-6. HeadyJA . Are PUFA harmful?British Medical Journal1974;1(898):115-6. MRC. Controlled trial of soya-bean oil in myocardial infarction. Lancet1968;2(570):693-9. "><b>MRC 1968</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Free‐living men who have survived a 1st MI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice and supplement (soy oil)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0007" title="LerenP . Prevention of coronary heart disease, some results from the Oslo secondary and primary intervention studies. Journal of the American College of Nutrition1989;8(5):407-10. LerenP . The Oslo diet-heart study. Eleven year report. Circulation1970;42(5):935-42. LerenP . The effect of a cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial) [Virkningen av cholesterolsenkende diett hos menn som har gjennomgatt hjerteinfarkt. Et kontrollert klinisk fors/ok]. Nordisk Medicin1967;77(21):658-61. LerenP . The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Medica Scandinavia1966;466 Suppl:1-92. LerenP . The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Bulletin of the New York Academy of Medicine1968;44(8):1012-20. "><b>Oslo Diet‐Heart 1966</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Men with previous MI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face and other</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice and supplement (food)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0008" title="CoppackSW , DollHA , PimB , HockadayTD . Intravenous glucose tolerance and mortality in non-insulin-dependant diabetes mellitus. Quarterly Journal of Medicine1990;75(277):451-60. HillsonRM , HockadayTD , MannJI , NewtonDJ . Hyperinsulinaemia is associated with development of ECG abnormalities in diabetics. Diabetes Research1984;1(3):143-9. HockadayTD , HockadayJM , MannJI , TurnerRC . Prospective comparison of modified fat-high-carbohydrate with standard low-carbohydrate dietary advice in the treatment of diabetes: one year follow-up study. British Journal of Nutrition1978;39(2):357-62. Howard-WilliamsJ , PatelP , JelfsR , CarterRD , AwdryP , BronA , et al. Polyunsaturated fatty acids and diabetic retinopathy. British Journal of Ophthalmology1985;69(1):15-8. Lopez-EspinozaI , HowardWJ , MannJI , CarterRD , HockadayTD . Fatty acid composition of platelet phospholipids in non-insulin-dependent diabetics randomized for dietary advice. British Journal of Nutrition1984;52(1):41-7. "><b>Oxford Retinopathy 1978</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Newly‐diagnosed non‐insulin‐dependent diabetics</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Moderate</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diabetes dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>After 1 month then at 3‐month intervals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. "><b>Rose corn oil 1965</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Men (?) with angina or following MI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Follow‐up clinic monthly, then every 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice and supplement (oil)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. "><b>Rose olive 1965</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Men (?) with angina or following MI</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Follow‐up clinic monthly, then every 2 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice and supplement (oil)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0011" title="DjuricZ , HeilbrunLK , ReadingBA , BoomerA , ValerioteFA , MartinoS . Effects of a low fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells. Journal of the National Cancer Institute1991;83(11):766-9. DjuricZ , MartinoS , HeilbrunLK , HartRW . Dietary modulation of oxidative DNA damage. Advances In Experimental Medicine and Biology1994;354:71-83. KasimSE , MartinoS , Kim P-N, KhilnaniS , BoomerA , DepperJ , et al. Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women. American Journal of Clinical Nutrition1993;57(2):146-53. SimonMS , HeilbrunLK , BoomerA , KresgeC , DepperJ , KimPN , et al. A randomised trial of a low-fat dietary intervention in women at high risk for breast cancer. Nutrition and Cancer1997;27(2):136-42. "><b>Simon 1997</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Women with a high risk of breast cancer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual followed by individual or group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Bi‐weekly over 3 months followed by monthly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice (individualised eating plan and counselling sessions)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0012" title="BlannAD , JacksonP , BathPM , WattsGF . Von Willebrand factor, a possible indicator of endothelial cell damage, decreases during long-term compliance with a lipid-lowering diet. Journal of Internal Medicine1995;237(6):557-61. WattsGF , BruntJN , ColtartDJ , LewisB . The St. Thomas Atherosclerosis Regression Study (STARS). Atherosclerosis1992;97:231. WattsGF , JacksonP , BurkeV , LewisB . Dietary fatty acids and progression of coronary artery disease in men. American Journal of Clinical Nutrition1996;64(2):202-9. WattsGF , JacksonP , MandaliaS , BruntJN , LewisES , ColtartDJ , et al. Nutrient intake and progression of coronary artery disease. American Journal of Cardiology1994;73(5):328-32. WattsGF , LewisB , BruntJN , LewisES , ColtartDJ , SmithLD , et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet1992;339(8793):563-9. WattsGF , LewisB , BruntJNH , SwanAV . Coronary atheroma regression trials. Lancet1992;339(i):1241-3. WattsGF , LewisB , JacksonP , BurkeV , LewisES , BruntJN , et al. Relationships between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography. Canadian Journal of Cardiology1995;11(Suppl G):110G-4G. WattsGF , MandaliaS , BruntJN , SlavinBM , ColtartDJ , LewisB . Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism: Clinical and Experimental1993;42(11):1461-7. WattsGF , MandaliaS , SlavinBM , BruntJN , ColtartDJ , LewisB . Metabolic determinants of the course of coronary artery disease in men. Clinical Chemistry1994;40(12):2240-6. WattsGF . Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group. Journal of Cardiovascular Pharmacology1995;25(Suppl 4):S11-9. "><b>STARS 1992</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Men with angina referred for angiography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Clinic visits at 3‐month intervals</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0013" title="BlacketRB , LeelarthaepinB , McGilchristC , PalmerAJ , WoodhillJM . The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart disease. Australian and New Zealand Journal of Medicine1979;9(5):521-9. RamsdenCE , ZamoraD , LeelarthaepinB , Majchrzak-HongSF , FaurotKR , SuchindranCM , et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ2013;346:e8707. [DOI: 10.1136/bmj.e8707]WoodhillJM , PalmerAJ , LeelarthaepinB , McGilchristC , BlacketRB . Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Advances in Experimental Medicine and Biology1978;109:317-30. "><b>Sydney Diet‐Heart 1978</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Men with angina referred for angiography</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3 times in 1st year and twice annually thereafter</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. "><b>Veterans Admin 1969</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Men living at the Veterans Administration Center</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Unclear (whole diet provided)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Diet provided</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. "><b>WHI 2006</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Postmenopausal women aged 50 ‐ 79 with or without CVD at baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low and High</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Nutritionists</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>18 sessions/1st yr and quarterly maintenance sessions after</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0016" title="ChlebowskiRT , BlackburnGL , BuzzardIM , RoseDP , MartinoS , KhandekarJD , et al. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. Journal of Clinical Oncology1993;11(11):2072-80. ChlebowskiRT , BlackburnGL , ThomsonCA , NixonDW , ShapiroA , HoyMK , et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition study. Journal of the National Cancer Institute2006;98(24):1767-76. ChlebowskiRT , BlackburnGL . Final survival analysis from the randomized Womens Intervention Nutrition Study (WINS) evaluating dietary intervention as adjuvant breast cancer therapy. Cancer Research2015;75(9 Supplement):S5-08. ChlebowskiRT , RoseD , BlackburnG , BuzzardM , KhandekarJ , YorkR , et al. Feasibility of using dietary fat intake reduction in adjuvant breast cancer management. Proceedings of American Society of Clinical Oncology1991;86:86. ChlebowskiRT , RoseDP , BuzzardIM , BlackburnGL , YorkM , Insull W Jr, et al. Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues. Adjuvant: the Cancer Journal1990;6:357-63. HoyMK , WintersBL , ChlebowskiRT , PapoutsakisC , ShapiroA , LubinMP , et al. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study. Journal of the American Dietetic Association2009;109(4):688-96. RoseDP , ChlebowskiRT , ConnollyJM , JonesLA , WynderEL . Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Cancer Research1992;52(19):5386-90. RoseDP , ConnollyJM , ChlebowskiRT , BuzzardIM , WynderEL . The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Research &amp; Treatment1993;27(3):253-62. WynderEL , CohenLA , WintersBL . The challenges of assessing fat intake in cancer research investigations. Journal of the American Dietetic Association1997;97(7 Suppl):S5-8. "><b>WINS 2006</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Women with localised resected breast cancer</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Low</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Individual followed by group</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Dietitian</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Face‐to‐face</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>8 bi‐weekly sessions, then 3‐monthly contact and optional monthly sessions</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>Advice</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="8"> <div class="table-footnote"> <p>MI: myocardial infarction<br/>N/A: not applicable </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 1.</span> <span class="table-title">Comparison of study interventions for included RCTs</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011737-tbl-0003"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Number of participants and number of outcomes for dichotomous variables (by intervention arm)</span></div> <tbody> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>All‐cause mortality</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>CV mortality</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>CVD events</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>MI</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Non‐fatal MI</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Stroke</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>CHD mortality</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>CHD events</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Diabetes Diagnoses</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0001" title="BlackHS , HerdJA , GoldbergLH , Wolf JE Jr, ThornbyJI , RosenT , et al. Effect of a low-fat diet on the incidence of actinic keratosis. New England Journal of Medicine1994;330(18):1272-5. BlackHS , ThornbyJI , Wolf JE Jr, GoldbergLH , HerdJA , RosenT , et al. Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer. International Journal of Cancer1995;62(2):165-9. JaaxS , ScottLW , Wolf JE Jr, ThornbyJI , BlackHS . General guidelines for a low-fat diet effective in the management and prevention of nonmelanoma skin cancer. Nutrition and Cancer1997;27(2):150-6. "><b>Black 1994</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0002" title="BurrML , FehilyAM , GilbertJF , RogersS , HollidayRM , SweetnamPM , et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet1989;2(8666):757-61. BurrML , FehilyAM , RogersS , WelsbyE , KingS , SandhamS . Diet and reinfarction trial (DART): design, recruitment, and compliance. European Heart Journal1989;10(6):558-67. BurrML , FehilyAM . Fish and the heart. Lancet1989;ii:1450-2. BurrML , HollidayRM , FehilyAM , WhiteheadPJ . Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). European Heart Journal1992;13(2):166-70. BurrML , SweethamPM , FehilyAM . Diet and reinfarction [letter]. European Heart Journal1994;15(8):1152-3. FehilyAM , Vaughan-WilliamsE , ShielsK , WilliamsAH , HornerM , BinghamG , et al. The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART). Journal of Human Nutrition &amp; Dietetics1989;2(4):225-5. "><b>DART 1989</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0003" title="HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Favourable influences of linoleic acid on the progression of diabetic micro- and macroangiopathy. Nutrition and Metabolism1980;24(Suppl 1):105-18. HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Influence of different diets on the progression of diabetic retinopathy. Progress in Food Nutritition and Science1980;4(5):41-6. HoutsmullerAJ , ZahnKJ , HenkesHE . Unsaturated fats and progression of diabetic retinopathy. Documenta Ophthalmologia1979;48(2):363-71. "><b>Houtsmuller 1979</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0004" title="LeySJ , MetcalfPA , ScraggRK , SwinburnBA . Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance. Diabetes Research and Clinical Practice2004;63(2):103-12. SwinburnBA , MetcalfPA , LeySJ . Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care2001;24(4):619-24. SwinburnBA , WoollardGA , ChangEC , WilsonMR . Effects of reduced-fat diets consumed ad libitum on intake of nutrients particularly antioxidant vitamins. Journal of the American Dietetic Association1999;99(11):1400-5. "><b>Ley 2004</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0005" title="MoyTF , YanekLR , RaquenoJV , BezirdjianPJ , BlumenthalRS , WilderLB , et al. Dietary counseling for high blood cholesterol in families at risk of coronary disease. Preventive Cardiology2001;4(4):158-64. "><b>Moy 2001</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0006" title="EdererF , LerenP , TurpeinenO , Frantz ID Jr. Cancer among men on cholesterol lowering diets: experience of five clinical trials. Lancet1971;2(7717):203-6. HeadyJA . Are PUFA harmful?British Medical Journal1974;1(898):115-6. MRC. Controlled trial of soya-bean oil in myocardial infarction. Lancet1968;2(570):693-9. "><b>MRC 1968</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0007" title="LerenP . Prevention of coronary heart disease, some results from the Oslo secondary and primary intervention studies. Journal of the American College of Nutrition1989;8(5):407-10. LerenP . The Oslo diet-heart study. Eleven year report. Circulation1970;42(5):935-42. LerenP . The effect of a cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial) [Virkningen av cholesterolsenkende diett hos menn som har gjennomgatt hjerteinfarkt. Et kontrollert klinisk fors/ok]. Nordisk Medicin1967;77(21):658-61. LerenP . The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Medica Scandinavia1966;466 Suppl:1-92. LerenP . The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Bulletin of the New York Academy of Medicine1968;44(8):1012-20. "><b>Oslo Diet‐Heart 1966</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0008" title="CoppackSW , DollHA , PimB , HockadayTD . Intravenous glucose tolerance and mortality in non-insulin-dependant diabetes mellitus. Quarterly Journal of Medicine1990;75(277):451-60. HillsonRM , HockadayTD , MannJI , NewtonDJ . Hyperinsulinaemia is associated with development of ECG abnormalities in diabetics. Diabetes Research1984;1(3):143-9. HockadayTD , HockadayJM , MannJI , TurnerRC . Prospective comparison of modified fat-high-carbohydrate with standard low-carbohydrate dietary advice in the treatment of diabetes: one year follow-up study. British Journal of Nutrition1978;39(2):357-62. Howard-WilliamsJ , PatelP , JelfsR , CarterRD , AwdryP , BronA , et al. Polyunsaturated fatty acids and diabetic retinopathy. British Journal of Ophthalmology1985;69(1):15-8. Lopez-EspinozaI , HowardWJ , MannJI , CarterRD , HockadayTD . Fatty acid composition of platelet phospholipids in non-insulin-dependent diabetics randomized for dietary advice. British Journal of Nutrition1984;52(1):41-7. "><b>Oxford Retinopathy 1978</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>249 (data not provided by arm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. "><b>Rose corn oil 1965</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. "><b>Rose olive 1965</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0011" title="DjuricZ , HeilbrunLK , ReadingBA , BoomerA , ValerioteFA , MartinoS . Effects of a low fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells. Journal of the National Cancer Institute1991;83(11):766-9. DjuricZ , MartinoS , HeilbrunLK , HartRW . Dietary modulation of oxidative DNA damage. Advances In Experimental Medicine and Biology1994;354:71-83. KasimSE , MartinoS , Kim P-N, KhilnaniS , BoomerA , DepperJ , et al. Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women. American Journal of Clinical Nutrition1993;57(2):146-53. SimonMS , HeilbrunLK , BoomerA , KresgeC , DepperJ , KimPN , et al. A randomised trial of a low-fat dietary intervention in women at high risk for breast cancer. Nutrition and Cancer1997;27(2):136-42. "><b>Simon 1997</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>194 (data not provided by arm)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0012" title="BlannAD , JacksonP , BathPM , WattsGF . Von Willebrand factor, a possible indicator of endothelial cell damage, decreases during long-term compliance with a lipid-lowering diet. Journal of Internal Medicine1995;237(6):557-61. WattsGF , BruntJN , ColtartDJ , LewisB . The St. Thomas Atherosclerosis Regression Study (STARS). Atherosclerosis1992;97:231. WattsGF , JacksonP , BurkeV , LewisB . Dietary fatty acids and progression of coronary artery disease in men. American Journal of Clinical Nutrition1996;64(2):202-9. WattsGF , JacksonP , MandaliaS , BruntJN , LewisES , ColtartDJ , et al. Nutrient intake and progression of coronary artery disease. American Journal of Cardiology1994;73(5):328-32. WattsGF , LewisB , BruntJN , LewisES , ColtartDJ , SmithLD , et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet1992;339(8793):563-9. WattsGF , LewisB , BruntJNH , SwanAV . Coronary atheroma regression trials. Lancet1992;339(i):1241-3. WattsGF , LewisB , JacksonP , BurkeV , LewisES , BruntJN , et al. Relationships between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography. Canadian Journal of Cardiology1995;11(Suppl G):110G-4G. WattsGF , MandaliaS , BruntJN , SlavinBM , ColtartDJ , LewisB . Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism: Clinical and Experimental1993;42(11):1461-7. WattsGF , MandaliaS , SlavinBM , BruntJN , ColtartDJ , LewisB . Metabolic determinants of the course of coronary artery disease in men. Clinical Chemistry1994;40(12):2240-6. WattsGF . Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group. Journal of Cardiovascular Pharmacology1995;25(Suppl 4):S11-9. "><b>STARS 1992</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0013" title="BlacketRB , LeelarthaepinB , McGilchristC , PalmerAJ , WoodhillJM . The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart disease. Australian and New Zealand Journal of Medicine1979;9(5):521-9. RamsdenCE , ZamoraD , LeelarthaepinB , Majchrzak-HongSF , FaurotKR , SuchindranCM , et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ2013;346:e8707. [DOI: 10.1136/bmj.e8707]WoodhillJM , PalmerAJ , LeelarthaepinB , McGilchristC , BlacketRB . Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Advances in Experimental Medicine and Biology1978;109:317-30. "><b>Sydney Diet‐Heart 1978</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. "><b>Veterans Admin 1969</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. "><b>WHI 2006</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0016" title="ChlebowskiRT , BlackburnGL , BuzzardIM , RoseDP , MartinoS , KhandekarJD , et al. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. Journal of Clinical Oncology1993;11(11):2072-80. ChlebowskiRT , BlackburnGL , ThomsonCA , NixonDW , ShapiroA , HoyMK , et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition study. Journal of the National Cancer Institute2006;98(24):1767-76. ChlebowskiRT , BlackburnGL . Final survival analysis from the randomized Womens Intervention Nutrition Study (WINS) evaluating dietary intervention as adjuvant breast cancer therapy. Cancer Research2015;75(9 Supplement):S5-08. ChlebowskiRT , RoseD , BlackburnG , BuzzardM , KhandekarJ , YorkR , et al. Feasibility of using dietary fat intake reduction in adjuvant breast cancer management. Proceedings of American Society of Clinical Oncology1991;86:86. ChlebowskiRT , RoseDP , BuzzardIM , BlackburnGL , YorkM , Insull W Jr, et al. Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues. Adjuvant: the Cancer Journal1990;6:357-63. HoyMK , WintersBL , ChlebowskiRT , PapoutsakisC , ShapiroA , LubinMP , et al. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study. Journal of the American Dietetic Association2009;109(4):688-96. RoseDP , ChlebowskiRT , ConnollyJM , JonesLA , WynderEL . Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Cancer Research1992;52(19):5386-90. RoseDP , ConnollyJM , ChlebowskiRT , BuzzardIM , WynderEL . The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Research &amp; Treatment1993;27(3):253-62. WynderEL , CohenLA , WintersBL . The challenges of assessing fat intake in cancer research investigations. Journal of the American Dietetic Association1997;97(7 Suppl):S5-8. "><b>WINS 2006</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total Participants</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56,675</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>55,858</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53,421</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53,758</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53,167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>52,834</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50,952</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53,159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>53,199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Percent of participants for this outcome</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>99%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>95%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>93%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>90%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>94%</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>86%</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="11"> <div class="table-footnote"> <p>These numbers are the numbers of participants in each study who were available for assessment of outcomes within meta‐analysis (not necessarily the number of participants randomised within the trial). </p> <p>CHD: coronary heart disease<br/>CV: cardiovascular<br/>CVD: cardiovascular disease </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 2.</span> <span class="table-title">Number of participants and number of outcomes for dichotomous variables (by intervention arm)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011737-tbl-0004"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Number of participants and number of participants with data for continuous outcomes (by intervention arm)</span></div> <tbody> <tr> <td align="" class="headercell" colspan="1" rowspan="1" valign=""></td> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Participants</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total cholesterol</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>LDL cholesterol</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>HDL cholesterol</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Triglycerides</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>TG/HDL ratio</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total cholesterol/HDL ratio</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>LDL/HDL ratio</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>LP (a)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Insulin sensitivity</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0001" title="BlackHS , HerdJA , GoldbergLH , Wolf JE Jr, ThornbyJI , RosenT , et al. Effect of a low-fat diet on the incidence of actinic keratosis. New England Journal of Medicine1994;330(18):1272-5. BlackHS , ThornbyJI , Wolf JE Jr, GoldbergLH , HerdJA , RosenT , et al. Evidence that a low-fat diet reduces the occurrence of non-melanoma skin cancer. International Journal of Cancer1995;62(2):165-9. JaaxS , ScottLW , Wolf JE Jr, ThornbyJI , BlackHS . General guidelines for a low-fat diet effective in the management and prevention of nonmelanoma skin cancer. Nutrition and Cancer1997;27(2):150-6. "><b>Black 1994</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>133</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0002" title="BurrML , FehilyAM , GilbertJF , RogersS , HollidayRM , SweetnamPM , et al. Effects of changes in fat, fish, and fibre intakes on death and myocardial reinfarction: diet and reinfarction trial (DART). Lancet1989;2(8666):757-61. BurrML , FehilyAM , RogersS , WelsbyE , KingS , SandhamS . Diet and reinfarction trial (DART): design, recruitment, and compliance. European Heart Journal1989;10(6):558-67. BurrML , FehilyAM . Fish and the heart. Lancet1989;ii:1450-2. BurrML , HollidayRM , FehilyAM , WhiteheadPJ . Haematological prognostic indices after myocardial infarction: evidence from the diet and reinfarction trial (DART). European Heart Journal1992;13(2):166-70. BurrML , SweethamPM , FehilyAM . Diet and reinfarction [letter]. European Heart Journal1994;15(8):1152-3. FehilyAM , Vaughan-WilliamsE , ShielsK , WilliamsAH , HornerM , BinghamG , et al. The effect of dietary advice on nutrient intakes: evidence from the diet and reinfarction trial (DART). Journal of Human Nutrition &amp; Dietetics1989;2(4):225-5. "><b>DART 1989</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2033</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1855</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>1855</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0003" title="HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Favourable influences of linoleic acid on the progression of diabetic micro- and macroangiopathy. Nutrition and Metabolism1980;24(Suppl 1):105-18. HoutsmullerAJ , Van Hal-FerwerdaJ , ZahnKJ , HenkesHE . Influence of different diets on the progression of diabetic retinopathy. Progress in Food Nutritition and Science1980;4(5):41-6. HoutsmullerAJ , ZahnKJ , HenkesHE . Unsaturated fats and progression of diabetic retinopathy. Documenta Ophthalmologia1979;48(2):363-71. "><b>Houtsmuller 1979</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>102</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>96</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0004" title="LeySJ , MetcalfPA , ScraggRK , SwinburnBA . Long-term effects of a reduced fat diet intervention on cardiovascular disease risk factors in individuals with glucose intolerance. Diabetes Research and Clinical Practice2004;63(2):103-12. SwinburnBA , MetcalfPA , LeySJ . Long-term (5-year) effects of a reduced-fat diet intervention in individuals with glucose intolerance. Diabetes Care2001;24(4):619-24. SwinburnBA , WoollardGA , ChangEC , WilsonMR . Effects of reduced-fat diets consumed ad libitum on intake of nutrients particularly antioxidant vitamins. Journal of the American Dietetic Association1999;99(11):1400-5. "><b>Ley 2004</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>176</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>103</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0005" title="MoyTF , YanekLR , RaquenoJV , BezirdjianPJ , BlumenthalRS , WilderLB , et al. Dietary counseling for high blood cholesterol in families at risk of coronary disease. Preventive Cardiology2001;4(4):158-64. "><b>Moy 2001</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>267</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>235</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0006" title="EdererF , LerenP , TurpeinenO , Frantz ID Jr. Cancer among men on cholesterol lowering diets: experience of five clinical trials. Lancet1971;2(7717):203-6. HeadyJA . Are PUFA harmful?British Medical Journal1974;1(898):115-6. MRC. Controlled trial of soya-bean oil in myocardial infarction. Lancet1968;2(570):693-9. "><b>MRC 1968</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>393</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>177</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0007" title="LerenP . Prevention of coronary heart disease, some results from the Oslo secondary and primary intervention studies. Journal of the American College of Nutrition1989;8(5):407-10. LerenP . The Oslo diet-heart study. Eleven year report. Circulation1970;42(5):935-42. LerenP . The effect of a cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial) [Virkningen av cholesterolsenkende diett hos menn som har gjennomgatt hjerteinfarkt. Et kontrollert klinisk fors/ok]. Nordisk Medicin1967;77(21):658-61. LerenP . The effect of plasma cholesterol lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Acta Medica Scandinavia1966;466 Suppl:1-92. LerenP . The effect of plasma-cholesterol-lowering diet in male survivors of myocardial infarction. A controlled clinical trial. Bulletin of the New York Academy of Medicine1968;44(8):1012-20. "><b>Oslo Diet‐Heart 1966</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>412</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>329</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0008" title="CoppackSW , DollHA , PimB , HockadayTD . Intravenous glucose tolerance and mortality in non-insulin-dependant diabetes mellitus. Quarterly Journal of Medicine1990;75(277):451-60. HillsonRM , HockadayTD , MannJI , NewtonDJ . Hyperinsulinaemia is associated with development of ECG abnormalities in diabetics. Diabetes Research1984;1(3):143-9. HockadayTD , HockadayJM , MannJI , TurnerRC . Prospective comparison of modified fat-high-carbohydrate with standard low-carbohydrate dietary advice in the treatment of diabetes: one year follow-up study. British Journal of Nutrition1978;39(2):357-62. Howard-WilliamsJ , PatelP , JelfsR , CarterRD , AwdryP , BronA , et al. Polyunsaturated fatty acids and diabetic retinopathy. British Journal of Ophthalmology1985;69(1):15-8. Lopez-EspinozaI , HowardWJ , MannJI , CarterRD , HockadayTD . Fatty acid composition of platelet phospholipids in non-insulin-dependent diabetics randomized for dietary advice. British Journal of Nutrition1984;52(1):41-7. "><b>Oxford Retinopathy 1978</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>249</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>58</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0009" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. "><b>Rose corn oil 1965</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>41</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>22</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0010" title="RoseGA , ThomsonWB , WilliamsRT . Corn oil in treatment of ischaemic heart disease. British Medical Journal1965;1(5449):1531-3. "><b>Rose olive 1965</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>39</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>24</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0011" title="DjuricZ , HeilbrunLK , ReadingBA , BoomerA , ValerioteFA , MartinoS . Effects of a low fat diet on levels of oxidative damage to DNA in human peripheral nucleated blood cells. Journal of the National Cancer Institute1991;83(11):766-9. DjuricZ , MartinoS , HeilbrunLK , HartRW . Dietary modulation of oxidative DNA damage. Advances In Experimental Medicine and Biology1994;354:71-83. KasimSE , MartinoS , Kim P-N, KhilnaniS , BoomerA , DepperJ , et al. Dietary and anthropometric determinants of plasma lipoproteins during a long-term low-fat diet in healthy women. American Journal of Clinical Nutrition1993;57(2):146-53. SimonMS , HeilbrunLK , BoomerA , KresgeC , DepperJ , KimPN , et al. A randomised trial of a low-fat dietary intervention in women at high risk for breast cancer. Nutrition and Cancer1997;27(2):136-42. "><b>Simon 1997</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>194</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>72</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>71</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0012" title="BlannAD , JacksonP , BathPM , WattsGF . Von Willebrand factor, a possible indicator of endothelial cell damage, decreases during long-term compliance with a lipid-lowering diet. Journal of Internal Medicine1995;237(6):557-61. WattsGF , BruntJN , ColtartDJ , LewisB . The St. Thomas Atherosclerosis Regression Study (STARS). Atherosclerosis1992;97:231. WattsGF , JacksonP , BurkeV , LewisB . Dietary fatty acids and progression of coronary artery disease in men. American Journal of Clinical Nutrition1996;64(2):202-9. WattsGF , JacksonP , MandaliaS , BruntJN , LewisES , ColtartDJ , et al. Nutrient intake and progression of coronary artery disease. American Journal of Cardiology1994;73(5):328-32. WattsGF , LewisB , BruntJN , LewisES , ColtartDJ , SmithLD , et al. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS). Lancet1992;339(8793):563-9. WattsGF , LewisB , BruntJNH , SwanAV . Coronary atheroma regression trials. Lancet1992;339(i):1241-3. WattsGF , LewisB , JacksonP , BurkeV , LewisES , BruntJN , et al. Relationships between nutrient intake and progression/regression of coronary atherosclerosis as assessed by serial quantitative angiography. Canadian Journal of Cardiology1995;11(Suppl G):110G-4G. WattsGF , MandaliaS , BruntJN , SlavinBM , ColtartDJ , LewisB . Independent associations between plasma lipoprotein subfraction levels and the course of coronary artery disease in the St. Thomas' Atherosclerosis Regression Study (STARS). Metabolism: Clinical and Experimental1993;42(11):1461-7. WattsGF , MandaliaS , SlavinBM , BruntJN , ColtartDJ , LewisB . Metabolic determinants of the course of coronary artery disease in men. Clinical Chemistry1994;40(12):2240-6. WattsGF . Nutritional, metabolic, and genetic determinants of the progression of coronary heart disease. STARS Group. Journal of Cardiovascular Pharmacology1995;25(Suppl 4):S11-9. "><b>STARS 1992</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>60</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0013" title="BlacketRB , LeelarthaepinB , McGilchristC , PalmerAJ , WoodhillJM . The synergistic effect of weight loss and changes in dietary lipids on the serum cholesterol of obese men with hypercholesterolaemia: implications for prevention of coronary heart disease. Australian and New Zealand Journal of Medicine1979;9(5):521-9. RamsdenCE , ZamoraD , LeelarthaepinB , Majchrzak-HongSF , FaurotKR , SuchindranCM , et al. Use of dietary linoleic acid for secondary prevention of coronary heart disease and death: evaluation of recovered data from the Sydney Diet Heart Study and updated meta-analysis. BMJ2013;346:e8707. [DOI: 10.1136/bmj.e8707]WoodhillJM , PalmerAJ , LeelarthaepinB , McGilchristC , BlacketRB . Low fat, low cholesterol diet in secondary prevention of coronary heart disease. Advances in Experimental Medicine and Biology1978;109:317-30. "><b>Sydney Diet‐Heart 1978</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>458</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0014" title="DaytonS , HashimotoS , DixonW , PearceML . Composition of lipids in human serum and adipose tissue during prolonged feeding of a diet high in unsaturated fat. Journal of Lipid Research1966;7(1):103-11. DaytonS , HashimotoS , PearceML . Adipose tissue linoleic acid as a criterion of adherence to a modified diet. Journal of Lipid Research1967;8(5):508-10. DaytonS , HashimotoS , PearceML . Influence of a diet high in unsaturated fat upon composition of arterial tissue and atheromata in man. Circulation1965;32(6):911-24. DaytonS , HashimotoS , RosenblumD , PearceM . Vitamin E status of humans during prolonged feeding of unsaturated fats. Journal of Laboratory and Clinical Medicine1965;65(5):739-47. DaytonS , PearceML , GoldmanH , HarnishA , PlotkinD , ShickmanM , et al. Controlled trial of a diet high in unsaturated fat for prevention of atherosclerotic complications. Lancet1968;2(577):1060-2. DaytonS , PearceML , HashimotoS , DixonWJ , TomayasuU . A controlled clinical trial of a diet high in unsaturated fat in preventing complications of atherosclerosis. Circulation1969;15(1, Suppl 2):II-1-63. DaytonS , PearceML , HashimotoS , FaklerLJ , HiscockE , DixonWJ . A controlled clinical trial of a diet high in unsaturated fat. New England Journal of Medicine1962;266:1017-23. DaytonS , PearceML . Diet and atherosclerosis. Lancet1970;1(644):473-4. DaytonS , PearceML . Diet and cardiovascular diseases. Lancet1969;1(584):51-2. DaytonS , PearceML . Diet high in unsaturated fat: a controlled clinical trial. Minnesota Medicine1969;52(8):1237-42. DaytonS , PearceML . Prevention of coronary heart disease and other complications of atherosclerosis by modified diet. American Journal of Medicine1969;46(5):751-62. DaytonS , PearceML . Trial of unsaturated-fat diet. Lancet1968;2(581):1296-7. HiscockE , DaytonS , PearceML , HashimotoS . A palatable diet high in unsaturated fat. Journal of the American Dietetic Association1962;40:427-31. PearceML , DaytonS . Incidence of cancer in men on a diet high in polyunsaturated fat. Lancet1971;1(697):464-7. SturdevantRA , PearceML , DaytonS . Increased prevalence of cholelithiasis in men ingesting a serum-cholesterol-lowering diet. New England Journal of Medicine1973;288(1):24-7. TompkinsMJ , DaytonS , PearceML . Effect of long-term feeding of various fats on whole blood clotting times in men. Journal of Laboratory and Clinical Medicine1964;64(5):763-72. "><b>Veterans Admin 1969</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>846</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>843</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0015" title="AndersonG , CummingsS , FreedmanLS , FurbergC , HendersonM , JohnsonSR , et al. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. AndersonGL , MansonJ , WallaceR , LundB , HallD , DavisS , et al. Implementation of the Women's Health Initiative study design. Annals of Epidemiology2003;13(9 Suppl):S5-17. BeresfordSA , JohnsonKC , RitenbaughC , LasserNL , SnetselaarLG , BlackHR , et al. Low-fat dietary pattern and risk of colorectal cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):643-54. BowenD , EhretC , PedersenM , SnetselaarL , JohnsonM , TinkerL , et al. Results of an adjunct dietary intervention program in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(11):1631-7. CartyCL , KooperbergC , NeuhouserML , TinkerL , HowardB , Wactawski-WendeJ , et al. Low-fat dietary pattern and change in body-composition traits in the Women's Health Initiative Dietary Modification Trial. American Journal of Clinical Nutrition2011;93(3):516-24. CurbJD , McTiernanA , HeckbertSR , KooperbergC , StanfordJ , NevittM , et al. Outcomes ascertainment and adjudication methods in the Women's Health Initiative. Annals of Epidemiology2003;13(9 Suppl):S122-8. HaysJ , HuntJR , HubbellFA , AndersonGL , LimacherM , AllenC , et al. The Women's Health Initiative recruitment methods and results. Annals of Epidemiology2003;13(9 Suppl):S18-77. HebertJR , PattersonRE , GorfineM , EbbelingCB , St JeorST , ChlebowskiRT , et al. Differences between estimated caloric requirements and self-reported caloric intake in the Women's Health Initiative. Annals of Epidemiology2003;13(9):629-37. HowardBV , CurbJD , EatonCB , KooperbergC , OckeneJ , KostisJB , et al. Low-fat dietary pattern and lipoprotein risk factors: the Women's Health Initiative dietary modification trial. American Journal of Clinical Nutrition2010;91(4):860-74. HowardBV , MansonJE , StefanickML , BeresfordSA , FrankG , JonesB , et al. Low-fat dietary pattern and weight change over 7 years: the Women's Health Initiative Dietary Modification Trial. JAMA2006;295(1):39-49. HowardBV , Van HornL , HsiaJ , MansonJE , StefanickML , Wassertheil-SmollerS , et al. Low-fat dietary pattern and risk of cardiovascular disease: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):655-66. HowardBV . Dietary fat and cardiovascular disease: putting the Women's Health Initiative in perspective. Nutrition Metabolism &amp; Cardiovascular Diseases2007;17(3):171-4. NeuhouserML , TinkerL , ShawPA , SchoellerD , BinghamSA , HornLV , et al. Use of recovery biomarkers to calibrate nutrient consumption self-reports in the Women's Health Initiative. American Journal of Epidemiology2008;167(10):1247-59. PattersonRE , KristalA , RodaboughR , CaanB , LillingtonL , Mossavar-RahmaniY , et al. Changes in food sources of dietary fat in response to an intensive low-fat dietary intervention: early results from the Women's Health Initiative. Journal of the American Dietetic Association2003;103(4):454-60. PattersonRE , KristalAR , TinkerLF , CarterRA , BoltonMP , Gurs-CollinsT , et al. Measurement characteristics of the Women's Health Initiative food frequency questionnaire. Annals of Epidemiology1999;9(3):178-87. PrenticeRL , AragakiAK , HowardBV , ChlebowskiRT , ThomsonCA , Van HornL , et al. Low-fat dietary pattern among postmenopausal women influences long-term cancer, cardiovascular disease, and diabetes outcomes. Journal of Nutrition2019;149(9):1565-74. PrenticeRL , AragakiAK , Van HornL , ThomsonCA , BeresfordSAA , RobinsonJ , et al. Low-fat dietary pattern and cardiovascular disease: results from the Women’s Health Initiative randomized controlled trial. American Journal of Clinical Nutrition2017;106(1):35-43. PrenticeRL , CaanB , ChlebowskiRT , PattersonR , KullerLH , OckeneJK , et al. Low-fat dietary pattern and risk of invasive breast cancer: the Women's Health Initiative Randomized Controlled Dietary Modification Trial. JAMA2006;295(6):629-42. PrenticeRL , ThomsonCA , CaanB , HubbellFA , AndersonGL , BeresfordSA , et al. Low-fat dietary pattern and cancer incidence in the Women's Health Initiative Dietary Modification Randomized Controlled Trial. Journal of the National Cancer Institute2007;99(20):1534-43. RitenbaughC , PattersonRE , ChlebowskiRT , CaanB , Fels-TinkerL , HowardB , et al. The Women's Health Initiative Dietary Modification trial: overview and baseline characteristics of participants. Annals of Epidemiology2003;13(9 Suppl):S87-97. RobinsonJG , WallaceR , SaffordMM , PettingerM , CochraneB , KoMG , et al. Another treatment gap: restarting secondary prevention medications: the Women's Health Initiative. Journal of Clinical Lipidology2010;4(1):36-45. RossouwJE , FinneganLP , HarlanWR , PinnVW , CliffordC , McGowanJA . The evolution of the Women's Health Initiative: perspectives from the NIH. Journal of the American Medical Women's Association1995;50(2):50-5. The Women's Health Initiative Study Group. Design of the Women's Health Initiative clinical trial and observational study. Controlled Clinical Trials1998;19(1):61-109. TinkerLF , BondsDE , MargolisKL , MansonJE , HowardBV , LarsonJ , et al. Low-fat dietary pattern and risk of treated diabetes mellitus in postmenopausal women: the Women's Health Initiative randomized controlled dietary modification trial. Archives of Internal Medicine2008;168(14):1500-11. TinkerLF , PerriMG , PattersonRE , BowenDJ , McIntoshM , ParkerLM , et al. The effects of physical and emotional status on adherence to a low-fat dietary pattern in the Women's Health Initiative. Journal of the American Dietetic Association2002;102(6):789-800. TinkerLF , RosalMC , YoungAF , PerriMG , PattersonRE , Van HornL , et al. Predictors of dietary change and maintenance in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2007;107(7):1155-66. Women's Health Initiative Study Group. Dietary adherence in the Women's Health Initiative Dietary Modification Trial. Journal of the American Dietetic Association2004;104(4):654-8. "><b>WHI 2006</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>48,835</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2832</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2832</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2832</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2832</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2832</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2832</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2832</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><a href="./references#CD011737-bbs2-0016" title="ChlebowskiRT , BlackburnGL , BuzzardIM , RoseDP , MartinoS , KhandekarJD , et al. Adherence to a dietary fat intake reduction program in postmenopausal women receiving therapy for early breast cancer. The Women's Intervention Nutrition Study. Journal of Clinical Oncology1993;11(11):2072-80. ChlebowskiRT , BlackburnGL , ThomsonCA , NixonDW , ShapiroA , HoyMK , et al. Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition study. Journal of the National Cancer Institute2006;98(24):1767-76. ChlebowskiRT , BlackburnGL . Final survival analysis from the randomized Womens Intervention Nutrition Study (WINS) evaluating dietary intervention as adjuvant breast cancer therapy. Cancer Research2015;75(9 Supplement):S5-08. ChlebowskiRT , RoseD , BlackburnG , BuzzardM , KhandekarJ , YorkR , et al. Feasibility of using dietary fat intake reduction in adjuvant breast cancer management. Proceedings of American Society of Clinical Oncology1991;86:86. ChlebowskiRT , RoseDP , BuzzardIM , BlackburnGL , YorkM , Insull W Jr, et al. Dietary fat reduction in adjuvant breast cancer therapy: current rationale and feasibility issues. Adjuvant: the Cancer Journal1990;6:357-63. HoyMK , WintersBL , ChlebowskiRT , PapoutsakisC , ShapiroA , LubinMP , et al. Implementing a low-fat eating plan in the Women's Intervention Nutrition Study. Journal of the American Dietetic Association2009;109(4):688-96. RoseDP , ChlebowskiRT , ConnollyJM , JonesLA , WynderEL . Effects of tamoxifen adjuvant therapy and a low-fat diet on serum binding proteins and estradiol bioavailability in postmenopausal breast cancer patients. Cancer Research1992;52(19):5386-90. RoseDP , ConnollyJM , ChlebowskiRT , BuzzardIM , WynderEL . The effects of a low-fat dietary intervention and tamoxifen adjuvant therapy on the serum estrogen and sex hormone-binding globulin concentrations of postmenopausal breast cancer patients. Breast Cancer Research &amp; Treatment1993;27(3):253-62. WynderEL , CohenLA , WintersBL . The challenges of assessing fat intake in cancer research investigations. Journal of the American Dietetic Association1997;97(7 Suppl):S5-8. "><b>WINS 2006</b> </a> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2437</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>196</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Total Participants</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>56,675</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7115</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3291</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5147</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3845</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2985</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>50</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>2882</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>3081</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign=""> <p><b>Percent of participants for this outcome</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>100%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>13%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>6%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>9%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>7%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>0.1%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5%</p> </td> <td align="right" bgcolor="#ffffff" colspan="1" rowspan="1" valign=""> <p>5%</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="11"> <div class="table-footnote"> <p>These numbers are the numbers of participants in each study who were available for assessment of outcomes within meta‐analysis (not necessarily the number of participants randomised within the trial). </p> <p>HDL: high density lipoprotein<br/>LDL: low density lipoprotein<br/>Lp(a): lipoprotein (a)<br/>TG: triglyceride </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 3.</span> <span class="table-title">Number of participants and number of participants with data for continuous outcomes (by intervention arm)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011737-tbl-0005"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Meta‐regression of effects of SFA reduction on cardiovascular events</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Regression factor</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>No. of studies</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Constant</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Coefficient (95% CI)</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>P value</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Proportion of between study variation explained</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Change in SFA as %E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.05 (‐0.03 to 0.13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.16</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Change in SFA as % of control</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.01 (‐0.01 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>89%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Baseline SFA as %E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.68</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.06 (‐0.15 to 0.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.19</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>81%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Change in TC, mmol/L</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.03</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69 (0.05 to 1.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.04</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>99%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Change in PUFA as %E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.01</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.02 (‐0.08 to 0.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.25</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Change in MUFA as %E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.26</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.03 (‐0.14 to 0.09)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐87%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Change in CHO as %E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.00 (‐0.05 to 0.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐273%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Change in total fat intake as %E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.01 (‐0.03 to 0.01)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.28</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>100%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Gender*</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.17</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.14 (‐0.63 to 0.35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐13%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Study duration</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.47</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.00 (‐0.01 to 0.02)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐24.8%</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>CVD risk at baseline**</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐0.44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.03 (‐0.48 to 0.55)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐39%</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="6"> <div class="table-footnote"> <p><sup>*Gender was coded as follows: 0 = women, 1 = mixed, 2 = men<br/><b>**</b>CVD risk at baseline was coded as follows: 1 = Low CVD risk, 2 = Moderate CVD risk, 3 = existing CVD</sup><br/><sup>CHO: carbohydrate<br/>CI: confidence interval<br/>CVD: cardiovascular disease<br/>E: energy<br/>MUFA: monounsaturated fatty acid<br/>PUFA: polyunsaturated fatty fat<br/>SFA: saturated fatty acid<br/>TC: total cholesterol</sup> </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 4.</span> <span class="table-title">Meta‐regression of effects of SFA reduction on cardiovascular events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table data-id="CD011737-tbl-0006"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">SFA cut‐off data</span></div> <tbody> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>Cut‐ off</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR of all‐cause mortality</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR of CVD mortality</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR of CVD events</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR of MI</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR of non‐fatal MI</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR of stroke</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR of CHD mortality</b> </p> </th> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>RR of CHD events</b> </p> </th> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>7%E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (0.66 to 1.20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.01 to 4.15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.01 to 4.15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>8%E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (0.66 to 1.20)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.01 to 4.15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.20 (0.01 to 4.15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>N/A</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>9%E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.96 (0.83 to 1.10)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.69 (0.51 to 0.94)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.79 (0.62 to 0.99)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76 (0.55 to 1.05)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.62 (0.31 to 1.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.59 (0.30 to 1.15)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82 (0.55 to 1.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.77 (0.56 to 1.04)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>10%E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.99 (0.90 to 1.09)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.95 (0.67 to 1.35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.88 (0.66 to 1.18)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (0.80 to 1.08)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (0.58 to 1.35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87 (0.58 to 1.33)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.05 (0.77 to 1.43)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.82 (0.60 to 1.13)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>11%E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.99 (0.88 to 1.12)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.92 (0.65 to 1.31)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.86 (0.66 to 1.13)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.94 (0.84 to 1.06)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.89 (0.58 to 1.35)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.76 (0.45 to 1.30)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.02 (0.84 to 1.24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.85 (0.63 to 1.15)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>12%E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.98 (0.91 to 1.07)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.95 (0.75 to 1.21)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (0.74 to 1.08)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.94 (0.85 to 1.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (0.72 to 1.14)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (0.55 to 1.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.02 (0.84 to 1.24)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.90 (0.77 to 1.06)</p> </td> </tr> <tr> <th align="" class="headercell" colspan="1" rowspan="1" scope="col" valign="top"> <p><b>13%E</b> </p> </th> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.02 (0.83 to 1.25)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.93 (0.63 to 1.38)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87 (0.65 to 1.17)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.87 (0.73 to 1.04)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.72 (0.50 to 1.03)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.54 (0.29 to 1.00)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>1.06 (0.76 to 1.48)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>0.84 (0.63 to 1.12)</p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="9"> <div class="table-footnote"> <p>CHD: coronary heart disease<br/>CVD: cardiovascular disease<br/>E: energy<br/>MI: myocardial infarction<br/>N/A: not applicable (no relevant studies)<br/>RR: risk ratio<br/>SFA: saturated fat, as percentage of energy </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Table 5.</span> <span class="table-title">SFA cut‐off data</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/full#CD011737-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011737-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">SFA reduction vs usual diet ‐ primary outcomes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.1 ALL‐CAUSE MORTALITY <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55858</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.90, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.2 All‐cause mortality, SA low summary risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53219</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.84, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.3 All‐cause mortality, SA aim to reduce SFA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.89, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.4 All‐cause mortality, SA statistically significant SFA reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54973</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.92, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.5 All‐cause mortality, SA TC reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53073</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.88, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.6 All‐cause mortality, SA excluding WHI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7023</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.83, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.7 All‐cause mortality, SA Mantel‐Haenszel fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55858</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.91, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.8 All‐cause mortality, SA Peto fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55858</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.90, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.9 All‐cause mortality, subgroup by any substitution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.82, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.2 replaced by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.33, 26.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.3 replaced by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53669</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.90, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.4 replaced by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53614</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.90, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.9.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.10 All‐cause mortality, subgroup by main substitution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4183</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.82, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.2 replaced by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.33, 26.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.3 replaced by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51636</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.90, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.4 replaced by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.10.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.11 All‐cause mortality, subgroup by duration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55858</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.90, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.1 up to 24mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.78, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.2 &gt;24 to 48mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1294</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.83, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.3 &gt;48mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52142</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.79, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.11.4 unclear duration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.07, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.12 All‐cause mortality, subgroup by baseline SFA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55858</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.90, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.1 up to 12%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2437</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.67, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.2 &gt;12 to 15%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51635</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.86, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.3 &gt;15 to 18%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.04, 3.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.4 &gt;18%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.83, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.12.5 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>885</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.62, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.13 All‐cause mortality, subgroup by SFA change <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55858</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.90, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.1 up to 4%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53939</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.86, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.2 &gt;4 to 8%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.08, 2.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.3 &gt;8%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.83, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.13.4 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>885</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.62, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.14 All‐cause mortality, subgroup by sex <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55858</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.90, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.1 Men</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4410</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.83, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.2 Women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.90, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.14.3 Mixed, men and women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.07, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.15 All‐cause mortality, subgroup by CVD risk <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55858</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.90, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.1 Low CVD risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.91, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.2 Moderate CVD risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.07, 1.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.15.3 Existing CVD disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3431</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.76, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.16 All‐cause mortality, subgroup by TC reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.1 serum chol reduced by at least 0.2mmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.81, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.2 serum chol reduced by &lt;0.2mmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51487</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.90, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.16.3 serum chol reduction unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.51 [0.05, 5.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.17 All‐cause mortality, subgroup decade of publication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55858</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.90, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.1 1960s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1731</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.80, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.2 1970s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.49 [0.95, 2.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.3 1980s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.76, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.4 1990s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.08, 2.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.17.5 2000s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51448</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.88, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.18 CARDIOVASCULAR MORTALITY <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53421</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.78, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.19 CVD mortality, SA low summary risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.67, 1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.20 CVD mortality, SA aim to reduce SFA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53112</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.79, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.21 CVD mortality, SA statistically significant SFA reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52536</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.75, 1.21]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.22 CVD mortality, SA TC reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53073</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.78, 1.15]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.23 CVD mortality, SA excluding WHI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4586</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.72, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.24 CVD mortality, SA Mantel‐Haenszel fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53421</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.85, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.25 CVD mortality, SA Peto fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53421</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.84, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.26 CVD mortality, subgroup by any substitution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.26.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.73, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.26.2 replaced by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.33, 26.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.26.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.85, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.26.4 replaced by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.86, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.26.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.27 CVD mortality, subgroup by main substitution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.27.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4196</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.73, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.27.2 replaced by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.33, 26.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.27.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.42, 1.46]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.27.4 replaced by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.27.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.28 CVD mortality, subgroup by duration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53447</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.78, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.28.1 up to 24mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2272</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.26 [0.54, 2.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.28.2 &gt;24 to 48mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1294</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.57, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.28.3 &gt;48 mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49705</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.73, 1.43]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.28.4 unclear duration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.03, 2.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.29 CVD mortality, subgroup by baseline SFA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53447</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.78, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.29.1 up to 12%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.29.2 &gt;12 to 15%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51635</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.84, 1.32]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.29.3 &gt;15 to 18%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.04, 3.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.29.4 &gt;18%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.51, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.29.5 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>911</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.61, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.30 CVD mortality, subgroup by SFA change <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53447</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.78, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.30.1 up to 4%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51502</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.85, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.30.2 &gt;4 to 8%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.05, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.30.3 &gt;8%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.51, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.30.4 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>911</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.61, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.31 CVD mortality, subgroup by sex <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53447</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.78, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.31.1 Men</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4436</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.73, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.31.2 Women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.84, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.31.3 Mixed, men and women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.03, 2.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.32 CVD mortality, subgroup by CVD risk <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53447</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.80, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.32.1 Low CVD risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47537</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.60, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.32.2 Moderate CVD risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.03, 2.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.32.3 Existing CVD disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5734</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.83, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.33 CVD mortality, subgroup by TC reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.33.1 serum chol reduced by at least 0.2mmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4251</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.73, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.33.2 serum chol reduced by &lt;0.2mmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49063</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.47, 2.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.33.3 serum chol reduction unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.34 CVD mortality, subgroup decade of publication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53421</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.78, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.34.1 1960s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1731</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.63, 0.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.34.2 1970s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>458</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.59 [0.99, 2.55]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.34.3 1980s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.77, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.34.4 1990s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.29 [0.05, 1.70]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.34.5 2000s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.27, 2.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.35 COMBINED CARDIOVASCULAR EVENTS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53758</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.70, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.36 CVD events, SA low summary risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50315</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.76, 1.20]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.37 CVD events, SA aim to reduce SFA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53449</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.70, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.38 CVD events, SA statistically significant SFA reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52771</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.74, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.39 CVD events, SA TC reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53410</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.69, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.40 CVD events, SA excluding WHI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>12</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4923</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.64, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.41 CVD events, SA Mantel‐Haenszel fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53758</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.89, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.42 CVD events, SA Peto fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53758</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.88, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.43 CVD events, SA excluding trials with additional interventions <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4456</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.67, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.44 CVD events, subgroup by any substitution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.44.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4353</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.62, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.44.2 replaced by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.53, 1.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.44.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51232</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.67, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.44.4 replaced by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51177</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.91, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.44.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.68 [0.41, 6.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.45 CVD events, subgroup by main substitution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.45.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4298</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.66, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.45.2 replaced by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.53, 1.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.45.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.39, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.45.4 replaced by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.45.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.68 [0.41, 6.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.46 CVD events, subgroup by duration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53758</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.70, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.46.1 up to 24mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2481</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.78, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.46.2 &gt;24 to 48mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1294</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.56, 0.95]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.46.3 &gt;48mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49705</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.72, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.46.4 unclear duration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.43 [0.17, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.47 CVD events, subgroup by baseline SFA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53758</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.70, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.47.1 up to 12%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.47.2 &gt;12 to 15%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51870</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.85, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.47.3 &gt;15 to 18%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.22, 0.78]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.47.4 &gt;18%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.63, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.47.5 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.51, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.48 CVD events, subgroup by SFA change <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53758</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.70, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.48.1 up to 4%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51737</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.86, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.48.2 &gt;4 to 8%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.22, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.48.3 &gt;8%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.63, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.48.4 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.72 [0.51, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.49 CVD events, subgroup by sex <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53758</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.70, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.49.1 Men</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4410</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.71, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.49.2 Women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.92, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.49.3 Mixed, men and women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>513</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.23, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.50 CVD events, subgroup by CVD risk <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53758</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.74, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.50.1 Low CVD risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47537</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.75, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.50.2 Moderate CVD risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>513</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.23, 1.49]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.50.3 Existing CVD disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5708</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.75, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.51 CVD events, subgroup by TC reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.51.1 serum chol reduced by at least 0.2mmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4575</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.63, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.51.2 serum chol reduced by &lt;0.2mmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49050</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.91, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.51.3 serum chol reduction unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>133</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.01, 4.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1.52 CVD events, subgroup decade of publication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>13</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53758</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.70, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.52.1 1960s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1731</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.69, 0.91]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.52.2 1970s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>560</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.66 [0.12, 3.80]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.52.3 1980s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.74, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.52.4 1990s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>188</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.22, 0.74]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.52.5 2000s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.91, 1.04]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">SFA reduction vs usual diet ‐ primary outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011737-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SFA reduction vs usual diet ‐ secondary health events</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.1 MYOCARDIAL INFARCTION <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.80, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.2 MI, SA by low summary risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49857</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.81, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.3 MI, SA aim to reduce SFA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52991</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.78, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.4 MI, SA statistically significant SFA reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.85, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.5 MI, SA by TC reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52952</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.77, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.6 MI, SA excluding WHI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4332</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.73, 0.98]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.7 MI, SA Mantel‐Haenszel fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.84, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.8 MI, SA Peto fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.83, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.9 MI, subgroup by any substitution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3895</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.67, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.2 replaced by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [0.51, 3.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51099</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.86, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.4 replaced by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51044</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.86, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.9.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.02 [0.19, 21.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.10 MI, subgroup by main substitution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3840</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.67, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.2 replaced by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.40 [0.51, 3.85]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49066</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.86, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.4 replaced by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.10.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.02 [0.19, 21.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.11 MI, subgroup by duration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.80, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.11.1 up to 24mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.77, 1.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.11.2 &gt;24 to 48mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1294</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.64, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.11.3 &gt;48mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.54, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.11.4 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.41 [0.02, 7.73]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.12 MI, subgroup by baseline SFA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.80, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12.1 up to 12%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12.2 &gt;12 to 15%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.87, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12.3 &gt;15 to 18%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.05, 5.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12.4 &gt;18%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.55, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.12.5 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.54, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.13 MI, subgroup by SFA change <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.80, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.13.1 up to 4%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51279</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.87, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.13.2 &gt;4 to 8%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.05, 5.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.13.3 &gt;8%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.55, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.13.4 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.54, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.14 MI, subgroup by sex <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.80, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.14.1 Men</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3819</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.73, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.14.2 Women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.86, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.14.3 Mixed, men and women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>513</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.13, 4.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.15 MI, subgroup by CVD risk <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.80, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.15.1 Low CVD risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49681</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.72, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.15.2 Moderate CVD risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>513</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.13, 4.47]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.15.3 Existing CVD disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2973</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.74, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.16 MI, subgroup by TC reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.16.1 serum chol reduced by at least 0.2mmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.70, 0.98]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.16.2 serum chol reduced by &lt;0.2mmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49050</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.87, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.16.3 serum chol reduction unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.17 MI, subgroup decade of publication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53167</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.80, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.17.1 1960s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1731</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.64, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.17.2 1970s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.08 [0.00, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.17.3 1980s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.73, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.17.4 1990s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.05, 5.39]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.17.5 2000s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.87, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.18 NON‐FATAL MYOCARDIAL INFARCTION <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52834</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.87, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.19 Non‐fatal MI, SA by low summary risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49681</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.89 [0.58, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.20 Non‐fatal MI, SA aim to reduce SFA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52834</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.87, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.21 Non‐fatal MI, SA statistically significant SFA reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51949</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.72, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.22 Non‐fatal MI, SA by TC reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52795</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.87, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.23 Non‐fatal MI, SA excluding WHI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3999</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.64, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.24 Non‐fatal MI, SA Mantel‐Haenszel fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52834</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.87, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.25 Non‐fatal MI, SA Peto fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52834</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.87, 1.08]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.26 Non‐fatal MI, subgroup by any substitution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.26.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3738</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.63, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.26.2 replaced by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.42, 3.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.26.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50868</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.72, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.26.4 replaced by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50868</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.72, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.26.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.02 [0.19, 21.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.27 Non‐fatal MI, subgroup by main substitution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.27.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3738</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.63, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.27.2 replaced by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.20 [0.42, 3.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.27.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.90, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.27.4 replaced by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.27.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.02 [0.19, 21.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.28 Non‐fatal MI, subgroup by duration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52834</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.87, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.28.1 up to 24mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2348</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.57, 1.22]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.28.2 &gt;24 to 48mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1239</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.53, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.28.3 &gt;48mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.88, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.28.4 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.29 Non‐fatal MI, subgroup by baseline SFA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52834</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.87, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.29.1 up to 12%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.29.2 &gt;12 to 15%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.83, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.29.3 &gt;15 to 18%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.29.4 &gt;18%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.31, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.29.5 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>885</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.65, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.30 Non‐fatal MI, subgroup by SFA change <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52834</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.87, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.30.1 up to 4%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51103</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.83, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.30.2 &gt;4 to 8%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.30.3 &gt;8%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.62 [0.31, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.30.4 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>885</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.65, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.31 Non‐fatal MI, subgroup by sex <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52834</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.87, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.31.1 Men</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3764</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.63, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.31.2 Women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.90, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.31.3 Mixed, men and women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.02 [0.19, 21.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.32 Non‐fatal MI, subgroup by CVD risk <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52834</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.80, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.32.1 Low CVD risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47404</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.68, 1.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.32.2 Moderate CVD risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.02 [0.19, 21.94]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.32.3 Existing CVD disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5195</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.76, 1.31]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.33 Non‐fatal MI, subgroup by TC reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.33.1 serum chol reduced by at least 0.2mmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3960</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.62, 1.03]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.33.2 serum chol reduced by &lt;0.2mmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48874</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.90, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.33.3 serum chol reduction unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.34 Non‐fatal MI, subgroup decade of publication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52834</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.87, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.34.1 1960s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1731</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.62, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.34.2 1970s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.34.3 1980s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.74 [0.48, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.34.4 1990s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.34.5 2000s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49070</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.90, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.35 STROKE <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50952</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.68, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.36 Stroke, SA by low summary risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49857</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.42, 1.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.37 Stroke, SA aim to reduce SFA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50776</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.90, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.38 Stroke, SA statistically significant SFA reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.55, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.39 Stroke, SA by TC reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50776</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.90, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.40 Stroke, SA excluding WHI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2117</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.35, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.41 Stroke, SA Mantel‐Haenszel fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50952</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.89, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.42 Stroke, SA Peto fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50952</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.89, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.43 Stroke, subgroup by any substitution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.43.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1706</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.37, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.43.2 replaced by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.43.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49066</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.29, 1.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.43.4 replaced by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.15, 2.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.43.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.06, 15.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.44 Stroke, subgroup by main substitution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.44.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.31, 2.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.44.2 replaced by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.44.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49066</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.29, 1.87]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.44.4 replaced by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.44.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.06, 15.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.45 Stroke, subgroup by duration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.67, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.45.1 up to 24mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>235</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.06, 15.93]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.45.2 &gt;24 to 48mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>901</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.57 [0.30, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.45.3 &gt;48mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.91, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.45.4 unclear duration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>176</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.20 [0.02, 1.68]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.46 Stroke, subgroup by baseline SFA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.67, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.46.1 up to 12%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.46.2 &gt;12 to 15%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.50, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.46.3 &gt;15 to 18%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.01, 8.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.46.4 &gt;18%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.30, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.46.5 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [0.18, 21.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.47 Stroke, subgroup by SFA change <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.67, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.47.1 up to 4%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.50, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.47.2 &gt;4 to 8%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.01, 8.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.47.3 &gt;8%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.30, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.47.4 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>412</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.00 [0.18, 21.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.48 Stroke, subgroup by sex <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.67, 1.23]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.48.1 Men</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1313</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.63 [0.33, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.48.2 Women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.91, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.48.3 Mixed, men and women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>411</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.07, 1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.49 Stroke, subgroup by CVD risk <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50559</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.89, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.49.1 Low CVD risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47404</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.52, 1.42]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.49.2 Moderate CVD risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>411</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.37 [0.07, 1.97]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.49.3 Existing CVD disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2744</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.86, 1.18]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.50 Stroke, subgroup by TC reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.50.1 serum chol reduced by at least 0.2mmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1941</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [0.38, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.50.2 serum chol reduced by &lt;0.2mmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49011</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.15, 2.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.50.3 serum chol reduction unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.51 Stroke, subgroup decade of publication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50952</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.68, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.51.1 1960s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1651</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.31, 2.69]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.51.2 1970s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.51.3 1980s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.51.4 1990s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.35 [0.01, 8.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.51.5 2000s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49246</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.50, 1.66]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.52 CORONARY HEART DISEASE MORTALITY <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.82, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.53 CHD mortality, SA by low summary risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50139</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.77, 1.43]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.54 CHD mortality, SA aim to reduce SFA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.82, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.55 CHD mortality, SA statistically significant SFA reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52172</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.84, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.56 CHD mortality, SA by TC reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53120</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.81, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.57 CHD mortality, SA excluding WHI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4324</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.76, 1.24]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.58 CHD mortality, SA Mantel‐Haenszel fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.86, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.59 CHD mortality, SA Peto fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.85, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.60 CHD mortality, subgroup by any substitution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.60.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4298</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.74, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.60.2 replaced by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.33, 26.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.60.3 replaced by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50868</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.85, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.60.4 replaced by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50868</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.85, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.60.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.61 CHD mortality, subgroup by main substitution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.61.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4298</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.74, 1.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.61.2 replaced by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.00 [0.33, 26.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.61.3 replaced by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.82, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.61.4 replaced by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.61.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.62 CHD mortality, subgroup by duration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.62.1 up to 24mo</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2113</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.78, 1.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.62.2 &gt;24 to 48months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1239</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.87 [0.64, 1.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.62.3 &gt;48 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49705</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.02 [0.72, 1.45]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.62.4 unclear duration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.63 CHD mortality, subgroup by baseline SFA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.63.1 up to 12%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.63.2 &gt;12% to 15%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.86, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.63.3 &gt;15 to 18%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.63.4 &gt;18%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.55, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.63.5 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.56, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.64 CHD mortality, subgroup by SFA change <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.64.1 up to 4%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51326</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.86, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.64.2 &gt;4 to 8%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.64.3 &gt;8%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.55, 1.21]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.64.4 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.56, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.65 CHD mortality, subgroup by sex <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.65.1 Men</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4222</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.98 [0.79, 1.23]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.65.2 Women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.82, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.65.3 Mixed, men and women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.66 CHD mortality, subgroup by CVD risk <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.66.1 Low CVD risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47404</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.78, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.66.2 Moderate CVD risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.09 [0.01, 1.60]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.66.3 Existing CVD disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5653</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.83, 1.27]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.67 CHD mortality, subgroup by TC reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.67.1 serum chol reduced by at least 0.2mmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4285</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.75, 1.24]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.67.2 serum chol reduced by &lt;0.2mmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48874</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.82, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.67.3 serum chol reduction unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.68 CHD mortality, subgroup decade of publication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53159</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.82, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.68.1 1960s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1731</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.66, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.68.2 1970s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>560</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.03, 9.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.68.3 1980s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.76, 1.30]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.68.4 1990s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.68.5 2000s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.82, 1.20]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.69 CORONARY HEART DISEASE EVENTS <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.68, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.70 CHD events, SA by low summary risk of bias <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49857</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.77, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.71 CHD events, SA excluding WHI <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4364</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.62, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.72 CHD events, SA statistically significant SFA reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52212</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.77, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.73 CHD events, SA by TC reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52984</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.65, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.74 CHD events, SA aim to reduce SFA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>10</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53023</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.67, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.75 CHD events, SA Mantel‐Haenszel fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.84, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.76 CHD events, SA Peto fixed‐effect <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53199</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Peto Odds Ratio (Peto, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.83, 0.99]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.77 CHD events, subgroup by any substitution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.77.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3895</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.57, 1.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.77.2 replaced by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [0.62, 3.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.77.3 replaced by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51104</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.78, 1.11]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.77.4 replaced by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51044</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.88, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.77.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.93 [0.31, 27.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.78 CHD events, subgroup by main substitution <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.78.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3840</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.60, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.78.2 replaced by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.50 [0.62, 3.61]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.78.3 replaced by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49071</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.39, 1.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.78.4 replaced by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.78.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>267</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.93 [0.31, 27.84]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.79 CHD events, subgroup by duration <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.79.1 up to 24 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2380</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.79.2 &gt;24 to 48 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1294</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.79 [0.55, 1.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.79.3 &gt;48 months</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49247</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.63, 1.15]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.79.4 unclear duration</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.60 [0.10, 3.58]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.80 CHD events, subgroup by baseline SFA <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.80.1 up to 12%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.80.2 &gt;12 to 15%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.88, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.80.3 &gt;15 to 18%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.10, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.80.4 &gt;18%E SFA baseline</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.56, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.80.5 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.49, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.81 CHD events, subgroup by SFA change <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.81.1 up to 4%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>51311</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.88, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.81.2 &gt;4 to 8%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>55</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.31 [0.10, 1.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.81.3 &gt;8%E difference</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>846</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.77 [0.56, 1.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.81.4 unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>987</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.49, 1.26]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.82 CHD events, subgroup by sex <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.82.1 Men</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3819</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.70, 1.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.82.2 Women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>48835</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.87, 1.07]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.82.3 Mixed, men and women</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>545</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.18, 4.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.83 CHD events, subgroup by CVD risk <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.83.1 Low CVD risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>47404</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.76, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.83.2 Moderate CVD risk</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>545</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.88 [0.18, 4.36]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.83.3 Existing CVD disease</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5250</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.75, 1.16]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.84 CHD events, subgroup by TC reduction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.84.1 serum chol reduced by at least 0.2mmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4149</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.58, 0.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.84.2 serum chol reduced by &lt;0.2mmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49050</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.88, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.84.3 serum chol reduction unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.85 CHD events, subgroup decade of publication <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>11</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>53201</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.68, 1.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.85.1 1960s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1731</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.68, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.85.2 1970s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>102</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.27 [0.14, 0.52]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.85.3 1980s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2033</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.91 [0.73, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.85.4 1990s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>57</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.10, 1.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.85.5 2000s</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>49278</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.97 [0.88, 1.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2.86 DIABETES DIAGNOSES <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">SFA reduction vs usual diet ‐ secondary health events</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011737-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">SFA reduction vs usual diet ‐ secondary blood outcomes</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.1 Total cholesterol, mmol/L <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>7115</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.24 [‐0.36, ‐0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.2 TC, mmol/L, subgroup by any replacement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3888</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.33 [‐0.47, ‐0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.2 replace by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.93, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5094</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.18 [‐0.32, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.4 replace by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4986</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.15 [‐0.27, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.34 [‐0.64, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.3 TC, mmol/L, subgroup by main replacement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>14</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>8</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3838</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.28 [‐0.37, ‐0.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.2 replace by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>24</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [‐0.93, 1.53]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3181</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.40, 0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.4 replace by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>72</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.34 [‐0.64, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.4 LDL cholesterol, mmol/L <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3291</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.33, ‐0.05]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.5 LDL, mmol/L, subgroup by any replacement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.48 [‐0.90, ‐0.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.2 replace by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.16 [‐0.35, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.4 replace by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2935</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.15, ‐0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.5.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.29 [‐0.51, ‐0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.6 LDL, mmol/L, subgroup by main replacement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6.2 replace by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.16 [‐0.35, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6.4 replace by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.6.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.29 [‐0.51, ‐0.08]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.7 HDL cholesterol, mmol/L <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>5147</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.02, 0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.8 HDL, mmol/L, subgroup by any replacement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.8.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1905</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.04, 0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.8.2 replace by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.8.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4840</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.03, 0.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.8.4 replace by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>4790</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.03, 0.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.8.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.10, 0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.9 HDL, mmol/L, subgroup by main replacement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.9.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>1855</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.04, 0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.9.2 replace by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.9.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.01 [‐0.03, 0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.9.4 replace by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.9.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>307</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.10, 0.12]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.10 Triglycerides, mmol/L <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3845</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.08 [‐0.21, 0.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.11 TG, mmol/L, subgroup by any replacement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.11.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>604</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐0.35, ‐0.02]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.11.2 replace by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.11.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.32, 0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.11.4 replace by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2935</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.01 [‐0.08, 0.09]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.11.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.52, 0.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.12 TG, mmol/L, subgroup by main replacement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>7</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.12.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>554</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.16 [‐0.30, ‐0.01]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.12.2 replace by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.12.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.04 [‐0.32, 0.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.12.4 replace by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.12.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>306</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.52, 0.33]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.13 total cholesterol /HDL ratio <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.33, 0.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.14 TC /HDL ratio, subgroup by any replacement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.14.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.58 [‐1.33, 0.17]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.14.2 replace by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.14.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.33, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.14.4 replace by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2935</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.09 [‐0.21, 0.04]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.14.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.15 TC /HDL ratio, subgroup by main replacement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.15.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.15.2 replace by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.15.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2985</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.10 [‐0.33, 0.13]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.15.4 replace by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.15.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.16 LDL /HDL ratio <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.17 Lp(a), mmol/L <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2882</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.00, 0.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.18 Lp(a), mmol/L, subgroup by any replacement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.18.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐1.37, 1.37]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.18.2 replace by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.18.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2882</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.00, 0.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.18.4 replace by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2832</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.00, 0.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.18.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.19 Lp(a), mmol/L, subgroup by main replacement <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.19.1 replaced by PUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.19.2 replace by MUFA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.19.3 replace by CHO</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2882</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.00, 0.00]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.19.4 replace by protein</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.19.5 replacement unclear</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3.20 Insulin sensitivity <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.20.1 HbA1c (glycosylated haemoglobin), %</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>0</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Not estimable</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.20.2 GTT (glucose tolerance test), glucose at 2 hours, mmol/L</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>249</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.69 [‐2.55, ‐0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.20.3 HOMA</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>2832</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.00 [‐0.04, 0.04]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">SFA reduction vs usual diet ‐ secondary blood outcomes</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD011737-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">SFA reduction vs usual diet ‐ secondary outcomes including potential adverse effects</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.1 Cancer diagnoses <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52294</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.83, 1.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.2 Cancer deaths <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>52283</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.61, 1.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.3 Weight, kg <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43062</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.77 [‐3.54, ‐0.01]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.4 BMI, kg/m2 <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>43894</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.42 [‐0.72, ‐0.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.5 Systolic Blood Pressure, mmHg <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3812</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.19 [‐1.36, 0.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.6 Diastolic Blood Pressure, mmHg <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>3812</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐0.36 [‐1.03, 0.32]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4.7 Quality of Life <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>40130</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.04 [0.01, 0.07]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">SFA reduction vs usual diet ‐ secondary outcomes including potential adverse effects</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD011737.pub3/references#CD011737-tbl-0010">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD011737.pub3&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD011737-note-0011">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD011737-note-0017">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD011737-note-0021">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD011737-note-0016">Français</a> </li> <li class="section-language"> <a class="" href="hr#CD011737-note-0015">Hrvatski</a> </li> <li class="section-language"> <a class="" href="ja#CD011737-note-0020">日本語</a> </li> <li class="section-language"> <a class="" href="ko#CD011737-note-0013">한국어</a> </li> <li class="section-language"> <a class="" href="ms#CD011737-note-0014">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="pl#CD011737-note-0022">Polski</a> </li> <li class="section-language"> <a class="" href="ro#CD011737-note-0023">Română</a> </li> <li class="section-language"> <a class="" href="ru#CD011737-note-0012">Русский</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD011737-note-0018">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD011737-note-0019">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734064000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734064000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772750000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772751000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772894000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739772746000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011737\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011737\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011737\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011737\x2epub3"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011737\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011737\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011737\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011737\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011737\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011737\x2epub3"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011737\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011737\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011737\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011737\x2epub3"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011737\x2epub3\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD011737\x2epub3\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD011737\x2epub3\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD011737\x2epub3"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734064000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=xcg9958b&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011737.pub3&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD011737.pub3';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD011737.pub3/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD011737.pub3/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD011737.pub3%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740715280898"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011737.pub3/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740715280901"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD011737.pub3/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918d83367f71f446',t:'MTc0MDcxNTI4MS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 